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SUMMARY 
Nonsense mediated mRNA decay (NMD) is a translation-coupled process that 
preferentially destroys mRNAs harboring premature translation termination codons 
(PTCs). In mammalian cells, NMD is linked to pre-mRNA splicing. Typically, PTCs 
elicit strong NMD only if positioned upstream of at least one intron. The exon 
junction complex (EJC) is believed to mediate the link between splicing and NMD. 
However, recent studies have questioned the importance of splicing and the EJC in 
NMD and instead they have proposed that, from yeast to mammalian cells, NMD is 
mostly determined by the distance of the PTC from the 3’ end. 
In this study, to investigate the link between pre-mRNA splicing and NMD, I used the 
fission yeast Schizosaccharomyces pombe. Many genes carry introns in fission yeast 
and unlike in Saccharomyces cerevisiae, the genome encodes for proteins 
homologous to EJC components. S. pombe is a powerful model organism which is 
easily genetically manipulated and we envisaged that studying NMD in this organism 
should facilitate the understanding of the molecular mechanism and in particular the 
link between NMD and splicing. 
During my PhD research, I have developed a versatile gene reporter system to study 
NMD; with it I discovered that splicing strongly enhances NMD in fission yeast and, 
surprisingly, that the EJC does not appear to be required. Unexpectedly, I found that 
splicing enhances NMD when the intron is either before or after the PTC, and 
furthermore, it does so only when the intron is close to the PTC. These observations 
suggest that the effect of splicing on NMD is direct and not a secondary consequence 
of splicing enhancing translation. Splicing is not an absolute requirement for NMD; I 
found that PTCs located early in the coding region could induce NMD even in the 
 - III - 
absence of a nearby intron. However, against the prediction of current models, I found 
no strong correlation with the distance of the PTC from the 3’ end.  In summary, 
during my PhD a versatile system has been developed to study NMD in fission yeast 
and what I have observed challenges current NMD models and provides new 
mechanistic insights into NMD.
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ABBREVATIONS AND ANNOTATIONS 
Abbreviations in the thesis 
NMD  Nonsense-mediated mRNA decay 
PTC Premature termination condon 
AS Alternative splicing 
PABPC Poly(A) binding protein, cytoplasm 
NPC Nuclear pore complex 
µORF Small upstream open reading frame 
UPF Up-frameshift 
eRF1/eRF3 Eukaryotic release factor 1 and 3 
eIF3/eIF4AIII/eIF4G Eukaryotic translation initiation factors 
DSE Downstream sequence 
EJC Exon junction complex 
GFP Green fluorescent protein 
UTR Untranslated region 
ivs Intervening sequence/intron 
EST Expressed sequence tag 
SMG Suppressor with morphological effect on genitalia 
CBC Cap binding complex 
CBP Cap binding protein 
BSA Bovine serum abulmin 
HRP Horseradish peroxidase 
SDS Sodium dodecyl sulfate 
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Tris Tris(hydroxymethyl) aminomethane 
EDTA Ethylenediaminetetraacetic acid 
PEG Polyethylene glycol 
FISH Fluorescent in situ hybridization 
DMSO Dimethyl sulfoxide 
HA Hemagglutinin 
 
Abbreviations names are usually given in full when they are first mentioned. This list 
only shows the most frequently used and those for which full names were not given in 
the text. 
 
Annotations of the nomeclature in S. pombe 
I have used a standardised style to refer to genes and proteins names. There are 
significant differences in the nomenclature among mammalian cells, S. cerevisiae, D. 
melanogaster and S. pombe. For example, UPF1 is the gene which encodes the 
protein UPF1; UPF1 is the protein encoded by UPF1; upf1Δ means the UPF1 gene 
was completely removed from the genome of S. pombe; upf1 is a mutation of the gene 
in the genome. However, when the abbreviation refers to a gene or protein of a 
specific organism, that organism spefic nomeclature was used. For example, the D. 
melanogaster alcohol dehydrogenase gene is abbreviated Adh according to the fly 
nomenclature, not ADH. Similarly, if the abbreviation refers to a S. cerevisiae protein, 
it is, for example, Upf1p, not UPF1. 
  3 
 
CHAPTER I. INTRODUCTION 
Gene expression is the process that leads from transctription of DNA into mRNA and 
the translation of mRNA into protein. Although key steps are conserved between 
prokaryotes and eukaryotes, there are essential differences between the two groups of 
organisms. One of the key differences is that eukaryotic cells have a nucleus enclosed 
by a double membrane; this separates transcripion from translation, which occurs in 
the cytoplasm: the mRNA is exported to the cytoplasm through nucleor pore 
complexes (NPC) that span the nuclear membranes. In addition, in eukaryotes the 
primary transcripts (pre-mRNAs) undergo several covalent modifications before 
export of the mature mRNA to the cytoplasm. Nuclear pre-mRNAprocessing typically 
included including 3’-end processing and polyadenylation, 5’-capping and splicing. 
The 5’-cap and poly(A) tail are required stabilize the mRNA and also ply a key 
function in translation initiation and termination. Since pre-mRNA processing and 
translation are occurring in different compartments, it was believed that the should not 
be any link between the nucler history of the mRNA and its cytoplasmic fate. 
However, recent studies have indicated that pre-mRNA splicing can impinge on 
translation, mRNA localization and nonsense mediated mRNA decay (NMD) (Moore 
and Proudfoot et al., 2009).  These findings suggests there are mechanisms that allow 
the ribosome to differentiate between spliced mRNA and transcript that have not 
undergone splicing; as reviewed below the link is probably mediated by proteins that 
are deposited on the transcript during pre-mRNA processing; these remain bound to 
the mRNA during export and then are recognized during translation of or by other 
cytoplasmic processes. 
  4 
 
1.1 Nonsense-mediated mRNA decay and its substrates 
Nonsense mediated mRNA decay (NMD) is a process served as a cellular mRNA 
qualiy control mechanism of gene expression. Here, I give a hystorical perspective of 
the phenomenon and an overiew of what is known, highlighting similarity and 
differences between model organisms. The first indications that NMD is a general 
feature of gene expression came from reports that nonsense mutations cause a rapid 
and drastic mRNA reduction in organism as different as bacteria, yeast and humans 
(Morse and Yanofsky, 1969; Peltz et al., 1993; Maquat, 1995). In eukaryotes, this 
phenomenon is thought to be a post-transcriptional process that probably protects 
cells from the potentially deleterious effect of truncated proteins. NMD has been 
extensively studied in Saccharomyces cerevisiae, Drosophila melanogaster, 
Caenorhabditis elegans, Arabidopsis thaliana and mammalian cells (He et al., 1993; 
Pulak and Anderson, 1993; Maquat, 1995; Brogna, 1999; Le Hir et al., 2001b; 
Gatfield et al., 2003; Amrani et al., 2004; Buhler et al., 2006; Kertesz et al., 2006).  
Nonsense mutations generate premature termination codons (PTCs) and cause 
premature translation termination. Different biological processes can generate PTCs. 
For example, errors during DNA replication can cause point mutations, deletions, and 
insertions, which often generate PTCs. The expectation is that 3 out of 64 nucleotide 
substitutions (~5%) generate stop codons. Small insertions or deletions which cause 
frame-shifts, often also generate downstream PTCs in the coding region. In addition, 
PTCs can be generated by transcriptional errors and by abnormal pre-mRNA 
processing. Mutations that alter splicing signals generate nonsense mutations, 
frequently due to the retention of intronic sequences (Mendell and Dietz, 2001; 
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Holbrook et al., 2004). Abnormally spliced mRNAs are probably the most frequent 
NMD substrates in cells. Computational analysis of the human EST database showed 
that around 64% of human transcripts are alternatively spliced (AS), and about 35% 
of the transcripts generate at least one splice isoform encoding a PTC (Green et al., 
2003; Lewis et al., 2003; McGlincy and Smith, 2008). In S. cerevisiae NMD 
inactivation causes an accumulation of many unspliced mRNAs, thus NMD might 
have an important role in discarding sub-optimally spliced transcripts (He et al., 1993; 
Sayani et al., 2008). On the basis of these findings, it has been proposed that NMD 
might contribute to splicing regulation (Green et al., 2003; Sayani et al., 2008). 
However, this proposal remains controversial because of recent studies that reported 
that only a small portion of the PTC-containing splice variants appears to be 
substantially regulated by NMD, which indicates that NMD might play a limited role 
in the regulation of PTC-containing AS transcripts (Baek and Green, 2005; Blencowe, 
2006; Pan et al., 2006; McGlincy and Smith, 2008). 
Studies in eukaryotes show that NMD substrates are not only PTC-containing 
transcripts. There is evidence that mRNAs containing small upstream open reading 
frames (µORFs) or bicistronic mRNAs are also NMD substrates (Oliveira and 
McCarthy, 1995). Additional NMD substrates are mRNAs with abnormally extended 
3' untranslated region (3’ UTR) (Muhlrad and Parker, 1999), and mRNAs with extra 
out-of-frame AUGs near the correct AUG (Welch and Jacobson, 1999) (table 1.1).  
1.2 Trans acting factors and NMD mechanisms  
NMD is not a passive mechanism and it requires specific trans acting factors. Some 
of these factors were initially identified in genetic screens aimed at the isolation of 
nonsense suppressor mutations. Others were identified in biochemical studies or
  6 
  
Table 1.1 Sources of NMD substrates 
Aberrant mRNA generated by DNA alterations  
Nonsense mutations  Nucleotide substitutions; 5% of all mutations generate 
PTCs (Chang and Kan, 1979) 
Insertions and deletions Random nucleotide insertions or deletions leading to a 
frameshift and PTCs (Culbertson et al., 1980) 
Splice signals mutations Mutations in splicing signals can cause splicing 
inhibition or aberrant splicing, leading to a frameshift 
or to intron-encoded PTCs (Mendell and Dietz, 2001; 
Holbrook et al., 2004) 
Somatic DNA rearrangement During programmed somatic maturation of the 
immunoglobulin and T-cell receptor genes, two thirds 
of the rearrangements generate frame shifts, often 
producing PTCs (Carter et al., 1995; Li and Wilkinson, 
1998; Weischenfeldt et al., 2008) 
Aberrant mRNA generated by transcription or posttranscriptional alterations  
Transcription errors  The transcription errors at low frequency can produce 
PTCs. 
Alternative splicing Alternative splicing often produces frame shifts and 
PTCs (Green et al., 2003; Lewis et al., 2003; Sayani et 
al., 2008) 
Physiological NMD substrates 
Programmed translational 
frameshift 
+1 or -1 frameshift can generate PTCs (Culbertson et 
al., 1980; Lee et al., 1995) 
mRNAs with introns in 3’ UTR Observed in mammalian cells (Mendell et al., 2004)  
Transcribed pseudogenes C. elegans, S. cerevisiae and S. pombe (He et al., 2003; 
Mitrovich and Anderson, 2005; Rodriguez-Gabriel et 
al., 2006) 
Transposons and retroviruses Observed in S. cerevisiae and mammalian cells (He et 
al., 2003; LeBlanc and Beemon, 2004) 
mRNAs with uORFs The termination codon of the uORF is likely to be 
recognized as a PTC (He et al., 2003; Mitrovich and 
Anderson, 2005) 
mRNAs with long 3’ UTRs Observed in yeast, fly, plant and human (He et al., 
2003; Mitrovich and Anderson, 2005; Schwartz et al., 
2006; Kebaara and Atkin, 2009) 
mRNAs encoding selenoproteins UGA is recognized as a PTC at low selenium 
concentrations (Moriarty et al., 1998; Sun and Maquat, 
2002) 
Bicistronic mRNAs Observed in S. cerevisiae (He et al., 2003) 
This table is modified from Muhlemann et al. (2008) 
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cropped up in various genetic screens aimed at studying unrelated processes. These 
proteins (listed in Table 1.2) are described below. 
1.2.1 Genetic identifications of trans acting factors functioning in NMD 
Trans acting factors involved in NMD were first identified in genetic screens in S. 
cerevisiae and C. elegans (Culbertson et al., 1980; Hodgkin et al., 1989). In S. 
cerevisiae, these factors were identified in a screen for suppressors of his4-38 
frameshift mutations, in a genetic background with a tRNA frameshift suppressor 
(Culbertson et al., 1980). The tRNA suppressor caused a low level of translation read- 
through that was sufficient to inhibit the His- phenotype at 30 °C, but not at 37 °C. 
Three mutations that suppress the His- phenotype at 37 °C were isolated and termed 
Up-frameshift (upf), UPF1, UPF2, and UPF3 (Leeds et al., 1992). UPF1 was also hit 
in other screens in budding yeast. For example, in screens for mutations that increase 
by -1 the ribosomal frameshift efficiency, the mutations are named mof (maintenance 
of frame) (Dinman and Wickner, 1994) and ifs (increased frameshifting) (Lee et al., 
1995). UPF2 was also identified between mutations that affect translation initiation, 
named sua (suppressor of upstream ATG) (Hampsey et al., 1991; Pinto et al., 1992). 
As a consequence UPF1 is also named MOF4/IFS2 (Cui et al., 1996), UPF2 (Cui et 
al., 1996) also SUA1/IFS1 (Cui et al., 1996), and UPF3 also SUA6 (Cui et al., 1995). 
Additionally, UPF1 is known as NAM7, since it was also isolated in a screen for 
mutations that suppress mitochondrial intronic mutations defective in RNA splicing 
(Altamura et al., 1992). Interestingly, mutations in other genes - MOF2/ SUI1, MOF5, 
MOF8, and PRT1 - also stabilize PTC-containing mRNAs (Cui et al., 1999; Welch 
and Jacobson, 1999). MOF2/SUI1 encodes for the translation initiation factor eIF1, 
which is essential for cap mediated initiation of translation (Pestova et al., 1998). The 
PTR1 gene encodes for the p90 subunit of eIF3 (eIF3b), which is another essential 
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translation initiation factor (Isken et al., 2008; Martineau et al., 2008). Furthermore, 
one subunit of translation initiation factor eIF3 (eIF3e), named as integration site 6 
protein (INT6) in mammalian cells, was co-immunoprecipitated with CBP80 and 
UPF2; interestingly, INT6 is not, unlike other eIF3 subunits, essential for global 
translation, but depletion of INT6 strongly inhibits NMD in human cells (Morris et al., 
2007). 
In C. elegans, NMD genes were originally isolated in a suppressor screen and 
grouped as smg (suppressor with morphogenetic effect on genitalia) mutations, which 
were classified as allele-specific but not gene-specific informational suppressors 
(Hodgkin et al., 1989; Pulak and Anderson, 1993; Morrison et al., 1997; Cali and 
Anderson, 1998; Cali et al., 1999). Genetic analysis of smg 1-7 mutants and smg-
suppressible alleles suggested that SMG genes functioned in all tissues of C. elegans 
at all times of development and were suggested to be involved in the same mRNA 
process or pathway (Hodgkin et al., 1989; Pulak and Anderson, 1993; Cali et al., 
1999). Among these seven SMG genes, SMG2, SMG3 and SMG4 correspond to 
UPF1, UPF2 and UPF3, respectively in S. cerevisiae. Recently, two additional 
proteins, named SMGL-1 and SMGL-2 have been identified in C. elegans, which are 
required for NMD in both nematodes and human cells (Longman et al., 2007). 
1.2.2 The UPF and SMG proteins 
Upf1p (also known as RENT1 in human) is a RNA binding protein with ATPase 
dependent helicase activity (Czaplinski et al., 1995). In S. cerevisiae and human cells, 
Upf1p associates with the ribosome via the interaction with the eukaryotic translation 
release factors eRF1 and eRF3 during premature translation termination (Weng et al., 
1996a, b; Czaplinski et al., 1998; Weng et al., 1998; Kashima et al., 2006; Ivanov et 
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al., 2008). UPF1 has two separate functional domains: a cysteine-histidine rich (CH) 
domain at the amino terminus and an ATPase/helicase domain at the carboxyl 
terminus. A subset of mutations in the helicase domain inactivates NMD, but the 
protein is still able to enhance translation termination (Weng et al., 1996a). Another 
subset of mutations in the CH domain reduces the ability of UPF1 to enhance 
translation termination at a stop codon (Weng et al., 1996b). Some studies reported 
that certain mutations in UPF1 gene result in a high frequency of ribosomal 
frameshifting and suggest that UPF1 may be directly involved in translation 
termination in addition to mRNA decay (Cui et al., 1996; Cui et al., 1998; Ruiz-
Echevarria et al., 1998b). However, the role of UPF1 in translation termination is still 
controversial. Some other studies in S. cerevisiae indicate that UPF1 is not directly 
involved in translation termination and the nonsense suppression phenotype is 
probably a secondary effect of mRNA stabilization (Bidou et al., 2000; Harger and 
Dinman, 2004).  
A number of observations indicate that UPF1, UPF2 and UPF3 form a complex 
(Weng et al., 1996b; He et al., 1997). Yeast two hybrid studies identified two 
interactions between UPF proteins, UPF1-UPF2 and UPF2-UPF3 (He et al., 1997). 
The interaction between UPF1 and UPF3 is bridged by UPF2. Deletion of UPF2 
completely abolished the UPF1-UPF3 interaction and high expression of the full-
length UPF2 or a fragmented UPF2 keeping the UPF1-UPF3 interaction domain, 
strongly enhanced the association of UPF1-3 in the complex. Surprisingly, mutations 
in the UPF1 domain which interacts with UPF2 do not abolish NMD (He et al., 1996). 
In human cells, UPF2 also interacts with UPF1 and UPF3 (Lykke-Andersen et al., 
2000; Mendell et al., 2000; Serin et al., 2001; Schell et al., 2003; Chamieh et al., 
2008). UPF2 contains three continuous middle domains which resemble eukaryotic 
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initiation factor 4G motifs (MIF4G) (Letunic et al., 2002). MIF4G domains are found 
in several proteins involved in mRNA processing and translation, such as eIF4G and 
CBP80 (Marcotrigiano et al., 2001; Mazza et al., 2001).  
In humans there are two UPF3 homologues, UPF3A and UPF3B (Lykke-Andersen et 
al., 2000).(Lykke-Andersen et al., 2000). Both proteins contain a putative RNA 
recognition motif (RRM) at the amino terminus, which is normally involved in RNA 
binding. Another recent study has reported the structure of the complex between the 
interaction domains of UPF2 (residues 761-1054) and UPF3B (residues 42-143) 
(Kadlec et al., 2004). Against expectations, this.structure revealed that UPF3 
(UPF3B) interacts with UPF2 via the RRM domain (Kadlec et al., 2004). In fact, the 
RRM domain of UPF3 does not bind RNA, instead the third MIF4G domain of UPF2 
binds to RNA in the UPF2/UPF3 complex (Kadlec et al., 2004). Another study 
reported the structure of the CH domain of UPF1 and showed that this domain that 
interacts with UPF2, and has remarkable structural similarities to the RING domain 
found in ubiquitin ligases (Kadlec et al., 2006). A more recent study suggested that in 
the UPF trimetric complex, the association of UPF2 and UPF3B to UPF1, stimulates 
the ATPase and RNA helicase activities of UPF1, activating NMD (Chamieh et al., 
2008). 
Additional data also indicate that these proteins should form a trimetric complex, 
however, the abundance of the proteins in the cell varies greatly. In S. cerevisiae the 
copy number of UPF proteins was measured: 1600, 160 and 80 copies of UPF1, UPF2 
and UPF3 per cell were estimated by Western blot of GST or HA fused Proteins and 
6091, 1280 and 1250 copies per cell using GFP fusions (Maderazo et al., 2000; 
Ghaemmaghami et al., 2003). In mammalian cells, UPF proteins are very abundant, 
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tens of thousands to millions copies per cell, much more than the protein levels in 
budding yeast (Maquat and Serin, 2001; Culbertson and Neeno-Eckwall, 2005). 
However, UPF1 is almost five to ten times more abundant than UPF2 and UPF3. 
Possibly, as suggested by many studies, UPF1 has additional non-NMD roles, 
independent of UPF2 and UPF3, (Kaygun and Marzluff, 2005; Kim et al., 2005; 
Azzalin and Lingner, 2006; Isken et al., 2008). 
A number of studies indicate that UPF1 can be phosphorylated and that regulation of 
the dephosphorylation /phosphorylation state of UPF1 is important for NMD in 
metazoa and human cells (Ohnishi et al., 2003; Grimson et al., 2004; Isken et al., 
2008). SMG1 is a phoshatidylinositol kinase-related kinase that phosphorylates UPF1 
(Yamashita et al., 2001; Grimson et al., 2004). SMG5 and SMG7 are involved in the 
dephosphorylation of UPF1 (Anders et al., 2003; Chiu et al., 2003; Ohnishi et al., 
2003; Fukuhara et al., 2005). The crystal structure of the amino-terminal domain of 
SMG7 revealed a 14-3-3-like domain (also found in SMG5 and SMG6), which 
mainly binds to the protein motifs containing phosphorylated threonine or serine 
(Rittinger et al., 1999; Fukuhara et al., 2005). Mutations in the 14-3-3 domain of 
SMG7 impair its interaction with UPF1 in vitro and recruitment of UPF1 to 
processing bodies (P bodies are cytoplasmic sites which accumulate enzymes 
involved in mRNA turnover and mRNAs storage (Sheth and Parker, 2003, 2006)) 
(Fukuhara et al., 2005). SMG5 and SMG6 contain a PilT N-terminus domain (PIN 
domain) at the carboxyl terminal (Glavan et al., 2006). PIN domains often exhibit 
nuclease activity, and they are found in many proteins, in bacteria and eukaryotes 
(Wall and Kaiser, 1999; Clissold and Ponting, 2000). The crystal structure of the PIN 
domains of SMG5 and SMG6 revealed that both have a similar fold structure but have 
different amino acids in the active sites – SMG5 lacks two key residues, which are 
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believed to be essential for catalysis (Glavan et al., 2006). In agreement with the 
prediction that only the PIN domain of SMG6 has ribonuclease activity, recent studies 
in D. melanogaster and human cells have shown that SMG6 functions as an 
endonuclease via its carboxyl terminal PIN domain, and that NMD is probably started 
by the endonucleolytic cleavage of mRNA in both Drosophila S2 cells and human 
cells (Huntzinger et al., 2008; Eberle et al., 2009). Two additional proteins, SMG-8 
and SMG-9, have also been shown to bind SMG1 (Yamashita et al., 2009). Both of 
them suppress SMG1 kinase activity and are components of the NMD inducing 
complex- a complex containing the NMD factors, SMG1, UPF1, and the release 
factor eRF1 and eRF3 (SURF) (Kashima et al., 2006; Yamashita et al., 2009). SMG-8 
also seems to play an important role in the interaction between the complex and EJC 
(Yamashita et al., 2009).  
There are no apparent SMG1 and SMG5-7 orthologs in S. cerevisiae, therefore it was 
expected that UPF1 should not be phosphorylated in this organism. However, it was 
recently reported that both UPF1 and UPF2 are phosphorylated in budding yeast 
(Wang et al., 2006). Surprisingly, the phosphorylation of UPF2 but not UPF1 plays an 
important role in NMD, probably by modulating the interaction UPF2 with Hrp1p 
(Wang et al., 2006). However, further studies will need to clarify whether the 
phosphorylation and dephosphorylation cycle of UPF1 is important to NMD in 
budding yeast as it is in human cells. 
1.2.3 Translation termination mechanism 
In eukaryotes, translation termination requires two release factors, eRF1 and eRF3. 
eRF1 recognizes all three termination codons in the A site of the stalling ribosomes 
and interacts with eRF3 (the carboxyl terminal domain) to form a complex. This 
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complex then promotes translation termination and releases the polypeptide chain 
from the ribosome; this reaction requires activation of the GTPase function of eRF3 
when the eRF1/3 complex associates with ribosome (Frolova et al., 1994; 
Zhouravleva et al., 1995; Frolova et al., 1996). Through its amino terminal domain, 
eRF3 interacts directly with the carboxyl terminus of cytoplasm poly(A) binding 
protein (PABPC, Pab1p in S. cerevisiae and PABPC1 in human) in both human cells 
and S. cerevisiae (Hoshino et al., 1999; Kozlov et al., 2001; Hosoda et al., 2003). 
PABPC is a multiple functional protein and has been implicated in several processes 
in S. cerevisiae: polyadenylation, mRNA export, stability and translation (Zhao et al., 
1999; Brune et al., 2005). PABPC contains four highly conserved RRM-like domains 
(RBD) at the amino terminus and a helical domain at the carboxyl terminus 
(containing 4 helices in S. cerevisiae but 5 in human), and two domains are connected 
by a unstructured proline-rich linker (Mangus et al., 2003).  
The studies in S. cerevisiae and human cells revealed that UPF1 directly interacts 
with the eRF1/3 complex, suggesting that the association of UPF1 might cause 
aberrant translation termination (Weng et al., 1996a, b; Czaplinski et al., 1998; Weng 
et al., 1998). It is still unknown how UPF1 is recruited to premature termination sites 
and whether UPF1 is also recruited to normal termination sites. A recent study 
reported that efficient translation termination requires interaction between eRF3 and 
PABPC, and that UPF1 can inhibit this interaction (Ivanov et al., 2008). These and 
other observations indicate that translation termination is intrinsically different at PTC 
(see below). 
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1.2.4 PTC recognition and NMD mechanisms 
1.2.4.1 cis-acting elements 
A key question in the NMD field is how premature translation termination is 
distinguished from normal termination. In S. cerevisiae, it was proposed that the 
presence of a downstream sequence element (DSE) distinguishes the NMD-inducing 
PTC from a normal stop codon (Peltz et al., 1993; Zhang et al., 1995). The consensus 
sequence motif for the DSE was proposed to be TGYYGATGYYYYY (Y stands for 
either T or C). Two copies of this DSE motif were identified in the GCN4, PGK1, 
ADE3 and HIS4 genes and were required for strong NMD (Zhang et al., 1995; Ruiz-
Echevarria and Peltz, 1996). It has been proposed that the DSE triggers NMD only if 
located no more than 200 nt downstream of the PTC (Ruiz-Echevarria and Peltz, 
1996; Ruiz-Echevarria et al., 1998a).   
It has been proposed that the DSE recruits some RNA binding proteins involved in 
the PTC recognition. In agreement with this suggestion, it was reported that the 
hnRNP-like RNA binding protein Hrp1p binds the DSE and activates NMD 
(Gonzalez et al., 2000). Purified Hrp1p binds specifically to the RNA substrates 
harboring a DSE and interacts with UPF1. Mutations in the HRP1 gene caused a 5 to 
10 fold stabilization of nonsense containing mRNAs without affecting the stability of 
wide type mRNAs, and one of these mutations abolished both its binding to the DSE 
and the interaction with UPF1 (Gonzalez et al., 2000). As referred above, Hrp1p also 
interacts with phosporylated UPF2 (Wang et al., 2006). These results suggest that the 
DSE is critical for eliciting NMD because it recruits specific RNA binding proteins 
that mediates the recruitment of NMD factors. Hrp1p is also involved in mRNA 3' 
end processing in yeast (Kessler et al., 1997; Gross and Moore, 2001). Contrary to 
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earlier studies, the structure of the Hrp1p-RNA complex revealed that Hrp1p 
recognizes a six base motif, AUAUAU, which is very different from the DSE 
consensus sequence (Perez-Canadillas, 2006).  
1.2.4.2 The faux 3’ UTR model 
Since the very first study of NMD in eukaryotes, it was apparent that not all nonsense 
mutations reduce the mRNA level: NMD is most readily apparent in the case of 5’ 
proximal mutations, but not with mutations located further downstream. In the first 
study of NMD, the authors characterized a number of nonsense mutations in the 
URA3 gene of S. cerevisiae and found that amber mutations (UAG) in the first half of 
URA3 gene caused a drastic reduction of the URA3 mRNA, while downstream 
mutations only slightly affected the URA3 mRNA level (Losson and Lacroute, 1979). 
This polarity phenomenon has been confirmed in the PGK1 and CYC1 genes and the 
general conclusion is that nonsense mutations in the 5’ half cause strong and rapid 
mRNA, whilst mutations in the second half of the gene behave like a normal stop 
codon (Losson and Lacroute, 1979; Peltz et al., 1993; Yun and Sherman, 1995).  
As referred above, the polarity effect was initially explained with the DSE model: the 
more 3’ located is the PTC, the less likely is to find a DSE. However, it was reported 
that mRNAs with extended 3’ UTRs are also NMD substrates in S. cerevisiae and C. 
elegans (Pulak and Anderson, 1993; Muhlrad and Parker, 1999). This discovery 
suggested that the important distinction between normal and premature terminations 
might simply rely on the distance between the stop codon and the 3’ end of mRNA. 
More recent studies indicate that premature translation termination is intrinsically 
aberrant (Amrani et al., 2004). According to this model – the faux 3’ UTR model - 
efficient termination requires an interaction with factors associated with the 3’ UTR. 
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The initial faux 3’ UTR model proposed that inefficient termination is due to lack of 
interaction between the terminating ribosome and PABPC (Pab1p in S. cerevisiae) 
(Amrani et al., 2004). This model is mainly based on the observations that the 
ribosome leaves a very different “toe-print” near PTCs than that left near normal stop 
codons. In addition, the abnormal ribosome toe-print is not detected in the absence of 
UPF1 or if the PTC was flanked by a normal 3’ UTR. The artificial tethering of 
PABPC at a downstream position close to the PTC also strongly inhibited NMD. A 
recent study reported that GFP mRNA, whose 3’ UTR was removed by a self-
cleaving hammerhead ribozyme, was susceptible to NMD only if an artificial poly(A) 
track (75 nt) is added at its 3’ end (Baker and Parker, 2006). This study therefore 
further indicated that the distinction of a PTC from a normal stop codon simply 
depends on the distance from the poly(A) tail. The faux 3’ UTR model thus provides a 
simple explanation for the polarity effect on nonsense mutations in S. cerevisiae (Fig. 
1A).  
In higher organisms, this model could explain the NMD polarity observed in the 
alcohol dehydrogenase (Adh) gene in D. melanogaster, chloramphenicol 
acetyltransferase (Cat) gene in Drosophila S2 cells, and immunoglobulin µ gene (Ig-
µ) in human cells (Brogna, 1999; Gatfield and Izaurralde, 2004; Buhler et al., 2006; 
Behm-Ansmant et al., 2007). In agreement with the faux 3’ UTR model, extension or 
shortening of the distance between PTCs and the poly(A) tail affected NMD in 
several systems (Buhler et al., 2006; Behm-Ansmant et al., 2007; Eberle et al., 2008). 
Moreover, tethering of PABPC at a downstream site close to the PTC suppressed 
NMD; the mRNA lacking the poly(A) tail escapes NMD and depletion of PABPC 
strongly inhibits NMD in Drosophila S2 cells, suggesting that the poly(A) tail and 
PABPC are crucial in NMD (Behm-Ansmant et al., 2007).  
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1.2.4.3 Splicing-dependent NMD - The EJC model in pioneer round translation 
Unlike in S. cerevisiae, in many instances NMD is splicing dependent in mammalian 
cells. Early studies of NMD of the β-glogin mRNA and triosephosphate isomerase 
(TPI) mRNA in human cells indicated that NMD might target nucleus-associated 
mRNAs, and reported that there was no change in the stability of cytoplasmic 
mRNAs with or without nonsense mutations (Baserga and Benz, 1992; Cheng and 
Maquat, 1993). The further studies with human TPI mRNA also reported that nucleus 
associated NMD took place after splicing, (Belgrader et al., 1994; Cheng et al., 1994). 
In another study, using the T-cell receptor beta (TCR-β) reporter genes, it was 
discovered that a PTC triggered NMD only if it was upstream of a functional and 
spliced intron (Carter et al., 1996). Similar observations were reported in the human 
TPI gene: nonsense mutations located less than 50 to 55 nt upstream of 3’-most intron 
were not subjected to NMD (Zhang and Maquat, 1996; Zhang et al., 1998a). It was 
concluded that splicing of the 3’ most intron marks to the exon junction position.  
This hypothesis was substantiated by the discovery that pre-mRNA splicing deposits 
multiple proteins about 20-24 nt upstream of the exon-exon junction site (Le Hir et 
al., 2000a). This set of proteins is the signature of exon exon junctions and forms a 
well-defined complex called the exon junction complex (EJC) (Le Hir et al., 2000b; 
Le Hir et al., 2001b). In vitro assembled EJC contains five components, SRm160, 
DEK, RNPS1, Y14, and REF (Le Hir et al., 2000a). To date, more than a dozen 
proteins has been identified as components of the EJC, including splicing co-
activators and alternative splicing factors (SRm160, RNPS1 and Pinin), the mRNA 
export proteins (UAP56, REF/Aly and NXF1/TAP: p15), mRNA localization factors 
(Y14, Magoh, MLN51 (known as Barentsz, BTZ, in Drosophila) and eIFIII4A) 
(Kataoka et al., 2000; Le Hir et al., 2000a; Lykke-Andersen et al., 2000; Zhou et al., 
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2000; Kataoka et al., 2001; Kim et al., 2001a; Kim et al., 2001b; Le Hir et al., 2001a; 
Le Hir et al., 2001b; Luo et al., 2001; Lykke-Andersen et al., 2001; Chan et al., 2004; 
Degot et al., 2004; Ferraiuolo et al., 2004; Palacios et al., 2004; Shibuya et al., 2004). 
The EJC provides a direct link between splicing and NMD by serving as the anchor 
site for UPF2 and UPF3 (Le Hir et al., 2001b). A conserved domain in UPF3A and 
UPF3B associate with Y14 and RNPS1, and this interaction is essential for NMD: 
NMD was strongly suppressed in the cells where the specific functional domains of 
Y14 and RNPS1 were deleted or where the proteins were depleted by RNAi (Lykke-
Andersen et al., 2001; Gehring et al., 2003; Singh et al., 2007). RNAi depletion of 
MAGO, MLN51 and eIF4AIII in mammalian cells also leads to defects in NMD 
(Ferraiuolo et al., 2004; Palacios et al., 2004; Shibuya et al., 2004). Recently, two 
functionally distinguishable EJC subgroups were defined, RNPS1-type EJC, which 
requires normal level of UPF2 to trigger efficient NMD, and Y14-Magoh-eIF4AIII-
BTZ type, which activates NMD in the cells with a low UPF2 level or in UPF2-
depleted cells (Gehring et al., 2005). All of these reports indicated that the EJC is 
essential for NMD in mammalian cells (Fig. 1B). These recent studies also indicated 
that the association between EJC and UPF1 activates the ATPase-dependent helicase 
activity of UPF1 and induces the formation of the SURF complex (Kashima et al., 
2006; Chamieh et al., 2008). 
Some studies in human cells indicate that NMD occurs while the mRNA is still 
associated with the nuclear cap binding complex (CBC, formed by CBP80 and 
CBP20 - Cbc1p and Cbc2p in S. cerevisiae), but not with eIF4E (cytoplasmic cap  
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Figure 1.1 The faux 3’ UTR and the EJC models of NMD 
(A) Faux 3’ UTR model in S. cerevisiae and D. melanogaster. The ribosome is stalled 
at termination codon. If the termination is far away from the 3’ end, poly(A) tail 
PABPC (Pab1p in yeast) is unable to interact with the terminating ribosome and 
termination is deemed aberrant and triggers a strong mRNA decay (NMD). 
Termination is normal when the stop codon is close to the poly(A) tail because 
PABPC can interact with the terminating ribosome.  
(B) EJC model in mammalian cells. NMD mainly occurs in the pioneer round of 
translation. If the PTC is upstream of an intron, the EJC accelerates the recruitment of 
UPF proteins. The association of UPF proteins causes triggers NMD. The main 
proteins and complexes in NMD are shown: UPF proteins, translation release factor 1 
and 3 (R1 and R3), ribosomes, EJC complex, cap binding complex (CBC), translation 
initiation factor 4G and 4E (4G and 4E), cytoplasmic poly(A) binding protein 
(PABP). 
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binding protein) bound transcripts (Ishigaki et al., 2001). The EJC appears to 
associate with CBP80 bound mRNA but not with eIF4E bound mRNA (Lejeune et al., 
2002). These studies therefore indicate that CBP80 is required for NMD in 
mammalian cells. RNAi depletion of CBP80 stabilizes NMD substrates (Hosoda et al., 
2005). In the same study, there is also evidence that CBP80 directly associates with 
UPF1, and as I referred above, that UPF1 is activated by an association with the EJC. 
1.2.5 Problems with current NMD models 
EJC model is not generally applicable in mammalian cells  
Many studies in mammalian cells support the EJC model of PTC recognition, but 
several observations contradict its predictions. Firstly, there is a report that PTCs 
located less than 50 nt from the last exon-exon junction can also cause strong NMD in 
TCR-β mRNA (Wang et al., 2002a). In addition, there is a report that strong NMD 
can also occur without downstream introns in the β-globin mRNA, but instead needs 
an upstream intron (Neu-Yilik et al., 2001; Matsuda et al., 2007). NMD without the 
requirement for a downstream intron has also been observed in the immunoglobulin-µ 
(Ig-µ) mini-gene system (Buhler et al., 2006). All of these observations suggest that 
there is also an EJC-independent NMD mechanism in mammalian cells. In addition, 
the finding that NMD does not require introns or EJC proteins in Drosophila S2 cells 
or C. elegans questioned the applicability of the EJC model in other organisms. As 
mentioned above (1.2.4.2), the faux 3’ UTR model explains NMD better than the EJC 
model in S2 cells. Furthermore, a number of recent studies have questioned the 
importance of downstream introns and the EJC in NMD in mammalian systems which 
were previously believed to require a downstream intron (Buhler et al., 2006; Eberle 
et al., 2008; Singh et al., 2008). These studies have shown that shortening or 
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lengthening of the distance between the PTC and the 3’ UTR respectively suppressed 
or enhanced NMD (Buhler et al., 2006; Eberle et al., 2008; Singh et al., 2008). It was 
also shown that extending the distance between the normal stop codon and the 3’ end 
caused an mRNA reduction that required the presence of UPF proteins, suggesting 
that the normal stop codon behaved like a PTC when placed further away from the 3’ 
end (Singh et al., 2008). NMD could be also suppressed by folding the poly(A) tail 
back to the vicinity of the PTC, or tethering PABPC1 near to the PTC (Eberle et al., 
2008). In summary, the emerging view is that the faux 3’ UTR model might explain 
NMD better than the EJC model even in mammalian cells (Fig. 2). 
 
Inconsistencies of the faux 3’ UTR model  
As mentioned above, many recent studies proposed that the faux 3’ UTR model 
explains NMD better than the EJC model. However, I will argue below that not all 
available data are consistent with the faux 3’ UTR model. The faux 3’ UTR model 
provides a good explanation for the ‘polarity effect’. However, the polarity effect is 
not gradual or linear with the distance from a PTC to the 3’ end in S. cerevisiae, D. 
melanogaster and mammalian cells (Yun and Sherman, 1995; Behm-Ansmant et al., 
2007; Eberle et al., 2008). In addition, the polarity effect is not typical in mammalian 
NMD: most of PTCs at reasonable positions cause mRNA reduction to a similar 
degree.  
The faux 3’ UTR model also does not take into account that mRNA is probably 
translated in closed-loop conformation (Tarun et al., 1997; Wells et al., 1998). In a 
circular mRNP, the 3’UTR is in fact close to both ends of the mRNA; therefore 5’ 
proximal NMD-inducing PTCs may be as close to the 3’ UTR as NMD-insensitive 
PTCs in the 3’ half of the coding region. Several observations support the view that 
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the mRNA is kept in a circular conformation during translation. The conformation is 
stabilized by the interaction between the 5’ end and the 3’ end, which is mediated by 
translation initiation factor eIF4E, eIF4G and PABP (Tarun and Sachs, 1996; Wells et 
al., 1998; Sachs and Varani, 2000; Amrani et al., 2008). This interaction between 
eIF4G and PABP is evolutionary conserved and the double rows structure of the 
ribosome resembling closed hairpins has been observed by electron microscopy 
(Christensen et al., 1987; Le et al., 1997; Imataka et al., 1998; Christensen and 
Bourne, 1999). The observation that in the human β-globin transcript, PTCs at codon 
5 and 17 do not trigger strong NMD whereas PTCs at codon 26 and 39 do, was taken 
as a validation of the faux 3’ UTR model prediction that 5’ proximal PTCs should not 
induce NMD (Romao et al., 2000). A similar phenomenon was also observed when 
the PTC was located at codon 32 in the β-globin mRNA (Eberle et al., 2008). 
However, we have previously argued that PTCs very close to the AUG do not induce 
NMD because translation is likely to reinitiate downstream of the PTC (Brogna and 
Wen, 2009). In addition, there are many examples of PTCs very close to the AUG 
which induce strong NMD; for example, PTCs at codon position 6 or 7 in S. 
cerevisiae (GFP reporter and CYC1 mRNA) and codon 23 in human TPI mRNA still 
cause strong NMD (Belgrader et al., 1994; Yun and Sherman, 1995; Kuperwasser et 
al., 2004).   
In support of the faux 3’ UTR model, many studies have reported that the tethering of 
PABP nearby the PTC suppresses NMD (Amrani et al., 2004; Behm-Ansmant et al., 
2007; Eberle et al., 2008; Singh et al., 2008). However, we have argued that the 
tethering of PABPC might stabilize the NMD substrates simply because it prevents 
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Figure 1.2 The unified 3’ UTR model for NMD. 
NMD is mainly determined by the flanking 3 UTR. PABP plays an antagonistic role 
in NMD. NMD is elicited if the PTC is far way from the poly(A) tail. When 
termination occurs near the poly(A) tail, PABP prevents the recruitment of UPF1, 
preventing NMD. The presence of a downstream intron deposits an EJC which can 
further stimulate the recruitment of UPF proteins and NMD.  
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standard mRNA decay rather than inhibits the NMD processes (Brogna and Wen, 
2009). The faux 3’ UTR model predicts a key role of PABPC in NMD. However, 
contrary to this prediction, it was reported that NMD is not affected by deletion of 
PABPC’s carboxyl terminal region -which is thought to mediate the interaction with 
terminating ribosomes to trigger the deadenylation of mRNAs (Simon and Seraphin, 
2007). The faux 3’ UTR model was further questioned by a recent study in S. 
cerevisiae (Meaux et al., 2008). This study reported that PTCs elicit strong NMD 
even in poly(A)-less transcripts with ribozyme-generated 3’ ends, or in the cells with 
the deletion of pab1, the gene encoding PABPC in S. cerevisiae . This study 
suggested that neither the poly(A) tail nor PABPC is essential for NMD in S. 
cerevisiae.  
In Arabidopsis thaliana both intron and intronless genes are subjected to NMD 
(Kertesz et al., 2006). In this study, it was reported that either the insertion of long 
DNA fragments in the 3’ UTR or introducing an intron into the 3’ UTR both trigger 
strong NMD. 
1.3 Cellular mRNA decay pathways and NMD 
There are many observations indicating that once it has been recognized as an NMD 
substrate, the mRNA is degraded by the canonical mRNA decay pathway that 
destroys “normal” mRNAs (He and Jacobson, 2001; Chen and Shyu, 2003; Lejeune et 
al., 2003; Sheth and Parker, 2003). Here, I present a brief review of mRNA decay in 
eukaryotes and the fate of NMD substrates following PTC recognition.  
Eukaryotic mRNAs have two internal stability elements, the 7–methylguanosine cap 
at the 5’ end and poly(A) tail at the 3’ end. Deadenylation typically precedes the 
breakdown of the mRNA. In S. cerevisiae deadenylation is catalyzed by 
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Protein Localization (human) Characteristics/Functions 
Homolog 
in S. c 
UPF1 
Shuttle protein; 
mainly in 
cytoplasm 
ATPase, ATP dependent helicase; SMD; 
Histone mRNA decay; telomere 
maintenance; DNA repair (Weng et al., 
1996a) 
Upf1p 
UPF2 
Shuttle; 
perinuclear and 
cytoplasm 
Telomere maintenance (Dahlseid et al., 
2003; Azzalin et al., 2007;) Upf2p 
UPF3A Shuttle; mainly in nucleus Weak NMD (Kunz et al., 2006) Upf3p 
UPF3B Shuttle; mainly in nucleus 
EJC component (Le Hir et al., 2001b; 
Gehring et al., 2003) Upf3p 
SMG1 Cytoplasm 
PPI 3-kinase; maintenance of genome 
stability, stress response and DNA repair 
(Yamashita et al., 2001; Brumbaugh et al., 
2004) 
No 
SMG5 Shuttle; mainly in cytoplasm 
PP2A interaction and dephosphorylation of 
UPF1 (Chiu et al., 2003) No 
SMG6 Shuttle; mainly in cytoplasm 
Endonuclease; endonucleolytic cleavage 
(Huntzinger et al., 2008; Eberle et al., 2009) No 
SMG7 Shuttle; mainly in cytoplasm 
PP2A interaction and dephosphorylation of 
UPF1 (Chiu et al., 2003) Est1p * 
NAG 
(SMGL-1) Unclear 
Function currently unclear (Longman et al., 
2007) No 
DHX34 
(SMGL-2) Unclear 
DEAD box protein 34, helicase (Longman et 
al., 2007) No 
SMG8 Unclear Subunit of SMG1 complex (Yamashita et al., 2009) No 
SMG9 Unclear Subunit of SMG1 complex (Yamashita et al., 2009) No 
eIF4AIII Shuttle; mainly in nucleus 
EJC scaffold protein (Palacios et al., 2004; 
Gehring et al., 2005) Fal1p 
MAGO Shuttle; mainly in nucleus 
EJC core component, MAGO/Y14 
heterodimer (Le Hir et al., 2001a; Gehring et 
al., 2005) 
No 
Y14 Shuttle; mainly in nucleus 
EJC core component, MAGO/Y14 
heterodimer (Le Hir et al., 2001a; Gehring et 
al., 2005) 
No 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 1.2 Proteins involved in human NMD and the homologs in S. cerevisiae 
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MLN51 Shuttle; mainly in cytoplasm 
EJC core component  (Palacios et al., 2004; 
Gehring et al., 2005) No 
RNPS1 Shuttle; mainly in nucleus 
EJC component; splicing coactivator (Le Hir 
et al., 2000a; Lykke-Andersen et al., 2001; 
Gehring et al., 2005) 
No 
PYM Shuttle; mainly in cytoplasm 
EJC component; interacts with MAGO/Y14 
(Bono et al., 2004) No 
eIF3b Mainly in cytoplasm 
Subunit of translation initiation factor 3 
(Welch and Jacobson, 1999; Martineau et 
al., 2008) 
Prt1p 
INT6 Mainly in nucleus 
Subunit of translation initiation factor 3 
(Morris et al., 2007) No 
PNRC2 Cytoplasm 
Energy balance control; estrogen synthesis; 
UPF1 binding; DCP1 binding (Cho et al., 
2009) 
No 
* Contradictory reports of its function in NMD 
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Figure 1.3 The inter-connection between NMD factors and other proteins involved in global mRNA decay. 
(A and B) Protein interaction network in S. cerevisiae and human cells. The specific proteins which are involved in NMD in S. cerevisiae and 
human are shown in purple (Hrp1p and PP2A) and green (SMG proteins and EJC components), which are summarized in Table 1.2. The 
proteins involved in normal mRNA decay process are shown in turquoise and described in Section 1.3. The EJC and P body are indicated by the 
ovals with dash lines. The drawing is according to Figure 5 in Conti and Izaurralde, (2005).
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PAN2-PAN3, a PABP-dependent poly(A) nuclease, which trims the mRNA’s poly 
(A) tail to about 60-80 nt length, and then CCR4-NOT, the main deadenylase, shorten 
the poly(A) tail further to 10-12 bases (Brown and Sachs, 1998; Funakoshi et al., 
2007). In higher eukaryotes, such as X. laevis and mammalian cells, PARN (poly(A) 
ribonuclease) is the main poly(A) nuclease of 5’ capped mRNA (Garneau et al., 
2007). Following the shortening of the poly(A) tail, mRNAs are attacked by the 
cytoplasmic exosome, a 3’-5’ exonucleolytic complex composed of 10-12 subunits 
and associated with the Ski complex (consist of Ski2, Ski3, Ski7 and Ski8) (Garneau 
et al., 2007; Ibrahim et al., 2008; Schmid and Jensen, 2008). At the same time, the 5’ 
ends are decapped by Dcp1 and Dcp2 enzymes. Decapped mRNAs are subjected to 
5’-3’ degradation by the exoribonuclease XRN1 (Anderson and Parker, 1998; Decker 
and Parker, 2002; Lejeune et al., 2003; Mangus et al., 2003). The rapid decapping of 
PTC-containing mRNAs is probably mediated by the interaction of UPF1 with 
Dcp1:Dcp2 (Lykke-Andersen, 2002; Wagner and Lykke-Andersen, 2002). Staufen 
mediated mRNA decay (SMD) and stem loop mediated histone mRNA decay might 
cause rapid decay also as a consequence of recruiting UPF1 (Kaygun and Marzluff, 
2005; Kim et al., 2005). The importance of decapping in NMD was further 
emphasized by the recent report that human proline-rich nuclear receptor coregulatory 
protein 2 (PNRC2) enhances NMD by stimulating the recruitment of DCP enzymes to 
UPF1 and the NMD machinery (Cho et al., 2009).  
As mentioned above, it has been reported that mRNA substrates are degraded by the 
standard 5’-3’ and 3’-5’ enzymes that destroy the bulk of mRNA. In S. cerevisiae, 
XRN1 was believed as the main exonuclease involved in NMD (He and Jacobson, 
2001; He et al., 2003). However, more recent studies have reported that in D. 
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Figure 1.4 Global mRNA decay in S. cerevisiae.    
The mRNA is initially deadenylated by PAN2-PAN3 during translation, and then is 
either further deadenylated to an oligo tail by CCR4 –NOT and degraded by the 
exosome, or decapped by Dcp1 and Dcp2 and degraded from 5’ to 3’ by XRN1.  
 
 PAN2-PAN3 
AUG Stop codon 
AAAAAAA m7GpppN 
> 70-90 nt 
60-80 nt 
AUG Stop codon 
AAAAA m7GpppN 
Dcp1p and Dcp2p 
AUG Stop codon 
AAAAA 
 
 
 
 CCR4-NOT 
AUG Stop codon
m7GpppN AA 
  XRN1 exosome 
5’-3’ mRNA decay 3’-5’ mRNA decay 
Translation phase 
Degradation 
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Figure 1.5 Aberrant mRNA decay and endonucleolytic cleavage 
Two different mRNA decay processes degrade aberrantly translated mRNAs. In one 
pathway (left diagram), the mRNA is rapidly decapped and deadenylated, and then 
degraded by exonucleases from both ends. In the other pathway (right diagram), the 
degradation is initiated by the endonucleolytic cleavage followed by 5’ to 3’ and 3’ to 
5’ decay of the two RNA fragments. 
AUG PTC
AAAAA m7GpppN 
 
 
5’-3’ and 3’-5’ mRNA decay  
UPF1-Dcp; 
 UPF2-exosome  
Endonucleolytic 
cleavage   
AUG Stop codon 
AAAAA m7GpppN 
+ 
(D. melanogaster and 
human cell)
(S.cerevisiae) 
5’-3’ and 3’-5’ mRNA decay 
of the two fragments 
Stem loop
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melanogaster and human cells, NMD substrates appear to be degraded by an 
alternative pathway, involving an endonucleolytic cleavage (Gatfield and Izaurralde, 
2004; Behm-Ansmant et al., 2007; Huntzinger et al., 2008; Eberle et al., 2009). This 
endonucleolytic cleavage occurs at the multiple sites near the PTC, surprisingly both 
before and after the stop codon. In both D. melanogaster and human cells, this 
cleavage depends on a functional SMG6 protein (Huntzinger et al., 2008; Eberle et 
al., 2009). Evidence of the involvement of the endonucleolytic cleavage was reported 
also in the no-go mRNA decay (NGD) in S. cerevisiae: a stem loop that prevents 
translation elongation, also triggers mRNA decay (Doma and Parker, 2006). These 
observations suggest a general link between the ribosome stalling and endonucleolytic 
cleavage. In summary, NMD substrates are likely to be degraded by a number of 
pathways, requiring both endonucleases and exonucleases. 
1.4 Does NMD occur in the nucleus? 
1.4.1 Nucleus associated NMD in human cells 
In an early study of NMD in mammalian cells it was observed that the β-globin 
mRNA was drastically reduced in beta-thalassemias caused by nonsense mutations 
(Chang and Kan, 1979). Surprisingly, it was also observed that mRNA level was also 
reduced in the nuclear fraction (Chang and Kan, 1979). This finding led to the 
speculation that NMD may be occurring while the mRNA is still associated with the 
nucleus. The reduction of the nuclear-associated mRNAs has been observed in 
transcripts coding for beta-globin (Baserga and Benz, 1992), dihydrofolate reductase 
(Urlaub et al., 1989) and triosephosphate isomerase (Belgrader et al., 1994; Cheng et 
al., 1994; Zhang and Maquat, 1996). It appears that the level of nucleus-associated 
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mRNA was always reduced to almost the same amount as the cytoplasmic mRNA 
with premature terminal codon (PTC) in human cells (Maquat, 1995). Furthermore, 
several studies reported that there is no obvious difference in stability between mRNA 
carrying PTCs and the corresponding wild-type mRNA, in spite of the low steady-
state level of the PTC-containing mRNAs (Baserga and Benz, 1992; Cheng and 
Maquat, 1993). These observations were the first suggestion that PTC-containing 
transcripts are degraded in the pioneer round translation while they are still associated 
with the nucleus(Maquat, 1995; Hentze and Kulozik, 1999). It was also proposed that 
mRNA escaping this first round of translation escape NMD as well. Nucleus 
associated NMD in mammalian cells presents a paradox, because it is believed that 
only cytoplasmic ribosomes recognize and scan the open reading frames.  
1.4.2 Can PTCs be recognized in the nucleus? 
Studies in immunoglobulin genes indicated that PTCs could inhibit splicing of the 
upstream intron in vivo and in nuclear extracts (Lozano et al., 1994; Aoufouchi et al., 
1996). Meanwhile, studies of the fibrillin (FBN1) RNA and the RNAs of parvovirus 
minute virus of mice suggested that the selection of splice sites could be influenced 
by the translating reading frames because nonsense mutations led to exon skipping 
but missense mutations did not (Dietz et al., 1993; Dietz and Kendzior, 1994; 
Gersappe and Pintel, 1999). However, the recent studies proposed a more reasonable 
explanation: that the typical pre-mRNA contains exonic splicing enhancers (ESE) and 
the effect of nonsense mutations in exon skipping may simply cause the dysfunctional 
ESEs in splice sites choice (Valentine, 1998; Cartegni and Krainer, 2002). Indeed, a 
recent study using FBN1 RNA indicated that nonsense mutations activate exon 
skipping by the disruption of an ESE, rather than a frame-dependent nuclear scanning 
mechanism (Caputi et al., 2002).  
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Nevertheless, additional studies suggest that PTCs can affect pre-mRNA splicing in 
the nucleus (Muhlemann et al., 2001; Li et al., 2002; Wang et al., 2002b). 
Furthermore, it was discovered that nonsense mutations also negatively affect pre-
mRNA 3' end processing and lead to longer poly (A) tails in both mature mRNA and 
the unspliced pre-mRNA (Brogna, 1999). Therefore, there are still data that suggest 
the existence of an ORF scanning mechanism in nucleus.  
This view is supported by several studies that have reported that transcription and 
translation are coupled in Drosophila and mammalian cells (Iborra et al., 2001; 
Brogna et al., 2002). In addition, it was reported that blocking mRNA export does not 
inhibit NMD of TCR-β in human cell (Buhler et al., 2002).  
Other studies, however, have reached opposite conclusions. One study reported that 
the domain-negative polypeptides of UPF proteins inhibited NMD only when they 
were overexpressed in the cytoplasm, but not when they were retained in the nucleus 
by introducing a nuclear localization signal (NLS) (Singh et al., 2007). This later 
discovery is in agreement with the discovery that block of mRNA export prevents 
NMD in S. cerevisiae (Kuperwasser et al., 2004).  
Therefore, there are many inconsistencies in the available data. My view is that only 
additional studies can resolve the issue of whether there is mechanism that scans the 
ORF in the nucleus.  
1.5 Different phenotypes of NMD mutants in eukaryotes 
Deletion of all three upf genes in S. cerevisiae does not have any obvious phenotype 
(He et al., 1997). However, mutations in NMD factors cause obvious phenotypes in A. 
thaliana, nematodes, fly, zebra fish and mice. In A. thaliana, mutations of upf1 result 
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in longer and heavier seeds (Yoine et al., 2006). Moreover, in this study it was found 
that knocking out upf1 causes seedling lethality. In C. elegans, mutant alleles of 
smg1-6 are viable but have morphogenetic defects of genitalia and one double mutant 
(smg1;smg3) grows distinctly slower than either of  the parental mutants (Hodgkin et 
al., 1989). In D. melanogaster, mutations in upf1 and upf2 cause lethality during 
larval development (Metzstein and Krasnow, 2006). Interestingly, mutations in NMD 
factors also enhance the expression of transgenes with no obvious NMD features – 
this mutations were named ‘photoshop’ because they were isolated for their ability to 
enhance the expression of GFP transgenes (Metzstein and Krasnow, 2006). In mice 
Rent1 (UPF1) is essential in embryonic viability (Medghalchi et al., 2001). In a very 
recent study in zebrafish, it was shown that mutations or deletions of upf1, upf2, 
smg1, smg5 or smg7 have a severe impact on embryonic development, early 
patterning and viability (Wittkopp et al., 2009).  
However, it is not yet clear whether it is the lack of NMD that causes these 
phenotypes, or whether instead these proteins have some other important functions 
outside NMD. Some studies indicated that NMD controls the telomere length and 
telomeric silencing in budding yeast, probably by regulating the mRNA level of 
telomere-related genes (Lew et al., 1998; Dahlseid et al., 2003; Enomoto et al., 2004). 
Some NMD factors, such as SMG1, UPF1, UPF2 and SMG6 also seem to be involved 
in telomere maintenance in mammalian cells (Reichenbach et al., 2003; Azzalin et al., 
2007). Furthermore, SMG1 and UPF1 are involved in genome stability and cell cycle 
regulation (S phase arrest) (Brumbaugh et al., 2004; Kaygun and Marzluff, 2005; 
Azzalin and Lingner, 2006).  
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1.6 NMD in S. pombe  
NMD in S. pombe has not been substantially investigated before this study. Two 
previous studies had shown that UPF1 and UPF2 are required for NMD also in S. 
pombe but did not investigate the key issue of how PTCs are recognized (Mendell et 
al., 2000; Rodriguez-Gabriel et al., 2006). One of these studies reported that early 
PTCs trigger stronger NMD than a PTC located later in the ADE6 coding region. In a 
microarray study aimed at the identification of mRNAs controlled by UPF1 in S. 
pombe, the authors revealed that there are only 27 genes (about 0.6% in the whole 
genome) whose mRNA levels were upregulated more than 2 fold in a upf1Δ mutant 
(Rodriguez-Gabriel et al., 2006). Surprisingly, UPF1 appears to affect the expression 
of very few genes in comparison to S. cerevisiae, where more than 580 genes (about 
12% of the whole genome) are upregulated at least 2 fold in upf1Δ (He et al., 2003). 
Among these NMD substrates in S. pombe, the authors found that half of the genes 
contain at least one out of frame AUG within the 80 nt upstream of the annotated 
initiation codon. The reason that the proportions of NMD substrates are so different 
between two yeasts S. cerevisiae and S. pombe is still unclear. Possibly, the study in 
S. pombe using cDNA microarray does not show the complete category of NMD 
sensitive mRNAs or ‘junk’ RNAs due to the deficiency of pre-mRNA detections by 
cDNA microarray. The new microarray investigation with the information of intron 
sequences would be great helpful to further clarify the native NMD substrates in S. 
pombe. In this study it was discovered that both UPF1 and UPF2 deletion leads to 
increased sensitivity to oxidative stress (Rodriguez-Gabriel et al., 2006). 
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CHAPTER II MATERIALS AND METHODS 
2.1 A note on solutions and buffers 
Solutions were prepared from analytical grade reagents supplied by Sigma-Aldrich, 
VWR or Fluka. All of the solutions and buffers were made in deionised water (Elix 5, 
Millipore) and sterilized by either autoclaving or filtration (0.22 µm, Millipore). All 
of the solutions used in RNA experiments were prepared in sterilized glassware and 
treated overnight with 0.1% (v/v) diethyl pyrocarbonate (DEPC), left overnight in a 
laminar flow hood and then autoclaved. Tris buffer solutions were not DEPC treated, 
but were prepared with DEPC treated water.  
2.2 DNA cloning in Escherichia coli 
Most standard protocols were as described in Molecular Cloning 2nd edition 
(Sambrook et al., 1989). 
2.2.1 E. coli strains  
DH5α  
Φ80 lacZΔM15 Δ(lacZYA -argF) U169 recA1 endA1 hsdR17 (rk-, mk+) phoA supE44 
λ– thi-1 gyrA96 relA1 
XL1 blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacIqZΔM15 Tn10 
(Tetr)] 
2.2.2 Bacterial growth media 
LB broth and LB agar recipes are shown in Appendix I. 
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2.2.3 Growth of bacteria cultures 
E.coli transformants were routinely grown overnight at 37 °C. For liquid culture, the 
flasks were kept in a shaking incubator at 220 rpm. Otherwise, E. coli were grown on 
inverted 9-cm LB agar plates.  
2.2.4 Ligation and E. coli transformation 
Ligation of DNA fragments was typically performed in a 20 µL reaction containing 
100 ng of linearized plasmid and a four fold molar excess of the insert DNA, typically 
with 10 units of T4 DNA ligase (New England Biolabs, NEB). The ligation reaction 
was kept at 18 °C overnight or at room temperature for 2 hours. 100 µL of E. coli 
competent cells were typically transformed with 5 µL of ligation mixture as follow. 
Ligation mixture was mixed with competent cells and kept on ice for 20 minutes; the 
cells were then heat shocked at 42 °C for 45 seconds and cooled on ice for 2 minutes; 
the competent cells were mixed with 0.5 mL of SOC media and incubated at 37 °C 
for 1 hour, with gentle shaking. The cells were briefly centrifuged and spread on an 
LB plate containing 100 µg/mL ampincillin. 
The competent cells were typically made by the Rubidium method: DH5α or XL1 
blue were grown in 100 mL LB with 10 mM MgCl2 and 10 mM MgSO4 at 37 °C until 
the cell density was about to 0.5 at OD650; the cells were then harvested at 5000 rpm 
for 15 minutes at 4 °C, resuspended in 30 mL filter sterilized Rb buffer 1(100 mM 
RbCl, 50 mM MnCl2⋅4H2O, 80 mM KAc, 10 mM CaCl2⋅2H2O, 15% glycerol and 
adjusting pH to 5.8 with 0.2 M acetic acid), and incubated on ice for 1 hour; the cells 
were then pelleted and resuspended in 8 mL filter sterilized Rb buffer 2 (10 mM 
RbCl, 10 mM MOPS, 75 nM CaCl2⋅2H2O, 15% glycerol and adjusting pH to 6.8 by 
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NaOH); the competent cells were aliquoted with 200 µL per tube, and kept at -80 °C 
for future use. 
2.2.5 Small-scale preparation of plasmids 
A single colony was inoculated into 5 mL of LB broth containing 100 µg/mL 
ampicillin and grown overnight. Plasmid DNA was typically purified from a 1 mL 
aliquot of this culture using the following boiling-prep method:  
1. 1 ml of the cell culture was transferred into a fresh 1.5 mL tube and spun 
briefly at 13000 rpm and the supernatant discarded. 
2. 110 µL of ice cold STET buffer (8% sucrose, 50 mM Tris pH 8.0, 50 mM 
EDTA pH 8.0, 5% Triton X-100) containing 5 µL of 20 mg/mL lyzozyme was 
added into each sample and the pellet was then completely resuspended by 
pipetting up and down. 
3. The samples were placed in boiling water for 20 seconds and then centrifuged 
at 13000 rpm for 10 minutes. The pellets were removed by using sterile 
toothpicks. 
4. 110 µL of isopropanol was added to the supernatant, mixed and centrifuged at 
13000 rpm for 15 minutes. 
5. The supernatant was discarded. The pellet was washed with 70% ethanol, air-
dried and resuspended in 40 µL TE (10 mM Tris⋅Cl, pH 8.0, 1 mM EDTA, pH 
8.0) containing 1 µL of 1 mg/mL RNase A stock. The DNA samples were 
incubated at 65 °C for 20 minutes to remove the RNA and stored at -20 °C if 
required for future use.  
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When needed the extra 4 mL of cell culture was used to prepare pure plasmids preps 
for sequencing and yeast transformations (typically using Fermentas GeneJET 
plasmid Miniprep kit).  
2.2.6 Large-scale preparation of plasmid DNA 
Typically a single colony was inoculated into 1 mL of LB broth containing 100 
µg/mL ampincillin and grown overnight, then 200 µL of the overnight culture was 
incubated into 100 mL of LB broth containing 100 µg/mL ampincillin for 4-5 hours 
until OD650 0.8-1.0. Plasmid DNA was then prepared from the culture by using 
commercial kits (typically QIAfilter Plasmid Midi Kit, Qiagen). The extracted 
plasmid DNA was resuspended in 500 µL TE, pH 8.0, and the concentration of 
plasmid DNA was measured with a spectrometer (ND-1000, NanoDrop).  
2.2.7 Restriction enzyme digestion 
Restriction enzyme digestions were carried out in a 10-50 µL reaction All restriction 
enzymes used in the study were obtained from New England Biolabs (NEB). The 
conditions of the single-enzyme or double-enzyme digestion were followed according 
to the NEB enzyme instructions. For a sequential digestion, the initial reaction 
contained the enzyme that is active in the buffer with the lowest salt concentration. 
After the reaction had proceeded for 2 hours, the second enzyme and the buffer with 
the higher salt concentration were added and the reaction continued to proceed for 
further 1 hour.  
2.2.8 Dephosphorylation of DNA 
Antarctic phosphatase (NEB) was used to remove the 5’ terminal phosphates of the 
DNA. This procedure was generally applied to prevent self-ligation of digested 
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plasmid DNA. Following the restriction enzyme digestion, 1 µL of antarctic 
phosphatase (5 units/µL) was added into the reaction and incubated at 37 °C for 1 
hour. The DNA samples was then inactivated at 65 °C for 15 minutes or purified by 
gel electrophoresis and gel extraction using a silica powder based technique (see 
below).  
2.2.9 DNA Purification  
In my study, two methods were used to perform DNA purifications following PCR 
and restriction digestion. One is the polyethylene glycol (PEG) method, and the other 
is gel extraction. 
2.2.9.1 PEG purification 
1. An equal volume of the PEG solution (13% PEG8000 (w/v), 0.6 M NaAc, and 
6mM MgCl2⋅6H2O) was added to each DNA sample, mixed by vigorous 
vortexing, and kept at room temperature for 20 minutes. If the DNA fragment 
size was less than 300 bp, three volumes of the PEG solution were used 
instead. 
2. The sample was centrifuged at 13000 rpm for 20 minutes and the supernatant 
was completely removed by a Pasteur pipette without touching the pellet. 
3. The DNA pellet was washed by 1 mL 96% ethanol and centrifuged at 13000 
rpm for 3 minutes, and then washed again by 70% ethanol. 
4. The pellet was air-dried and dissolved in 20-30 µL TE buffer. 
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2.2.9.2 Gel purification 
The DNA fragment was sliced-out of the gel and placed into a 1.5 mL eppendorf tube. 
The DNA was then purified by silica powder as described in the manufacturer’s 
instructions (Silica Bead DNA Gel Extraction Kit, Fermentas).  
2.2.10 Standard PCR  
All primers used in my study are shown in Appendix II. The primers were purchased 
from either Sigma or MWG. The PCR conditions varied, depending on the DNA 
polymerase, the melting temperature (Tm) of the primer and the length of DNA to be 
amplified. PCR was run in a thermal cycler (PTC-200, DNA Engine) and the product 
analyzed by agarose gel electrophoresis. 
2.2.10.1 PCR for colony screening 
For a bacteria colony PCR, the fresh colonies were mixed with 10 µL PCR solutions 
which contained 1× PCR buffer, dNTP mixture (0.2 mM for each), 1.5 mM MgCl2, 2 
µM primers and 0.25 U Taq DNA polymerase (typically GoTaq, Promega), and 
amplified using standard cycling parameters. 
The procedure for a yeast colony PCR is a slightly modification of a previously 
described protocol (Danilevich and Grishin, 2002). A fresh S. pombe colony was 
treated with 50 µL of lysis buffer D2 (4 M guanidine hydrothiocyanate, 50 mM Tris-
HCl (pH 8.0), 5 mM EDTA, 0.1 M β-mercaptoethanol, and 0.5% laurylsarcosine). 
The samples were kept in boiling water for 5 minutes, and then centrifuged at 12000 
rpm for 1 minute. The pellets were harvested, washed twice with 1 ml deionized 
water. Finally, the pellets were dissolved in 20 µL water and 2-4 µL of the cell 
samples were amplified in 25 µL PCR reaction for 35 cycles.  
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2.2.10.2 PCR for cloning 
Pyrobest DNA polymerase (TaKaRa) was used to amplify the DNA fragments from 
yeast genomic DNA. 20 ng of S. pombe genomic DNA was used template and 
amplified in 50 µL PCR reactions which contained 1× pyrobest buffer, dNTP mixture 
(0.2 mM for each), 2 µM primers and 0.5 U pyrobest DNA polymerase. The PCR was 
run as follow: 95 °C initial denaturation for 5 minutes; 95 °C for 30 seconds, (Tm-5) 
°C as the annealing temperature for 30 seconds, 72 °C extension for 1 minute per kb 
of the expected DNA length and running for 30 or 35 cycles; 72 °C extension for 5 
minutes. 
Phusion DNA polymerase (NEB) was used to amplify DNA fragments from 
plasmids. ~1 ng of plasmid DNA was used as template and amplified in 50 µL 
reactions which contained 1× HB buffer, dNTP mixture (0.2 mM for each), 2 µM 
primers and 1 U Phusion DNA polymerase. The PCR amplification was as follow: 98 
°C denaturation for 1 minutes; 98 °C for 5 seconds, Tm °C as the annealing 
temperature for 20 seconds, 72 °C extension for 0.5 minute/kb of the expected DNA 
length and running for 25 or 30 cycles; 72 °C extension for 5 minutes. 
2.2.11 Reverse transcription of RNA 
Reverse transcription was performed on 1 µg of total-RNA using an oligo-dT primer 
with a 5’ end anchor sequence and SuperScript II reverse transcriptase (Invitrogen). 
The reverse transcription process was followed as described in the manufacturer’s 
instructions. 1µL of reverse transcription product (20 µL) was used in PCR 
amplification by a combination of gene specific primers and an anchor primer. 
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2.2.12 Agarose gel electrophoresis of DNA 
PCR or restriction enzyme digestion of DNA samples was resolved in agarose gels to 
confirm and separate the correct bands by molecular weight. DNA samples and the 
loading control were mixed with DNA loading buffer (10× stock, 20% glycerol, 0.1 
M EDTA, pH8.0, 1.0% SDS, 0.25% bromphenol blue and 0.25% xylene cyanol), 
loaded onto the 0.8% -2% (w/v) horizontal agarose gel and run in TAE buffer (40 
mM Tris base, 40 mM acetic acid and 2 mM EDTA) with 0.5 µg/mL ethidium 
bromide at a constant voltage of 90 V. The 1kb DNA ladder and the 100 bp DNA 
ladder were used as the loading control (NEB). The DNA sizes in descending order 
correspond to 10000 bp, 8000 bp, 6000bp, 5000bp, 4000 bp, 3000 bp, 2000 bp, 1500 
bp, 1000 bp and 500 bp for 1 kb ladder; 1500 bp, 1200 bp, 1000 bp, 900 bp, 800 bp, 
700 bp, 600 bp, 500 bp, 400 bp, 300 bp, 200 bp and 100 bp for 100 bp DNA ladder 
respectively.  
2.2.13 DNA sequencing 
Sequencing of some DNA samples was carried out by the Functional Genomics and 
Proteomics Unit of the School of Biosciences. Some samples were sequenced and 
analyzed by GATC biotech (Germany).  
2.3 Plasmids construction 
The plasmids used in this study are derived from pREP41 (Map 1, Appendix III) 
(Maundrell, 1993). pREP41 is a S. pombe E. coli shuttle vector. The plasmid contains 
the pUC19 backbone, and is easily engineered and manipulated in E. coli. The LEU2 
gene from S. cerevisiae is incorporated as the selection marker, which was used to 
screen the transformants by complementation of the leucine auxotroph of leu1Δ32 or 
leu1Δ strains. In S. pombe cells, the expression is driven by the nmt41 promoter (no 
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message thiamine, moderate strength) with a high level of transcription when 
thiamine is absent (Basi et al., 1993; Zurlinden and Schweingruber, 1997). The 
plasmid constructs used for chromosomal integration into S. pombe genome were 
derived from pDUAL-nmt41 (Map 2, Appendix III). pDUAL-nmt41 is a shuttle 
vector, like pREP41 but containing URA4 as the selective marker in episomal 
expression (Matsuyama et al., 2004). The marker for integration is LEU1 5’ half 
fragment which rescues the leu1d32 mutation by homologous recombination only if 
correctly integrated. All of the primers used in the cloning are listed in Appendix II 
(Table 1); and all of plasmids in the study are listed and shown in Appendix II (Table 
3) and Appendix III (Map 1-11).  
2.3.1 GFP reporters (intronless NMD reporters) 
The GFP reporters described in this study derive from a plasmid clone encoding GFP 
S65T (gift from Professor M. Rosbash), (Kuperwasser et al., 2004). The GFP coding 
region was amplified by PCR using primers: gfp-ks and gfp-rev, digested with BamH 
I and inserted into the BamH I site of pREP41. Then the colonies were confirmed by 
small scale DNA preparation and Nde I digestion (pREP41 has a unique Nde I site, 17 
bp upstream of the BamH I site, and the GFP coding region has a Nde I site, 
positioned at 244 bp from the beginning of the ORF).  
The nonsense mutation (TAA) at triplet position 6 (PTC6) was introduced directly 
with the primer, N6-sens (combined with gfp-rev); the other two nonsense mutations 
(triplets positions 27 and 140) were introduced by overlapping PCR. The principle of 
overlap PCR is shown in Figure 2.1. The primer pairs used to introduce the TAA 
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Figure 2.1 The principle of overlap PCR to introduce nonsense mutations. 
This strategy was used to introduce the nonsense mutations into GFP or the 
endogenous gene YPT3 and mutate the 5’ splice site in the intron-containing NMD 
reporters. A-D, four primers used in overlap PCR. 
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mutations at triplets positions 27 and 140 are sens-N27 /rev-N27 and sens-N140 /rev-
N140, respectively; the primers for the full length amplification of GFP ORF are gfp-
ks and gfp-rev. Primer sequences are shown in Table 1, Appendix II. All of the 
intronless GFP constructs were initially screened by proof reading PCR with the 
primers N6-ch-sens, N27-ch-sens and N140-ch-sens, restriction digestion (Nde I), and 
further confirmed by sequencing with primer SSP41 flanking the cloning site. The 
schematic maps are shown in Fig. 4.1A and Map 3, Appendix III.  
By using the same cloning and screening strategy, I made several batches of NMD 
reporters based on the intronless GFP reporter.  
2.3.2 GFP reporters with longer AUG-PTC distance 
To make the constructs with extended AUG-PTC distance, an extra Avr II site, 
between AUG and PTC6, was introduced into the GFP coding region with the 
primers, Gavr-2-sens, PTC6avr-2-sens and gfp-rev. After the desired colonies were 
screened by colony PCR, as described in 2.3.1, a small scale DNA preparation was 
carried out for the further confirmation with Nde I and Avr II digestions. The 
intermediate plasmids were named pGFP-AvrII and pPTC6-AvrII.  
Then, two in-frame DNA fragments, 147 bp and 297 bp, both from the EGFP coding 
region, were amplified from pC3-GFP (lab stock) with the primers InHAeG-sens, 
InHAeGS-rev (147 bp) and InHAeGL-rev (291 bp). The PCR products were digested 
by Avr II and cloned into the intermediate plasmids. All of the constructs with the 
longer AUG-PTC distance were screened by colony PCR (the primers InHAeG-sens 
and gfp-rev) and Nde I digestion, and confirmed by sequencing with SSP41. The 
schematic maps are shown in Fig. 4.7A and Map 4, Appendix III. 
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2.3.3 GFP reporters with long 3’ UTRs  
Two DNA fragments, 102 bp and 418 bp, were amplified from the coding region of 
the firefly luciferase gene with the primers, luc102-sens, luc102-rev and luc418-rev. 
The PCR products digested by Xma I and cloned into the intronless GFP reporter 
constructs at the Xma I site, which is located 6 bp downstream of the GFP coding 
region, immediate upstream of the nmt1 3’ UTR. The constructs with the long 3’ UTR 
were screened by colony PCR (the primers luc102-sens and RSP41), and further 
confirmed by Xma I digestion. The schematic maps are shown in Fig. 4.2A and Map 
5, Appendix III. 
2.3.4 GFP reporters with longer PTC-3’ end distances 
An Avr II site was introduced directly into the GFP coding region immediately 
upstream of the normal stop codon with the primers Gavr2-243-rev and gfp-ks/N6-
sens. The PCR fragments containing an Avr II site at the end of the GFP coding 
region were cloned into pREP41 as described in 2.3.1. The intermediate plasmids 
were named pGFP-Avr243, pPTC6-Avr243, pPTC27-Avr243 and pPTC140-Avr243.  
An in-frame 402 bp DNA fragment was then amplified from the EGFP coding region 
with the primers InHAeG-sens and HAeG402-rev, and cloned into the plasmids at Avr 
II site as described in 2.3.2. All the constructs with longer PTC-3’ end were screened 
by colony PCR with the primers InHAeG-sens and RSP41 and BamH I digestion, and 
further confirmed by sequencing with the primer RSP41. The schematic maps are 
shown in Fig. 4.3A and Map 6, Appendix III. 
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2.3.5 GFP reporters with ade6 3’ UTR  
The ade6 3’ UTR (1.1 kb) was amplified with the primers, ade6-3Us and ade6-3Ur, 
from S. pombe genomic DNA, and digested by Xma I and Sac I. Then, nmt1 3’ UTR 
which is located between the two enzyme sites was replaced by ade6 3’ UTR by Xma 
I and Sac I digestion. The replacement was confirmed by colony PCR with the 
primers, Sgfp-sens and ade6-3Ur and Xma I and Sac I digestion. The schematic maps 
are shown in Fig. 4.4A.  
2.3.6 GFP reporters with short PTC-3’ end distance 
The 5’ half of the GFP coding region (327 bp from ATG) was amplified with the 
primers, gfp-ks and GFPsh-rev, and cloned into pREP41 at Bam HI site as described 
in 2.3.1. The nonsense mutation at triplet position 6 was introduced directly by the 
primer N6-sens. The constructs were screened by colony PCR (the primers, SSP41 
and GFPsh-rev) and Nde I digestion, and confirmed by sequencing. The schematic 
maps of the constructs are shown in Fig. 4.5A. 
2.3.7 GFPivs reporters (intron-containing NMD reporters) 
A unique Pml I site is located at 326 bp in the GFP coding region. The second intron 
of UBC4 was amplified from S. pombe genomic DNA by the primers, INubc4-sens 
and INubc4-rev, phosphorylated by T4 DNA polynucleotide kinase (NEB), and 
cloned in GFP coding region at Pml I located at 326 bp in the GFP coding region. All 
the intron-containing GFP reporters were screened by colony PCR with the primers 
SSP41 and INubc4 rev, and further confirmed by sequencing with the primers SSP41 
and RSP41 respectively. The intron insertion splits the GFP coding region at triplet 
position 110. The schematic maps are shown in Fig. 5.1A and Map 7, Appendix III. 
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2.3.8 GFPivs reporters with 5’ splice-site mutation  
Derived from the GFPivs reporters, the 5’ splice-site was mutated by overlap PCR 
with the primers, 5SP-SENS and 5SP-REV. The cloning and screening strategy is the 
same as described in 2.3.1, with the exception that the primer 5sp-ch-sens is used in 
proof reading PCR. The 5’splicing site GTAT was mutated as CTAA, which caused 
an in frame nonsense mutation at triplets position 111. The 5’ splice-site mutation 
constructs were confirmed by sequencing with the primers SSP41 and RSP41. The 
schematic maps are shown in Fig. 5.2A. 
2.3.9 GFP reporters with a 3’ UTR intron  
The intron from UBC4 was amplified with the primers IN3UTR-sens and IN3UTR-
rev, digested by Xma I, and cloned into the GFP reporters at the Xma I site, which is 
located 6 bp downstream of the GFP normal stop codon. All the constructs were 
screened by colony PCR with primers, IN3UTR-sens and RSP41, and confirmed by 
sequencing with the primer RSP41. The schematic maps are shown in Fig. 5.7A and 
Map 8, Appendix III. 
2.3.10 GFPivs reporters with long PTC-intron distance 
Derived from GFPivs reporters, an Avr II site was introduced into the GFP coding 
region at triplet position 120 by overlap PCR with the primers, Gavr-120-sens, Gavr-
120-rev, gfp-ks and gfp-rev. The plasmids were screened by colony PCR with primer 
SSP41 and gfp-rev and Avr II digestion, and confirmed by sequencing with the primer 
RSP41. The two intermediate plasmids were named pGFPivs-Avr120 and 
pPTC140ivs-Avr120.  
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Then, two different lengths of DNA fragments, 147 bp and 291 bp, as described in 
2.3.2, were cloned into the intermediate plasmids. The constructs were screened by 
colony PCR with the primers InHAeG-sens and RSP41, and confirmed by sequencing 
with the primers SSP41 and RSP41. The schematic maps are shown in Fig. 5.8A and 
Map 9, Appendix III. 
2.3.11 Integrated GFP reporters 
All of the integration constructs are derived from pDUAL-HFF41 (Matsuyama et al., 
2004). pDUAL-HFF41 was cleaved by BamH I to remove the DNA fragment of C 
terminal fused His-tag and Flag-tag. The digested vector was self-ligated and 
harvested as pDUAL-nmt41 (Map 2, Appendix III).  
The GFP fragments with/without introns were digested by BamH I and cloned into 
pDUAL-nmt41 at BamH I site. The integrated GFP reporters were screened by colony 
PCR with the primers SSP41 and gfp-rev and confirmed by sequencing with the 
primers, SSP41 and Sgfp. The schematic maps are shown in Map 10, Appendix III. 
2.3.12 YPT3 and YPT3 cDNA NMD constructs 
For the intron-containing YPT3 constructs, the YPT3 gene, which contains two 
introns, was directly amplified from S. pombe genomic DNA by the primers ypt3-sens 
and ypt3-rev, and inserted into pREP41 at BamH I. The nonsense mutation at triplets 
position 6 was introduced directly with the primer ypt3N6-sens; the other nonsense 
mutation at triplets position 131 was mutated by overlap PCR with the primers 
ypt3N130-sens, ypt3N130-rev, ypt3-sens and ypt3-rev.  
For making the YPT3 cDNA constructs, the YPT3 cDNA was obtained by reverse 
transcription from total RNA extracts from S. pombe. The YPT3 cDNA cloning use 
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the same procedure as indicated above. The YPT3 and its cDNA NMD constructs 
were screened by colony PCR with the primers SSP41 and ypt3-rev and confirmed by 
sequencing with the primers SSP41 and RSP41. The schematic maps are shown in 
Fig. 5.3A and Map 11, Appendix III. 
2.4 S. pombe methods  
2.4.1 Strains 
The S. pombe strains used in the project are shown in Appendix II, Table 3. All strains 
were stored at -80 °C in YES or EMM media plus 40% sterile glycerol. Deletion 
strains were validated by PCR of genomic DNA, using the appropriate primer pair 
(Appendix II Table 1), A schematic of how knock-out and knock-in cells were 
verified by PCR is shown in Fig. 2.2. 
2.4.2 S. pombe media and culturing 
S. pombe cells were cultured in YES or EMM medium. The recipes of these media are 
shown in Appendix I. For cultures on Petri dishes, cells were streaked on YES or 
EMM plates and incubated at 30 °C or 25 °C for temperature sensitive strains (ts 
strains) for 2-4 days until colonies reached at least 1 mm diameter. 
Liquid cultures were typically inoculated from single colonies from streaked plate. 
First in small start-up cultures, 1-2 mL culture was grown overnight at 30 °C or 25 °C 
(ts strains) in shaking incubator. Fresh small cultures were then used to inoculate 10-
50 mL (1 to 50 dilution) and grown overnight. 
54 
Fig. 2.2 
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Figure 2.2 S. pombe strain confirmations by PCR of genomic DNA. 
(A) Schematic of the PCR procedure to test if the marker cassette was inserted in the 
right location. 
 (B-C) Confirmation of upf1Δ and exo2Δ strains in which the Kan MX6 cassette and 
URA cassette were used to knock out the genes respectively. (B) Genomic DNA from 
upf1Δ was prepared and assayed by PCR with the primers upf1ch-sens1 and upf1ch-
rev1 (lanes 1 and 2, upf1Δ and lane 3, wild-type as the control); and the combined 
primers of upf1ch-sens/kan-inp1r (lane 4 and 5) and kan-inp1s/upf1ch-rev (lane 6 and 
7). (C) Genomic DNA from exo2Δ was assayed with primers exo2-sens and exo2-rev 
(lanes 1 and 3, exo2Δ and lane 4, wild-type); and the combined primers exo2-sens and 
ura4ch-rev (lane 2 and 5). The expected DNA fragments were produced in the deleted 
strains, 1.9 kb in upf1Δ (B, lane 1) but 3.2 kb in wild-type (B, lane 3); 3.4 kb in exo2Δ 
(C, lane 1), but no DNA present in wild-type (C, lane 4, 5.4 kb DNA expected)  
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2.4.3 S. pombe DNA transformation 
Three slightly different procedures were used, depending on the aims for episomal 
expression, DNA integration or gene replacement. The strain to be transformed was 
cultured in 5-10 mL YES until the cell density reached 0.8-1.0 at OD650  (1×107, 
measured by haemocytometer). Cells were made competent for transformation using 
the LiAc method described below (Forsburg and Rhind, 2006). 
1. The cell culture was centrifuged at 3000 rpm for 5 minutes and the pellet was 
washed once with 10 mL of sterile water. 
2. The cells were centrifuged again in the same condition and resuspended in 
100-200 µL of sterilized water. An equal volume of LiAc buffer (10 mM Tris-
HCl pH 8.0, 1 mM EDTA, 0.1 M Lithium acetate) was added and thoroughly 
mixed with the resuspended cells (cell density should be above to 5×108).  
3. For each transformation, 100 µL of LiAc-resuspended cells were transferred 
into a 1.5 mL sterile microtube and kept at room temperature (lower than 28 
°C) for 15-30 minutes. 
4. Then 1 µg of plasmid DNA (episomal expression) or 10 µg linerized DNA for 
homologous recombination (plasmid integration or gene knock-out), and 2 µL 
of 10 mg/mL ssDNA were mixed with 100 µL of LiAc-treated cells. The 
mixture was then kept at room temperature for 20-30 minute. 
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Figure 2.3 Plasmid integrated into the genome of S. pombe.  
The LEU1 5’ half and 3’ half DNA sequences in pDUAL-recombine with the 
homologous sequences of the chromosomal leu1 locus. The recombination reaction 
removes the mutation of the leu1d32 allele and leads to a fully functional LEU1 gene 
and leucine prototrophy, giving in cells that had a successful recombination. Between 
the two LEU1 recombination sequences there is the nmt41 promotor, multiple cloning 
sites and the adh terminator  (Map 2, Appendix III). 
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5. After, 220 µL of 50% PEG solution and 40 µL of LiAc buffer were added to 
the transformation mixture and mixed gently. The sample was kept at 30 °C 
(25 °C for ts strain) for 1 hour. 
6. Then the sample was heat shocked at 42 °C for 20 minutes; briefly centrifuged 
at 3000 rpm and the pellet washed with 1 mL of sterile water 
7. At the end, the cells were pelleted, and resuspended in 100 µL of sterilized 
deionized water and spread on the appropriate selection plate  
2.4.4 Genomic DNA extraction 
Single colonies were grown in 20 ml cultures to stationary phase for 1.5-2 days, and 
spun down at 3000 rpm for 5 minutes. The pellets were then briefly washed in sterile 
water and the genomic DNA was extracted using the CPES method described below 
(Alfa et al., 1993). 
1. The cell pellet was resuspended in 1ml of Citrate/ Phosphate buffer (50 mM 
citric acid and phosphate pH5.6, 40 mM EDTA pH 8.0, and 1 M sorbitol). 
2. 50 µl of Zymolyase 20T (Europa Bioproducts Ltd) was added and then the 
mixture was incubated at 37 °C for 60 minutes. Cells are ready for next step if 
more than 50% cells show a loss in refractivity under the microscope, (the 
change in refraction is apparent by adding 1% SDS to the aliquot of culture to 
be examined) 
3. Cells were pelleted at 8000 rpm and resuspended in 0.55 ml TE and 1 % SDS 
and incubated at 65°C for 1 hour for lysis. Then 300 µl of 3 M potassium 
acetate (pH 5.0) was added and the tubes were kept on ice for 15 minutes. 
  59 
4. After the samples were centrifuged at 13000 rpm for 15 minutes at 4 °C, 600 
µl of supernatant was transferred into a fresh tube, and an equal volume of ice-
cold isopropanol was mixed completely with the supernatants. The mixture 
was incubated at -20°C for 10 minutes and centrifuged at 13000 rpm for 15 
minutes at 4 °C. 
5. After washed by 70 % cold ethanol, the pellet was resuspended in 300 µl TE 
buffer with 50 µg/ml RNase, and incubated at 65 °C for 15 minutes.  
6. The sample was mixed with 300 µl of saturated phenol (pH 
7.9):chloroform:isoamyl alcohol (25:24:1), vortexed vigorously and 
centrifuged. The supernatant was then transferred into a 1.5 mL sterile tube. 
The phenol: chloroform extraction was repeated several times (typical 2 times) 
until the interface turned clear.  
7. The water phase was transferred into a fresh tube, and then 30 µl of 3 M 
sodium acetate (pH 7.5) and 700 µl of cold absolute ethanol were added to 
precipitate the DNA. The tubes were kept at -20 °C for 5-10 minutes.  
8. After the tubes were centrifuged at 13000 rpm for 10 minutes at 4 °C, the 
pellet was washed with 70 % ethanol and air-dried. The dry pellet was 
dissolved in 50 µl TE and 1 µl of the solution was run in agarose gel to 
estimate the quality and quantity of the genomic DNA (there should be a band 
at proximate 20 kb).  
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2.4.5 RNA extraction   
Total-RNA was purified from either 10 mL (plasmid transformed cells) or 20 mL 
cultures (strains with integrated constructs). The RNA was extracted with the hot-acid 
phenol method, with slight modifications (Ausubel et al., 1996). 
1. Cells were centrifuged at 3000 rpm for 3 minutes at 4 °C, washed once with 
10 mL of sterile water. 
2.  Cells were centrifuged again and the pellet was resuspended in 600 µL of 
TES buffer (10 mM Tris pH 7.5; 10 mM EDTA pH 8; 0.5% SDS). Then the 
resuspended cells were mixed with 600 µL of acid phenol pre-heated at 65 °C.  
3. The sample was incubated at 65 °C for 1 hour and vortexed for 10 seconds 
every 10 minutes. At the end the sample was cooled on ice briefly. 
4. The sample was centrifuged at 13000 rpm for 20 minutes at 4 °C; 550 µL of 
the aqueous phase was transferred into a clean sterile tube and mixed (by 
vortexing) with 500 µL acid phenol:chloroform:isoamyl alcohol (25:24:1) . 
5. The mixture was centrifuged at 13000 rpm for 15 minutes at 4 °C and 500 µL 
of the aqueous phase transferred into a clean sterile tube. The aqueous phase 
was re-extracted with 500 µL chloroform: isoamyl alcohol (24:1) as above. 
6.  The final aqueous phase was transferred into a nuclease free sterilized tube 
and the RNA precipitated by adding 50 µL of 3M NaAc (pH 5.2) and 1.2 mL 
of pre-chilled 100% ethanol. 
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7. The tube was kept at -20 °C for 20 minutes, and then centrifuged at 13000 rpm 
for 15 minutes at 4 °C; the pellet was washed once by 70% ethanol, dried and 
dissolved in 50 µL DEPC-treated water. 
2.4.6 Northern blot analysis of RNA samples 
2.4.6.1 Gel electrophoresis 
5 to 20 µg of RNA samples were mixed with 5.5 µl of 35% formaldehyde, 15 µl of 
100% formamide, 3 µl 10× MOPS (0.2 M MOPS, 80 mM NaAc and 10 mM EDTA) 
buffer and DEPC water to the final volume of 30 µl. The sample mixtures were 
incubated at 65 °C for 20 minutes and then immediately put on ice for at least 5 
minutes. The 1.2 % agarose/formaldehyde gel (1.4 g agarose, 12 ml 10× MOPS, 
21.45 ml formaldehyde, and 86.25 ml DEPC water) was pre-run for 5 minutes. 1 µl of 
RNA loading buffer was added into each sample and the gel was run at 80 V for 4-5 
hours in 1× MOPS buffer. 
2.4.6.2 Capillary blot, crosslinking and staining 
The gel was then washed in DEPC water for 20 minutes and in 20× SSC (3M NaCl, 
300 mM Sodium citrate pH 7.0) buffer for 20 minutes. During gel washing, the 
membrane (HyBond, Amersham Biosciences), 3 MM papers and paper towels were 
prepared. The RNA was transferred onto HYBOND membrane by the blot and left 
overnight as described in Molecular cloning II (Sambrook et al., 1989). 
The membrane was removed from the blot and put on wet filter paper to be 
crosslinked by 254 nm ultraviolet light (UV) at 120 J. After UV crosslinking, the 
membrane was washed by DEPC water for 5 minutes, stained with 50 mL methylene 
blue (0.5 M Na acetate, pH 5.2, 0.04% methylene blue) by shaking for 5 minutes and 
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destained by DEPC water for 10 minutes until the 18S and 25S rRNA bands were 
visible on the membrane. 
2.4.6.3 Probe labeling and hybridization 
30 ml hybsol buffer (1.5× SSPE (0.27 M NaCl, 15 mM sodium phosphate pH 7.4, 1.5 
mM EDTA), 7% SDS and 10% PEG8000) containing 100 µg/ml boiled ssDNA and 
250 µg/ml heparin was added into a hybridization tube and the prehybridization was 
carried out in the hybridization oven at 68 °C for 4 hours at 30 rpm. 
The radioactive probe was synthesized by random priming as following. Firstly, 40 ng 
of template DNA was mixed with 10 µl of 5× reaction buffer (promega, random 
primer already premixed in the buffer) and 30 µl of sterile water. The mixture was 
boiled at 100 °C for 5 minutes and immediately cooled on ice for 5 minutes. After the 
sample was denatured, 2 µl of dNTPmix (15 mM for each) without dCTP, 1 µl of 
Klenow DNA polymerase and 3-5 µl of P35-dCTP (3000cci) were added into the 
sample and kept at room temperature for 1-2 hours. The G50 sepharose column was 
used to purify the radioactive labeled probes. The purified probes were heated at 100 
°C for 5 minutes and immediately cooled on ice for 5 minutes. Meanwhile, the 
prehybridization buffer was discarded, and then the labeled probes and 20 ml of 
Hybsol containing 100 µg/ml boiled ssDNA and 250 µg/ml heparin were added into 
the tube and mixed well together. The hybridization was carried out at 68 °C 
overnight. 
2.4.6.4 Membrane washing, signal development and quantitative analysis 
The membrane was washed with 60 ml of 2× SSC and 0.1% SDS with four intervals, 
2, 5, 30 and 30 minutes respectively and then washed with 0.2× SSC and 0.1% SDS 
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for an extra 30 minutes at 68 °C. After washing, the membrane was wrapped in Saran 
film. The membrane was either exposed to X-ray film at -70 °C in a cassette with 
intensifying screens and developed by X-graph or exposed to a Kodak phosphor-
imaging screen and developed by the phosphorimager FX (Bio-Rad). The signal 
intensities were analyzed using the Quantity-one program (Bio-Rad). 
2.4.7 Counting the number of cells 
Cell cultures were diluted in water (1:10), and 10 µL of the dilution were loaded onto 
a haemocytometer and counted with a phase-contrast microscope equipped with a 40× 
objective. The calculation of cell numbers is based on the manufacturer’s instructions. 
2.4.8 Fluorescent in situ hybridization (FISH)  
FISH was performed as previously described for S. cerevisiae with minor 
modifications (Kuperwasser et al., 2004). All the procedures that are related to the 
fluorescent dye and labeled probes were performed in a dark environment. The tubes 
or containers were also wrapped in foil. 
Cell cultures (2 mL, OD600 ~ 0.5) were fixed with 0.4% formaldehyde and 10% 
glacial acetic acid at room temperature for 15 minutes. The cells were pelleted and 
washed with 1 mL of SPPi buffer (1.2 M sorbitol, 0.1 M potassium phosphate, pH 
6.5) three times. Cells were resuspended in 50 µl of SPPi. Before FISH, the cell wall 
was removed using the following spheroplasting procedure. Cells were incubated with 
Novozyme 234 (200 µg/mL, Interspex Products Inc) and zymolyase 20T (500 µg/mL, 
Europa Bioproducts Ltd) for 15-30 min at 37 oC in SPPi buffer with 0.2 % β-
mercaptoethanol, 20 mM Vanadyl-ribonucleoside, until approximate 80% cells were 
spheroplasted (confirmed by microscope observation). The spheroplasts were 
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centrifuged at 3500 rpm for 2 minutes, washed by 1 mL of SPPi buffer once and 
resuspended in 40 µL SPPi buffer. Then, 20 µL of the cell suspensions was spread 
onto one of the circles of a coated coverslip (see below) and incubated in a humid 
chamber for 1-2 hour. The coverslip was washed as follow: 5 minutes in SPPi buffer 
twice; 5 minutes in 0.1 M potassium phosphate pH 6.5; 5 minutes in 0.1 M potassium 
phosphate pH 6.5 with 0.1% NP40; 5 minutes in 0.1 M potassium phosphate pH 6.5. 
Lastly the coverslip was washed in 70% ethanol at - 20 oC for 20 minutes. Before 
hybridization, the coverslip was briefly washed twice with 2× SSC, each for 5 
minutes, and then treated with 40% formaldehyde in 2× SSC for 20 minutes. After 
washing and discarding the SSC, The coverslip was covered with 20 µL per circle of 
hybridization solution containing Cy3-labbeled oligonucleotide probes (see below) 
and incubated in a dark humid chamber at 37 oC for at least 10 hours (typically 
overnight). Post-hybridization the coverslip was washed as follow: twice with 40% 
formamide in 2× SSC at 37 oC for 15 minutes; with 2× SSC with 0.1% Triton X-100 
for 15 minutes at room temperature; twice with 1× SSC for 15 minutes and twice with 
1× PBS for 5 minutes. The wells were then dried for 5-10 min (avoid over drying the 
coverslip prevent cell shrinkage). Drop 6-7 µL of mounting solution (1×PBS, pH 8.0, 
1 mg/mL phenylenediamine, 90% glycerol, optional for 0.1 mg/mL DAPI) was 
dropped onto the coverslip, and the coverslip picked-up with a glass slide. The 
coverslip was immobilized with nail polish. The slides were viewed with a fluorescent 
microscope equipped with Ds-Red filter-set using a 100× oil lens (Nikon ECLIPSE 
E600). Images were captured with a CCD camera (HAMAMATSU C4743-95) using 
the Simple PCI 4.0.6.1605 software (HAMAMATSU). 
For probe labeling, the oligos used for FISH were a gift from Dr. T. H. Jensen 
(University of Aarhus) and listed in Table 1, Appendix II. The GFP probes consist of 
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four amino modified oligonucleotides complementary to the GFP coding region, as 
previously described (Dower and Rosbash, 2002). The oligos were labeled with Cy3 
using the CyTM 3-mono-Reactive Dye Pack (GE Healthcare). 20 µg of amino-
modified oligonucleotide (4 oligos, 5 µg for each sample dissolved in water) was 
dried in a speed vacuum concentrator and then dissolved in 25 µL of 0.1M sodium 
bicarbonate pH 9.0. 25 µL of the Cy3 dye solution (made by 75 µL DMSO per vial as 
described in manufacturer’s instructions) was mixed with the oligos; the tube was 
wrapped in foil and incubated 3 hours at room temperature in the dark. After the 
conjugation, the sample was mixed with 50 µL of water and purified by a G50 
column (Sambrook et al., 1989).(Sambrook et al., 1989). The labeled oligos were kept 
at a concentration of 200 ng/µL; the tubes were wrapped in foil and stored at -20 °C. 
For attaching the spheroplasted cells, on the glass coverslip (20 mm×70 mm), 6 wells 
(~6 mm square each) were made by using a hydrophobic pen. 20 µL 0.1% poly-L-
lysine (Sigma, P8920) was added into each well and incubated in a humid chamber 
for 2 hours. The poly-L-lysine solution was discarded and the wells were briefly 
washed twice by 20 µL water and then air dried to be used.  
For hybridization, 5 µL of labeled oligos were mixed with 20 µL of 10 mg/mL 
salmon sperm DNA and 20 µL of 10 mg/mL yeast tRNA. The mixture was 
lyophilized in a speed vacuum and resuspended in 80 µL of 100% formamide (Sigma 
Aldrich). The solution was heated at 100˚C for 3 minutes, cooled on ice, and then 
mixed with 80 µL of ice-cooled hybridization buffer (4 mg/mL BSA, 4 mM Vanadyl-
ribonucleoside (200 mM stock, Sigma), 20% Dextran Sulfate, 4× SSC).  
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2.4.9 Protein extraction from S. pombe cells  
Two different methods were used to extract proteins from yeast cells. One method 
makes use of glass beads. A 5-15 mL aliquot of a fresh cell culture (cell number > 
108) was spun at 3000 rpm for 5 minutes, and the pellet was washed with 1.2 mL of 
cold distilled water, and then transferred into a 1.5 mL fresh screw cap tube and spun 
again. The pellets were resuspended in 200 µL of protein lysis buffer (50 mM Tris, 
pH 7.5,150 mM NaCl, 5 mM EDTA, 10% glycerol, 1 mM phenylmethylsulphonyl-
fluoride (PMSF),) and about 400 µL of 0.5 mm acid-washed glass beads (Sigma) 
were added into each tube. Each sample was vortexed at 5500 rpm for 15 seconds in 
Precellys 24 homogenizer (Bertin Technologies) and kept at 4 °C for 2 minutes. The 
process was repeated 2-3 times until more than 70% of cells were broken as observed 
under the microscope. To recover the cell lysate, the bottom of the tube was pierced 
with a needle (the needle can be heated over a flame to facilitate piercing). The 
punctured tube was placed in a fresh 1.5 mL tube and centrifuged at 13000 rpm for 10 
minutes at 4 °C. 30 µL of supernatant was mixed with 30 µL of 2× SDS loading 
buffer (120 mM Tris-HCl, pH 6.8, 8% SDS, 8% β-mercapto-ethanol, 25 mM EDTA, 
0.04 % bromophenol blue, 20% glycerol). The extract was boiled for 5 minutes and 
either loaded on a SDS-PAGE gel or stored at -20 °C for future use.  
The second protein extraction method involves sodium hydroide mediated lysis of the 
cells (Matsuo et al., 2006). A 2-5 mL aliquot of cell culture was spun down and 
washed once with 0.5 mL of water. The pellet was completely resuspended in 300 µl 
water, and then 130 µL of 1 M NaOH was added and into the sample and mixed 
gently by flipping the tube. The tube was incubated at room temperature for 10 
minutes. The sample was then spun at 8000 rpm for 3 minutes at 4 oC and the 
supernatant was fully removed. 50-100 µL of 1× SDS loading buffer was used to 
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resuspend the cells completely, and then boiled for 5 minutes and centrifuged at 
13000 rpm for 2 minutes. Typically 20 µL of the sample were loaded on the gel or 
stored at -20 oC for future use. 
2.4.10 SDS-PAGE and Western blot 
SDS-PAGE gels (10%) were prepared as described in Molecular Cloning 2nd edition 
(Sambrook et al., 1989). SDS-PAGE gels were run at 120 V for 60-100 minutes at 
room temperature by using 1× running buffer (10× stock buffer: 0.25 M Tris-HCl, 
1.92 M Glycine, 1.0% SDS, pH 8.3). The proteins were transferred onto nitrocellulose 
membranes (Schleicher & Schuell) using a standard wet electroblotter apparatus at 
100 V for 60-90 minutes in cold room in transfer buffer (25 mM Tris-HCl, 190 mM 
Glycine, 20% Methanol). Membranes were blocked with 30 ml of 5% skimmed milk-
TBS (25 mM Tris-HCl, 137 mM NaCl) at room temperature for 1-2 hours and then 
washed with TBS 0.1% Tween 20 (TBST) three times, each for 10 minutes. The 
primary antibody was diluted 1:3000 directly in TBST and incubated with the 
membrane overnight in the cold room. The following day, the membrane was washed 
with TBST three times, each for 10 minutes. The secondary antibody, horseradish 
peroxidase (HRP) label anti-mouse (Sigma), was diluted 1:10000 in TBST and 
incubated with the membrane for 40-60 minutes. The membrane was washed with 
TBST three times, each for 10 minutes. The signal was developed by Supersignal 
West Pico Chemiluminescent Substrate kit (PIERCE). 0.5 mL of Supersignal 
WestPico Luminol/Enhance solution was mixed with 0.5 mL Stable Peroxide solution 
and the mix spread uniformly onto the membrane and incubated for 5 minutes. The 
solution was drained away and the membrane wrapped in cling film. The signal was 
detected with X-ray films or visualized with a ChemiDoc imaging system (Bio-Rad).  
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2.4.11 Polysome profile 
2.4.11.1 Preparation of sucrose gradients 
Tubes with 10-50% (w/v) sucrose gradients were prepared with DEPC-treated water 
and 10× polysome buffer (100 mM Tris acetate pH7.4, 700 mM ammonium acetate, 
40 mM magnesium acetate). Sucrose solutions were prepared as detailed in Table 2.1 
and dispensed, starting with 50% solution, into SW41 polyallomer centrifuge tube 
(Beckman Coulter) in 2.25mL fractions and quick frozen in liquid nitrogen between 
each layer. The dispensing of sucrose solutions started with 50% sucrose, following 
with 40%, 30%, 20% and 10% sucrose solution sequentially. Gradients were stored at 
-80 oC, defrosted and equilibrated at 4 oC for 12 hours prior to loading the samples. 
 
Table 2.1 Sucrose solutions for gradient preparation 
 50% 40% 30% 20% 10% 
10× polysome buffer (mL) 3 3 3 3 3 
 Sucrose (g) 15 12 9 6 3 
DEPC water Adjust the final volume to 30 mL 
 
2.4.11.2 Cell extract preparation 
A 50 mL S. pombe cell culture was grown at 30 oC until OD650 0.3-0.4, mixed with 
500 µL of 10 mg/mL cycloheximide and incubated for further 15 minutes. The 
following steps were all performed on ice or in a cold room. After the cycloheximide 
treatment, the cells were harvested by centrifuging at 3000 rpm and washed by 10 mL 
of lysis buffer (20 mM HEPES pH7.4, 2 mM magnesium acetate, 100 mM potassium 
acetate, 100 µg/mL cycloheximide, 0.5 mM dithiothreitol). The cells were pelleted 
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again and resuspended in 300 µL of lysis buffer with RNase inhibitor (40 U/mL, 
Invitrogen) and protease inhibitor cocktail, EDTA free (Roche). The suspension was 
transferred into a fresh 2 mL screw-cap tube and filled with acid-washed glass beads 
(0.5 mm) until the beads reached the meniscus of the solution. Cells were lysed by 
vortexing for three rounds of 15 seconds at 5500 rpm in homogenizer with 2 minutes 
cooling in between. Typically more than 70% of cells were broken after 2-3 rounds. 
An additional 300 µL of lysis buffer with 40 U/mL RNase inhibitor and protease 
inhibitor cocktail was added to dilute the sample. The 2 mL screw-cap tube was 
pierced at the bottom with a needle, placed trough a hole cut through the cap of a 15 
mL screw cap tube, and centrifuged at 5000 rpm for 5 minutes at 4 °C to recover the 
cell lysate. The lysate was transferred into a fresh 1.5 mL tube and cleared by 
centrifugation at 13000 rpm for 15 minutes at 4 °C. The supernatant was transferred 
into a fresh 1.5 mL tube and kept on ice .A 1:10 dilution of the extract was used to 
measure the absorbance at 260 nm with a NanoDrop spectrometer (ND-1000 
NanoDrop). The absorbance at 260 nm is proportional to the RNA concentration and 
therefore can be used to normalize polysome extracts loading.  
2.4.11.3 Sedimentation of translation complexes 
The polysome extracts were adjusted to 10 Abs260 units/mL and carefully loaded onto 
the top of the 10-50% sucrose gradients. The tubes were carefully balanced, loaded 
into the buckets of a Beckman SW41 rotor and centrifuged at 38000 rpm for 160 
minutes. The gradients were pumped (from the bottom, using a steel capillary) 
through a flow-through UV spectrophotometer (Pharmacia LKB-Optical Unit UV-1) 
by using a peristaltic pump (P-1, Pharmacia) with the speed at 1.2 mL/min. The 
absorbance was measured at 254nm and recorded on crart recorder (Pharmacia LKB 
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REC 102, speed setting, 1 cm/min). Fractions (0.8 mL per tube, 15 fractions) were 
collected with a fraction collector (FRAC100, Pharmacia).  
2.4.11.4 RNA and protein purification from sucrose fractions 
To extract the RNA from the fractions, the phenol:chloroform method was adopted. A 
400 µL aliquot of every fraction was mixed with 600 µL of phenol:chloroform and 
centrifuged at 13000 rpm at 4 °C for 10 minutes. The aqueous phase was transferred 
into a fresh tube and extracted with 400 µL of chloroform:isoamyl alcohol (24:1) and 
centrifuged at 13000 rpm at 4°C for 10 minutes. The aqueous phase was transferred 
into a nuclease free sterilized tube, and then mixed with 40 µL of 3M NaAc (pH 5.2) 
plus 1 mL of 100% ethanol (pre-chilled) and kept at -20 °C for 30 minutes. The 
sample was centrifuged at 13000 rpm for 15 minutes and washed once by 70% 
ethanol (RNase free). The RNA sample was then dried and dissolved in 20 µL of 
DEPC water with 60% of formamide for future use.  
To precipitate the proteins from the fractions, a 400 µL aliquot was mixed with 70 µL 
of 100% (w/v) trichloroacetic acid and kept at 4 °C overnight. The sample was 
centrifuged at 13000 rpm for 20 minutes to precipitate proteins from the sucrose 
solution. The pellet was washed with 300 µL of acetone three times, dried in a heat 
block at 95 °C, resuspended in 30 µL of 1× SDS loading buffer and boiled for 5 
minutes. Protein samples were run in 10% SDS-PAGE and analyzed by Western blot. 
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RESULTS 
Aims of the study 
As described in Intronduction (Chapter I), the studies of NMD mechanism how the 
PTC has been differentiated from the normal termination codon mainly studied in S. 
cerevisiae, D. melanogaster and mammalian cells. Both of the proposed dominated 
merchanisms, faux 3’ UTR model and EJC model, which explain NMD in eukaryotes 
have the contradictory observations, suggesting that NMD might be a complexed 
consequence of mRNA reductions due to PTCs. To further investigate the 
explanations, the fission yeast, S. pombe, was chosen as the model organism in my 
PhD study to investigate NMD mechanism, mainly including the following questions: 
1. Whether the current explanation of NMD mechanism, faux 3’ UTR, are 
applied in S. pombe? 
2. Since S. pombe have much more introns in its genome, in comparison with S. 
cerevisiae, whether intron or splicing play a certain role in NMD in S. pombe? 
3. As suggested in fly and human cells, whether the endonucleolytic cleavage 
occurred in NMD in S. pombe? 
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CHAPTER III. BIOINFORMATIC ANALYSIS OF NMD PROTEINS 
IN S. POMBE 
3.1 Introduction 
It has already been reported that the genome of S. pombe contains orthologs of NMD 
factors such as UPF1 and UPF2 (Mendell et al., 2000; Rodriguez-Gabriel et al., 
2006). However, a systematic search for putative homologs of all known NMD 
factors has not yet been performed. In this chapter, I present the results of such a 
bioinformatic search. The study aimed to identify all the possible orthologs of NMD 
proteins in S. pombe, and also to analyze the domain organization of the proteins and 
their molecular evolution by using multiple sequence alignments, from single cell 
organisms, such as yeast, to metazoa.  
3.2 Results 
3.2.1 The orthologs of UPF proteins in S. pombe 
At the start of the project, I searched for homologs of the S. cerevisiae proteins, 
UPF1, UPF2 and UPF3 in the S. pombe complete protein database 
(http://www.genedb.org/) by omniBlast; The other protein sequences were retrieved 
from at the NCBI website (http://www.ncbi.nlm.nih.gov/sites/entrez?db =protein) and 
shown in Table 3.1. 
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Table 3.1 The homologs of NMD factors. 
 
 Human X. laevis D. 
melanogaster 
A. thaliana C. elegans S. pombe S. cerevisiae 
UPF1 Q92900 AAH73441 NP_572767 AAL92018 NP_490829 NP_593080 NP_013797 
UPF2 AAG60689 NP_001089661 NP_572434 NP_181459 NP_500974 NP_593784 NP_011944 
UPF3 AAG48511 (3B) 
NP_075387 
(3A) 
ENSXETG000
00007440 
NP_726375 NP_001117406 CAD18872 NP_593705 CAA97074 
SMG1 NP_055907 156595 NP_727132 No. AAD48773 No No 
SMG5 NP_056142 AAI23019* NP_609685 No. NP_491929 No No 
SMG6 NP_060045 356705* NP_651321 No. NP_497566 No No 
SMG7 NP_775179 NP_989258 No. NP_197441 NP_501033 N.A. N.A. 
eIF4AIII NP_055555 AAH84859 NP_649788 NP_188610 AAB96704 NP_592863 NP_010304 
MAGO NP_002361 NP_001079724 NP_476636 NP_171716 P49029 NP_596666 No 
Y14 NP_005096 NP_001083872 NP_610454 NP_564591 CAA83626 NP_594439 No 
RNPS1 NP_006702 Q5XG24 NP_649903 NP_173107 AAK21429 NP_596549 No 
MLN51 O15234 NP_001089026 NP_733229 NP_850944 NP_493346 No No 
 
Underlined accession numbers are derived from http://www.xenbase.org/ by blastp. Asterisk means that the sequences are not identified by 
blastp of SMG5/6 from C. elegans, but identified by using SMG5/6 from human. N.A. means that the sequences are not identified by blastp, 
although studies suggested the homolog in S. cerevisiae. 
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I identified orthologs of the three genes:  SPAC16C9.06c (UPF1), SPAC19A8.08 
(UPF2) and SPAC13G7.03 (UPF3). Protein sequence alignment with the 
corresponding orthologs in A. thaliana, C. elegans, D. melanogaster, Human, S. 
cerevisiae, S. pombe and X. laevis, showed the UPF1 and UPF2, are highly conserved 
from yeast to human (Fig 3.1 and 3.2), while UPF3 is much less conserved (Fig 3.3).  
S. pombe UPF1 shares 55.3% amino acid identity with human UPF1and 53.5% with 
S. cerevisiae UPF1. The fact that S. pombe UPF1 is slightly closer related to the 
human ortholog than S. cerevisiae UPF1. High sequence identity is apparent in two 
domains of UPF1, the cysteine-histidine rich domain (CH domain) and the RNA 
dependent ATPase/helicase domain. As described in the Introduction, the CH domain 
binds zinc and is involved in the interaction with UPF2 and eRF3 (Weng et al., 1996a; 
He et al., 1997; Serin et al., 2001; Kadlec et al., 2006; Ivanov et al., 2008; Clerici et 
al., 2009).  The helicase domain in the middle part of the protein is essential for NMD 
(Czaplinski et al., 1995; Weng et al., 1996a; Bhattacharya et al., 2000; Cheng et al., 
2007). As mentioned previously, the carboxyl termini of C. elegans and human UPF1 
have serine/threonine-glutamine rich (SQ-rich) motifs, which act as the 
phosphorylation sites of UPF1 and then regulate NMD via a phosphorylation/ 
dephosphorylation cycle of UPF1 (Page et al., 1999; Pal et al., 2001; Yamashita et al., 
2001). The alignment clearly shows that the SQ-rich motifs are present only in the 
UPF1 homologs derived from multicellular species. The lack of SQ motifs suggests 
that the phosphorylation of UPF1 might not be required for NMD in both yeasts or 
that at least the phosphorylation sites of UPF1 is very different between yeast and 
metazoa, although a study has reported the UPF1 and UPF2 are also phospholylated 
in S. cerevisiae (Wang et al., 2006).  
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Xl-UPF1 
At-UPF1 
Ce-UPF1 
Dm-UPF1 
H-UPF1 
Sc-UPF1 
Sp-UPF1 
10 20 30 40 50 60 70 80 90 100
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
--MSVEAYGPSSQTLTFLDTEEAELL-GADTQGSEFEFTDFTLPSQTQ----------------------GQSQSQLDGQVNGPDGMLQNG--TVDDGVG
-ASQPDTVADEYTFLEFNTQGDSEFDYQDFGSPTAWPTPSDSISIADVADRGEGGAAADHHSEAS--SPSSLSAGAGNGAKVGRGGVGGSGGVSSSSQVD
MDDSDDEYSRSHGETLTFVDPEDDGVSIGNTQDSQFAYEQFSVPTQSS--------------------------QATDLLPGGTDGTTNDLP--------
--MSVDTYAPSS-ALSFLDMDDNELLPGADTQPTQYDYRDFTMPSTSQ--------------------------SQTQNDQLEIAQRCSAG--DSHPRLA
--MSVEAYGPSSQTLTFLDTEEAELL-GADTQGSEFEFTDFTLPSQTQTPPGGPGGPGGGGAGGPGGAGAGAAAGQLDAQV-GPEGILQNG--AVDDSVA
--------------------------MVGSGSHTPYDISN----------------------------------SPSDVNVQPATQLNSTL---------
---------------------------MSLGLQPNNDISS----------------------------------LVSSKNMTSENGL-------------
110 120 130 140 150 160 170 180 190 200
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
KTSQLLGELNFEEDEED--TYYTK-DLPVHACSYCGIHDPACVVYCN--TSKKWFCNGRGNTSGSHIVNHLVRAKCKEVTLHKDGPLGETVLECYNCGCR
ALAAGVGNLNFEETGDDDGFDYGKNDFTEHACKYCGISNPACVVRCNVASCRKWFCNSRGNTSGSHIVNHLVRAKHKEVCLHRDSPLGETILECYNCGCR
-FHDVEDDESDSEKSLTEEQQQQK--LPEHACRYCGISDPLCVAKCT--VCRKWFCNSNDGTSGGHIVHHMVRSQHKEAYTHKDSPCGDTQLECYRCGSK
SITNDLADLQFEEEDDEPGSSYVK-ELPPHACKYCGIHDPATVVMCN--NCRKWFCNGRGSTSGSHIINHLVRAKHREVTLHGEGPLGETILECYSCGVR
KTSQLLAELNFEEDEED--TYYTK-DLPIHACSYCGIHDPACVVYCN--TSKKWFCNGRGNTSGSHIVNHLVRAKCKEVTLHKDGPLGETVLECYNCGCR
VEDDDVDNQLFEEAQVTETGFRSP-SASDNSCAYCGIDSAKCVIKCN--SCKKWFCNTKNGTSSSHIVNHLVLSHHNVVSLHPDSDLGDTVLECYNCGRK
-------EHQFEELLVEKQ-------YSEEHCAYCHIKNPNSILKCL--HCNKWFCNVRGKSGASHIISHLVRARHKQVALHSHSSLSDTVLECYNCGTR
210 220 230 240 250 260 270 280 290 300
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
NVFLLGFIPAKADSVVVLLCRQPCASQSSLKDINWDSSQWQPLIQDRCFLSWLVKIPSEQEQLRARQITAQQINKLEELWKENPSATLEDLEKPGVDEEP
NVFLLGFISAKTDSVVVLLCRDPCLNVNALKDMNWDLSQWCPLIDDRCFLPWLVKVPSEQEQLRARQISAQQINKIEELWKTNPDATLEDLEKPGVDDEP
NVFNLGFIPGKKDQVVVIICRTPCASIAFQNDDNWSPEDWKSVIAEKQLLSWIVNVPSEEQVARARKITATQAVRMEELWRDHPEATVDDLNKPGLDREP
NVFVLGFIPAKADSVVVLLCRQPCAAQNSLKDMNWDQEQWKPLIADRCFLAWLVKQPSEQGQLRARQISAAQINKLEELWKENIEATFQDLEKPGIDSEP
NVFLLGFIPAKADSVVVLLCRQPCASQSSLKDINWDSSQWQPLIQDRCFLSWLVKIPSEQEQLRARQITAQQINKLEELWKENPSATLEDLEKPGVDEEP
NVFLLGFVSAKSEAVVVLLCRIPCAQT---KNANWDTDQWQPLIEDRQLLSWVAEQPTEEEKLKARLITPSQISKLEAKWRSNKDATINDIDAPEEQEAI
NVFLLGFIPAKAKTVVVLLCRQPCARASIAKDMNWDLTQWQPIISDRQFLPWLITPPSEEEQKLAIPITSQQMVRLEELWRKDPNANLEDLDKPIEDDSL
310 320 330 340 350 360 370 380 390 400
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
QHVLLRYEDAYQYQNIFGPLVKLEADYDKKLKESQTQDNITVRWDLGLNKKRIAYFTLPKTDS-----------DMRLMQGDEICLRYKG-DLAPLWKGI
QPVQPKYEDAYQYQNVFAPLIKLEADYDKMMKESQSKENLTVRWDIGLNKKRVAYFVFPKEEN-----------ELRLVPGDELRLRYSGDAVHPSWQSV
DHVQLRYVDAHHYSKVFRPLVAIEAEYDRRVKESASQAVGTVRWEQGLRQSVLAFFHLPQFADG----------VMKLAKGDELRLKHSQTVDGSEWTKI
AHVLLRYEDGYQYEKTFGPLVRLEAEYDQKLKESATQENIEVRWDVGLNKKTIAYFTLAKTDS-----------DMKLMHGDELRLHYVG-ELYNPWSEI
QHVLLRYEDAYQYQNIFGPLVKLEADYDKKLKESQTQDNITVRWDLGLNKKRIAYFTLPKTDSGNEDLVIIWLRDMRLMQGDEICLRYKG-DLAPLWKGI
PPLLLRYQDAYEYQRSYGPLIKLEADYDKQLKESQALEHISVSWSLALNNRHLASFTLSTFESN----------ELKVAIGDEMILWYSG-MQHPDWEGR
PSVELRYKDAHAYQAVLSPLIQAEADYDKRLKESQTQKDVVVRWDQAINKRYTAWFLLPKLESG----------EIRLAIGDEMKLTYEG-ELRAPWSST
410 420 430 440 450 460 470 480 490 500
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
GHVIKVPDNYGDEIAIELRSSVG-APVEVTHNFQVDFVWKSTSFDRMQSALKTFAVDETSVSGYIYHKLLGH----EVEDVIIKCQLPKRFTAQGLPDLN
GHVIKLTA--QEEVALELRANQG-VPIDVNHGFSVDFVWKSTSFDRMQGAMKNFAVDETSVSGYIYHQLLGH----EVEAQMVRNTLPRRFGVPGLPELN
GSVFKIPDNHGDEVGIEIRGAVDKSVMESRIMFTVDVVWNATTFERQYKALAALLNDSKAISPYLYQKLLGH----PAEEMMLKFDLPRRLSVAGLPELN
GHVIKVPDNFGDDVGLELKSSTN-APVKCTSNFTVDFIWKCTSFDRMTRALCKFAIDRNSVSNFIYSRLLGHGRADSNDEVLFRGPQPKLFSAPHLPDLN
GHVIKVPDNYGDEIAIELRSSVG-APVEVTHNFQVDFVWKSTSFDRMQSALKTFAVDETSVSGYIYHKLLGH----EVEDVIIKCQLPKRFTAQGLPDLN
GYIVRLPNSFQDTFTLELKPSKTPPPTHLTTGFTAEFIWKGTSYDRMQDALKKFAIDKKSISGYLYYKILGH----QVVDISFDVPLPKEFSIPNFAQLN
GYVIKIPNNVSDEVGLELKRSDK-VPIECTHNFSVDYVWKSTSFDRMQTALRLFATDGSRLSSFLYHKLLGH----DIPPSFLKPKLPSDLSVPNLPKLN
510 520 530 540 550 560 570 580 590 600
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
HSQVYAVKTVLQRPLSLIQGPPGTGKTVTSATIVYHLARQGNGP------VLVCAPSNIAVDQLTEKIHQTGLKVVRLCAKSREAIDSPVSFLALHNQIR
ASQVNAVKSVLQKPISLIQGPPGTGKTVTSAAIVYHMAKQGQGQ------VLVCAPSNVAVDQLAEKISATGLKVVRLCAKSREAVSSPVEYLTLHYQVR
SSQMQAVKQVLTRPLSLIQGPPGTGKTVVSATIVYHLVQKTEGN------VLVCSPSNIAVDHLAEKIHKTGLKVVRLCARSREHSETTVPYLTLQHQLK
RSQVYAVKHALQRPLSLIQGPPGTGKTVTSATIVYQLVKLHGGT------VLVCAPSNTAVDQLTEKIHRTNLKVVRVCAKSREAIDSPVSFLALHNQIR
HSQVYAVKTVLQRPLSLIQGPPGTGKTVTSATIVYHLARQGNGP------VLVCAPSNIAVDQLTEKIHQTGLKVVRLCAKSREAIDSPVSFLALHNQIR
SSQSNAVSHVLQRPLSLIQGPPGTGKTVTSATIVYHLSKIHKDR------ILVCAPSNVAVDHLAAKLRDLGLKVVRLTAKSREDVESSVSNLALHNLVG
ASQSEAVRAVLSKPLSLIQGPPGTGKTVTSASVVYHLATMQSRKRKSHSPVLVCAPSNVAVDQLAEKIHRTGLRVVRVAAKSREDIESSVSFLSLHEQIK
610 620 630 640 650 660 670 680 690 700
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
NMES--MPELQKLQQLKDETGELSSADEKRYRALKRTAERELLMNADVICCTCVGAGDPRLAKMQFRSILIDESTQATEPECMVPVVLGAKQLILVGDHC
HLDTSEKSELHKLQQLKDEQGELSSSDEKKYKNLKRATEREITQSADVICCTCVGAADLRLSNFRFRQVLIDESTQATEPECLIPLVLGVKQVVLVGDHC
VMGG---AELQKLIQLKDEAGELEFKDDLRYMQLKRVKEHELLAAADVICCTCSSAADARLSKIRTRTVLIDESTQATEPEILVSIMRGVRQLVLVGDHC
NMET--NSELKKLQQLKDETGELSSADEKRYRNLKRAAENQLLEAADVICCTCVGAGDGRLSRVKFTSILIDESMQSTEPECMVPVVLGAKQLILVGDHC
NMDS--MPELQKLQQLKDETGELSSADEKRYRALKRTAERELLMNADVICCTCVGAGDPRLAKMQFRSILIDESTQATEPECMVPVVLGAKQLILVGDHC
-RGAK--GELKNLLKLKDEVGELSASDTKRFVKLVRKTEAEILNKADVVCCTCVGAGDKRLDT-KFRTVLIDESTQASEPECLIPIVKGAKQVILVGDHQ
NYKFN--PELQRLLKLRSENNELSIQDEKKLRILVAAAEKELLRAAHVICCTCVGAGDRRISKYKFRSVLIDEATQASEPECMIPLVLGAKQVVLVGDHQ
710 720 730 740 750 760 770 780 790 800
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
QLGPVVMCKKAAKAGLSQSLFERLVVLGIRPIRLQVQYRMHPALSAFPSNIFYEGSLQNGVTAADRVKKGFDFQWPQPDKPMFFYVTQGQEEIASSGTSY
QLGPVIMCKKAARAGLAQSLFERLVTLGIKPIRLQVQYRMHPALSEFPSNSFYEGTLQNGVTIIERQTTGIDFPWPVPNRPMFFYVQLGQEEISASGTSY
QLGPVVICKKAAIAGLSQSLFERLVLLGIRPFRLQVQYRMHPVLSEFPSNVFYDGSLQNGVTENDRHMTGVDWHWPKPNKPAFFWHCSGSEELSASGTSF
QLGPVVMCKKAARAGLSQSLFERLVVLGIRPFRLEVQYRMHPELSQFPSNFFYEGSLQNGVCAEDRRLK-LDFPWPQPERPMFFLVTQGQEEIAGSGTSF
QLGPVVMCKKAAKAGLSQSLFERLVVLGIRPIRLQVQYRMHPALSAFPSNIFYEGSLQNGVTAADRVKKGFDFQWPQPDKPMFFYVTQGQEEIASSGTSY
QLGPVILERKAADAGLKQSLFERLISLGHVPIRLEVQYRMNPYLSEFPSNMFYEGSLQNGVTIEQRTVPNSKFPWPIRGIPMMFWANYGREEISANGTSF
QLGPVVMNKKVALASLSQSLFERLIILGNSPFRLVVQYRMHPCLSEFPSNTFYEGTLQNGVTTSERIARHVDFPWIQPDSPLMFYANFGQEELSASGTSF
CH domain 
ATP binding 
To next page 
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Figure 3.1 UPF1 protein analysis.  
Sequence alignment of UPF1 in S. cerevisiae (S.c.), S. pombe (S.p.), C. elegans (C.e.), 
A. thaliana (A.t.), D. melanogaster (D.m.), X. laevis (X.l.) and human (H). Protein 
sequences are listed in Table 3.1. The alignment was performed with ClustalW, 
BioEdit (described in http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Identical 
residues are highlighted in red; similar residues in green. 
 
Xl-UPF1 
At-UPF1 
Ce-UPF1 
Dm-UPF1 
H-UPF1 
Sc-UPF1 
Sp-UPF1 
810 820 830 840 850 860 870 880 890 900
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
LNRTEAANVEKITTKLLKAGAKPDQIGIITPYEGQRSYLVQYMQFSGSLHTKLYQEVEIASVDAFQGREKDFIILSCVRANEHQGIGFLNDPRRLNVALT
LNRTEAANVEKLVTAFLKSGVVPSQIGVITPYEGQRAYIVNYMARNGSLRQQLYKEIEVASVDSFQGREKDYIILSCVRSNEHQGIGFLNDPRRLNVALT
LNRTEAANVEKLVSKLIKAGVQPHQIGVITPYEGQRSFIVNYMHTQGTLNSKLYENVEIASVDAFQGREKDYIIVTCVRSNDILGIGFLSDPRRLNVAIT
LNRTEAANVEKITTRFLKAGIKPEQIGIITPYEGQRAYLVQYMQYQGSLHSRLYQEIEIASVDAFQGREKDIIIMSCVRSNERQGIGFLNDPRRLNVALT
LNRTEAANVEKITTKLLKAGAKPDQIGIITPYEGQRSYLVQYMQFSGSLHTKLYQEVEIASVDAFQGREKDFIILSCVRANEHQGIGFLNDPRRLNVALT
LNRIEAMNCERIITKLFRDGVKPEQIGVITPYEGQRAYILQYMQMNGSLDKDLYIKVEVASVDAFQGREKDYIILSCVRANEQQAIGFLRDPRRLNVGLT
LNRTEASTCEKIVTTFLRSNVLPEQIGIVTPYDGQRSYIVQYMQNNGSMQKDLYKAVEVASVDAFQGREKDFIILSCVRSSEHQGIGFVNDPRRLNVALT
910 920 930 940 950 960 970 980 990 1000
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
RARYGVIIVGNPKALSKQPLWNHLLNYYKEQKVLVEGPLNNLRESLMQFSKPRKLVNT----INPGARFMTTA---MYDAREAIIP--------GSVYDR
RARYGIVILGNPKVLSKQPLWNGLLTHYKEHECLVEGPLNNLKQSMVQFQKPRKIYNDRRLFYGGGAGMIGND---NFGSGNPNADRRGSRGRAGGSYLP
RAKYGLVLVGNAKVLARHDLWHELINHYKSKEMLYEGPINALKPLNLALPKATIRTKNN--IAGNANRFGIKRMQYTFNEYKSNDP--------------
RAKFGIIIVGNPKVLAKQQLWNHLLNFYKDRKVLVEGSLNNLKESLIHFQKPKKLVNS----MNIGAHFMSTI---IADAKEVMVP--------GSIYDR
RARYGVIIVGNPKALSKQPLWNHLLNYYKEQKVLVEGPLNNLRESLMQFSKPRKLVNT----INPGARFMTTA---MYDAREAIIP--------GSVYDR
RAKYGLVILGNPRSLARNTLWNHLLIHFREKGCLVEGTLDNLQLCTVQLVRPQ-PRKTER---PMNAQFNVESEMGDFPKFQD-----------------
RAKYGVIVLGNPKVLAKHALWYHFVLHCKEKGYLVEGTLNSLQKFSLTLTPPQKPQKFKR---DLNVQR-------SLSPIQN-----------------
1010 1020 1030 1040 1050 1060 1070 1080 1090 1100
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
SS---QGR-----------------------------PSN------------------------------MYFQTHDQIGMIG----SGPSHVTAMNIPI
SGPPNGARPGLHPAGYPIPRVPLSPFPGGPPSQPYAIPTRGPVGAVPHAPQPGNHGFGAGRGTSVGGHLPHQQATQHNVGTIGPSLNFPLDSPNSQPSPG
------------------------------------------------------------------------------SQPRLPPTYSNSQNLLSMSKLA
SGGYGQGRQMVGQSMNGGQYGGSGGGPYGNSPLGYGTPSSNSMVGFGLGNGGNGAAGGNNNFGGAGPSWAAAHLHHDSIGYISN--EHGAAALGNMPVPV
SS---QGR-----------------------------PSS------------------------------MYFQTHDQIGMIS----AGPSHVAAMNIPI
---------------------------------------------------------------------------------------FDAQSMVSFSGQI
---------------------------------------------------------------------------------------AGSAMLPSFS---
1110 1120 1130 1140 1150 1160 1170 1180 1190 1200
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
PFNLVMPPMPP----------------------PGYFGQANGPAPGRGMPKGKSTR--GGRPKQRGIGLQGMS---QGNMPNSQASQDVVSQPFSQGP--
GPLSQPGYGSQAFRDGFSMGGISQDFLADDIKSQGSHDPYNMADFATQASPGGFAVDYATQGAHGAFPGNFMNQNSQGGYSRFSGINDFMSQEYMAHGGQ
QTFNKNVPIP------------------------------------AHMMDPNVYAAARNQKDRRRGDQRRPPPQAEAAMDLSQGMMSQQSQQYPPQG--
GMFMNMSNIPPRFYNQHQQAIMAVKQNRAIQQQTGNFSPGNSGPGVTGVGVGRSATP-GGNKKTNKLGKSRVTGGGTGGAPLTQGSSVCNAAPYSQHP--
PFNLVMPPMPP----------------------PGYFGQANGPAAGRGTPKGKTGR--GGRQKNR-FGLPGPS---QTNLPNSQASQDVASQPFSQGA--
GDFGN------------------------------------------------------------------------AFVDNTELSSYINNEYWNFEN--
------------------------------------------------------------------------------NLPNLYSSSYL--EEWN-----
1210 1220 1230 1240 1250 1260 1270
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. ..
---LTQGYISMSQPSQMSQPG-LSQPELSQDSYLGDEFKSQIDVALSQDSTYQGERAYQHGGVTGLSQY----
GLFTQAGFIDSSQDDGQQNPYGVNNPNLQSQGLPNSLYSQPFAHYNTQPLNLSGPQQSQPNQSSQNPKHPYNG
----ASSQSQYLLDGASSLSG---WSQSQTTTTTTRHHHHRQNRNSQQQMSQDMDDIQQKMDDLLFSQDC---
---MPLS-LQMTQPSGFALS---QQPELSQD--FG--QISQMDGLLSQDVAFN---ASGERSLNQFSQPY---
---LTQGYISMSQPSQMSQPG-LSQPELSQDSYLGDEFKSQIDVALSQDSTYQGERAYQHGGVTGLSQY----
---FKSAFSQKQNRNEIDDRN---------------LYQEEASHLNSNFARELQREEQKHELSKDFSNLGI--
------VFAQYKRR-------------------------ESNATDFEDFRSQVGDDESKFDEPTRF-------
SQ motif 
RNA helicase domain 
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Multiple sequence alignment of UPF2 showed 22.5% identity of amino acids between 
S. pombe and human, 19.8% between S. cerevisiae and human, and 16.5% between S. 
cerevisiae and S. pombe. UPF2 contains three consecutive well-conserved MIF4G 
domains (middle domain of eukaryote initiation factor 4G) and the last MIF4G 
mediates the interaction with the RRM domain of UPF3 (He et al., 1997; Serin et al., 
2001; Kadlec et al., 2004). In UPF2, downstream of the MIF4G domains, there is the 
conserved carboxyl terminus that interacts with UPF1 (He et al., 1997; Serin et al., 
2001). Additionally, the amino terminus of human UPF2 contains two functional 
domains, the nuclear localization signals which are not conserved in S. cerevisiae and 
S. pombe, and an extra UPF1 interaction domain (residues 93 -133) which is not 
present in both yeasts (Fig. 3.2) (Serin et al., 2001). In contrast, S. cerevisiae UPF2 is 
phosphorylated at an amino-terminal serine residue, and the residues in the amino-
terminus mediate the interaction with Hrp1p and modulate NMD (Wang et al., 2006). 
The region between the third MIF4G and UPF1 binding domain, an extraordinary 
long Glu and Asp rich sequence, termed as acidic amino-acid rich domain (Ac 
domain), has been reported as an essential motif to interact with eRF3 in S. cerevisiae 
and human cells (He et al., 1997; Serin et al., 2001). As for the UPF1 interaction and 
eRF3 interaction regions, the Ac domain is not well conserved between S. cerevisiae 
and the other organisms, especially S. pombe (Fig. 3.2).  
Unlike UPF1, UPF3 is not well conserved between yeast and metazoa. The protein is 
poorly conserved even between S. cerevisiae and S. pombe. Protein sequence 
alignment showed the 20.7% amino acid identity between S. pombe and human, 9.5% 
between S. cerevisiae and human, and 12.9% between S. cerevisiae and S. pombe. 
The UPF2 interaction region is well conserved between the two yeast species and the 
other organisms. The carboxyl terminus of human UPF3 has been previously shown 
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Xl-UPF2 
At-UPF2 
Ce-UPF2 
Dm-UPF2 
H-UPF2 
Sc-UPF2 
Sp-UPF2 
10 20 30 40 50 60 70 80 90 100
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
MPAERKKPAGMEEKESPSSPRDKECTEKKATSSKDRVKDEPKACTKRDQSKASEEKKKQTDEDKQRKEDKECKTKEEDQVKADDEQMNTDG----KNQDD
----------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------
------------------------------------MLANDSATTDSEVSTPPSSRKDLADGVAEGDNDNDIDTGDTD----------------------
MPAERKKPASMEEKDSLPNNKEKDCSERRTVSSKERPKDDIKLTAKKEVSKAPEDKKKRLEDDKRKKEDKERKKKDEEKVKAEEESKKKEEEEKKKHQEE
----------------------------------------------------------------------------------------------------
----------------------------------------------------------------------------------------------------
110 120 130 140 150 160 170 180 190 200
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
EMKKKQEEEEANQREAAALQIKEKDEANQLHQEAWERHHTRKELRSKNQNAPENRPEESFFSRLDSSLKKNTAFVKKLK-TITEQQRDSLSHDFNSLNLS
---------MDHPEDESHSEKQDDEEALARLEEIKKSIEAKLTLRQNNLNP--ERPDSAYLRTLDSSIKRNTAVIKKLK-QINEEQREGLMDDLRGVNLS
----MRRKVETSWLEELKKRVKYQETSRLQMVEIRETLLD----------------NEKELRSLDSTLKKTTSFMKKVK-LLSAATVPQLIEELSKLNLS
----ANADEDVDAAAAIALEAEEREELQQFISELREKIESKRQLR--LQNSTIELPGEEYFAKLDSNLKKNTAFVKKLK-LFTATQLDGLLREISALNLS
ERKKQEEQAKRQQEEEAAAQMKEKEESIQLHQEAWERHHLRKELRSKNQNAPDSRPEENFFSRLDSSLKKNTAFVKKLK-TITEQQRDSLSHDFNGLNLS
-----MDDGRKKELHDLNTRAWNGEEVFPLKS-----------------------------KKLDSSIKRNTGFIKKLKKGFVKGSESSLLKDLSEASLE
-------MSREEQIKKLNQYLDNRELAFRAKDGDKNIFHT--------------------ESQLDSSLKKNTAFMKRCKSSLTSENYDSFIKEIKTLSLK
210 220 230 240 250 260 270 280 290 300
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
KYIAEAAASIVEAKLKIS----DVNCAVHLCSLFHQRY-ADFAQSLLQVWKKHFEARK------EEKTPNITKLRTDLRFIAELTIIGIFTDKEGLSLNY
KFVSEAVTAICEAKLKSS----DIQAAVQICSLLHQRY-KEFSASLTQGLLKVFFPGKSAEDLEADKNSKAMKKRSTLKLLLELYYVGVIEDSNIFINII
KFVEEMASGIIETKLKLS----DIPKVTELCLAISAKY-SNFSEQMAGEFKKVLPVKK------SDKIANVAKLRVDIIFLAELCLCGVFNEKEGLQVLG
KYISEICAALVEAKLKMT----DVPAVVTLASRLHCTY-ADFDVHFLEAWQKALNIKA------TEKIGNPSKLRVDLRLFAELVSSGVIQMKPGLAQLG
KYIAEAVASIVEAKLKIS----DVNCAVHLCSLFHQRY-ADFAPSLLQVWKKHFEARK------EEKTPNITKLRTDLRFIAELTIVGIFTDKEGLSLIY
KYLSEIIVTVTECLLNVLNKNDDVIAAVEIISGLHQRFNGRFTSPLLGAFLQAFENPSVDIESERDELQRITRVKGNLRVFTELYLVGVFRTLDDIESKD
KFIPEITAAIVEGMMKCK----ATKDILSSVKIVWALN-LRFSTAFTGPMLANLYCAL------YPNPGYSLCHESYFELKQNENEVSEKDRSSHLLKVR
310 320 330 340 350 360 370 380 390 400
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
EQLKNIINADR--ETHTHVSVVISFCRHCGDDIAGLV---PRKVKCAAEKYNLNFPPSEIINPEKQQPFQNLLKEYFTSLTKHLKRDHRELQNIERQNRR
KDLTSVEQLKDRDTTQTNLTLLTSFARQGRIFLG-----------LPISGQDEDFFKGLDVTADQKKSFKKAFNTYYDALADLLQSEHKLLLQMEKENAK
AVLSYLIQTDK--TDFVNVGLLATVSRTVGWQIANIVP-IPMDDAETVEIQDEELPESSALSVEQKKSIRELFKSYYDSLYSKTEKTCSARNKAMKRVKR
VVLVHLIALDK--DDHSNFSIILSFCRHCGEEYAGLV---PQKMQQLATKYGVEVPKSDFLTADKQLNLRTMLKGYFKALCKHVLAEQAELMNMTKNIRR
EQLKNIINADR--ESHTHVSVVISFCRHCGDDIAGLV---PRKVKSAAEKFNLSFPPSEIISPEKQQPFQNLLKEYFTSLTKHLKRDHRELQNTERQNRR
AIPNFLQKKTGRKDPLLFSILREILNYKFKLGFTTTIATAFIKKFAPLFRDDDNSWDDLIYDSKLKGALQSLFKNFIDATFARATELHKKVNKLQREHQK
PLLRFLIEFWLNGVVGTPEDFVSYLPSTDSNDKKFRK---PWFEEQNLKKPLVVLLFNDLMDTRFGFLLLPVLTSLVRTFSCELFTTEDFEDKETLELVN
410 420 430 440 450 460 470 480 490 500
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
ILHTKGELSEDRHKQYEEFATSYQKLLASCQSLADLLDENMPELPQDKPAPEEHGPGIDIFTPGKPGDYDLEGGIWEDEDARNFYENLIDLKAFVP----
LVNAKGELSEDSASSYEKLRKSYDHLYRNISSLAEALDMQPPVMPED--GTTRLTAGDEASPSGTVKDTSVPEPIWDDEDTKTFYECLPDLRAFVPAVLL
QERSRGDAGDEEKTTLNDLQSELDSLRKMAIEISSAIGVEMKPLKEEASDDEEDEAANLEMG---RKLAEGAIKLWSDEETKAFYEDLIDLRQMVP----
TMECKGEISTEKREKCELMQAGFDKLLASAQSLSELLGEPLPELAKE---SEGCNPGTVIDNMLDSASFGVLD-PWGDEETRAFYTDLPDLRQFLPNFSA
ILHSKGELSEDRHKQYEEFAMSYQKLLANSQSLADLLDENMPDLPQDKPTPEEHGPGIDIFTPGKPGEYDLEGGIWEDEDARNFYENLIDLKAFVP----
CQIRTGKLRDEYVEEYDKLLPIFIRFKTSAITLGEFFKLEIPELEGASNDDLKETASPMITN----QILPPNQRLWENEDTRKFYEILPDISKTVE----
RLN-PVVWRTYLRKSLNSYVDKLEVYCQKRKSLFEELNKQYQEQSIIRADPNNEKFQRLANFSKSIESEFSSYASLSEVLNRKASEDLLELNFMEKASSG
510 520 530 540 550 560 570 580 590 600
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
-----AILFKDNEKSSQSKETGKDNVKDTKE----KDVPTTEE---LELELETLDINDDGIEMEGAEDAEDLTKKLLDEQEQEDEEASTGSHLKLIVDAF
GEAEPKSNEQSAKAKEKLSESSSEVVENQQTTEDTTEVSADSASMDDRSNAEQPKEKEEVEKEKAKDTKKEKGKEKDSEKKMEHEKEKGKSLDVANFERL
-----KDLYKESEQRTLSKAKMAERIEDVDMENINESGAMDAK---------------RSSLQRGESEKETTPEDSQLQALLKEAVDASEERGVSKWQSF
PKVDLETLEEPSELTEEAIDANLDAEMDLDDPPSTTSDTTPENPI-EEQPTTPVAAAEDLKPQKMGNALMELGRQQQQQSQLNQNPIQIQNQMRQQFDGF
-----AILFKDNEKSCQNKESNKDDTKEAKESKENKEVSSPDD---LELELENLEINDDTLELEGGDEAEDLTKKLLDEQEQEDEEASTGSHLKLIVDAF
-------------------------------------------------------------------------------ESQSSKTEKDSNVNSKNINLF
----TNSVFNASGERSESANVETAQVWDDREQYFFYEVFPNFN------EGSIAEMKSSIYESSQEGIRSSSENNKKEDDLKDSTGDLNTTQVSSRVDNF
610 620 630 640 650 660 670 680 690 700
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
IQQLPNCVNRDLIDKAAMDFCMN-MNTKANRRKLVRALFIVPRQRLDLLPFYARLVATLHPCMSDIAEDLCSMLKGDFRFHVRKKDQ-----INIETKNK
LQRLPGCVSRDLIDQLTVEYCY--LNSKTNRKKLVKALFNVPRTSLELLAYYSRMVATLASCMKDIPSMLVQMLEDEFNSLVHKKDQ-----MNIETKIR
VLDLDHLVSKYSTDQAAIYFVSN-LNNKGCRKRLVKLMIDPPPSRIDVVPFYARLVATLENVMPDLTTEIVTQLLEKFRGFLQQKPSSATAIIKVESKMV
LVNLFNCVNKELIDSAAIEFLLN-FNTKHQRKKLTRTIFSVQRTRLDILPYLSRFVAIVHMCNTDVATDLAELLRKEFKWHIHKKNQ-----LNIETKLK
LQQLPNCVNRDLIDKAAMDFCMN-MNTKANRKKLVRALFIVPRQRLDLLPFYARLVATLHPCMSDVAEDLCSMLRGDFRFHVRKKDQ-----INIETKNK
FTDLEMADCKDIIDDLSNRYWSSYLDNKATRNRILKFFMET--QDWSKLPVYSRFIATNSKYMPEIVSEFINYLDNGFRSQLHSNKIN----------VK
LLKLPSMVSLELTNEMALEFYD--LNTKASRNRLIKALCTIPRTSSFLVPYYVRLARILSQLSSEFSTSLVDHARHSFKRMIHRKAK-----HEYDTRLL
710 720 730 740 750 760 770 780 790 800
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
TVRFIGELAKFKMFNKTDTLHCLKMLLSDFSH-HHIEMACTLLETCGRFLFRSSDSHLRTSVLLEQMMRKKQAMHLDARYVTMVENAYYYCNPPPAEK--
NIRFIGELCKFKIVPAGLVFSCLKACLDEFTH-HNIDVACNLLETCGRFLYRSPETTLRMTNMLDILMRLKNVKNLDPRQSTLVENAYYLCKPPERSA--
CVMMIAELMKFGVISRAEGLSCLRQLVYDLRG-HSVEMTATFMESSGLYLYRHTESHAKMKRLLEVVKAKR-ERMKDQRQAMLIDNAYFTCLPPEDSKEE
IVRFIGELVKFGLFKKFDALGCLKMLLRDFQH-HQIEMACAFVEVTGVYLYNCRDARLLMNVFLDQMLRLKTATAMDSRHAAQIESVYYLVKPPESSK--
TVRFIGELTKFKMFTKNDTLHCLKMLLSDFSH-HHIEMACTLLETCGRFLFRSPESHLRTSVLLEQMMRKKQAMHLDARYVTMVENAYYYCNPPPAEK--
NIIFFSEMIKFQLIPSFMIFHKIRTLIMYMQVPNNVEILTVLLEHSGKFLLNKPEYKELMEKMVQLIKDKKNDRQLNMNMKSALENIITLLYPPSVKSLN
IVRYISELTKFQLMPFHMVFECYKLCINEFTP-FDLEVLALLLESCGRFLLRYPETKLQMQSFLEAIQKKKLASALASQDQLVLENALHFVNPPKRGI--
Hrp1p binding domain 
MIF4G 
MIF4G 
To next page 
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Figure 3.2 UPF2 protein analysis. 
Sequence alignment of UPF2 in S.c., S.p., C.e., A.t., D.m., X.l. and human. Protein 
sequences are listed in Table 3.1. The alignment was performed with ClustalW, 
BioEdit (described in http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Identical 
residues are highlighted in red; similar residues in green. 
 
Xl-UPF2 
At-UPF2 
Ce-UPF2 
Dm-UPF2 
H-UPF2 
Sc-UPF2 
Sp-UPF2 
810 820 830 840 850 860 870 880 890 900
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
----TVKKKRPPLQEYIRKLLYKDLSKVTTEKVLRQMRKLSWQDLEVKNYVICCMINIWNVKYNSIHCVANLLAGLV--LYQEDVGIHVVDGVLEDIRLG
----RISKVRPPLHQYVRKLLFSDLDKDSIANVLKQLRKLPWS--ECEQYILKCFMKVHKGKYGQIHLIASLTSGLS--RHHDEFVVAVVDEVLEEIRVG
RLRLKLDEEDTPMKRFIRHIILDIN-ESTVDVFLKCLRRLEWYDPEVADYAIRYLSSTWLLPIENLQHVASAIAGLCNLVHLQWIGMAVIDSTIETIRIS
----REPMVRPAMHEYIRYLIFEELCKQNVDRCIKMLRRIDWQDPETNCYAIKCLSKAYLLRFQLIRCLADLVSGLS--SYQPRAVTIVIDNVFEDIRAG
----TVKKKRPPLQEYVRKLLYKDLSKVTTEKVLRQMRKLPWQDQEVKDYVICCMINIWNVKYNSIHCVANLLAGLV--LYQEDVGIHVVDGVLEDIRLG
----VTVKTITPEQQFYRILIRSELSSLDFKHIVKLVRKAHWDDVAIQKVLFSLFSKPHKISYQNIPLLTKVLGGLY--SYRRDFVIRCIDQVLENIERG
----IVSKKKSLKEEFLYDLIQIRLKDDNVFPTLLLLRKFDWK--DDYQILYNTIMEVWNIKYNSLNALARLLSALY--KFHPEFCIHVIDDTLESLFSA
910 920 930 940 950 960 970 980 990 1000
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
MEVNQPKFNQRRISSVKFLGELYNYRMVESAVIFRTLYSFIFFGVNSD-GSPSPLDPP---EHLFRLRLVCTILDTCGQYFDRGSSKRKLDCFLVYFQRY
LELNEYGAQQKRLAHMRFLGELYNYEHVDSSVIFETLYLTLLYGHDTS--EQEVLDPP---EDFFRVRMVIILLETCGHYFDRGSSKKRLDQFLIHFQRY
LENPG-VYNQWAHSAAVYLAELYSFELCDEDLVLKILYQLISY--------PEPENSW---RDLHRIRMICAMLEILREFFMKGSGKIKMRYFLSYFHRY
LEIHSPRMAQRRIAMAKYLGEMYNYKLVESTNILNTLYSIISLGVSNDQNVVSPLDPP---DSLFRLKLACMLLDTCAPYFTSQATRKKLDYFLVFFQHY
MEVNQPKFNQRRISSAKFLGELYNYRMVESAVIFRTLYSFTSFGVNPD-GSPSSLDPP---EHLFRIRLVCTILDTCGQYFDRGSSKRKLDCFLVYFQRY
LEINDYGQNMHRISNVRYLTEIFNFEMIKSDVLLDTIYHIIRFGHINNQPNPFYLNYSDPPDNYFRIQLVTTILLNINR--TPAAFTKKCKLLLRFFEYY
VNNSDHVEKQKRLAQARFISELCVIHMLDVRAITNFLFHLLPLEKFESFLTMKASTLTNINNDMFRLRLIVVVLQTCGPSIIRSKTKKTMLTYLLAYQCY
1010 1020 1030 1040 1050 1060 1070 1080 1090 1100
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
FWWKKSLDVWTKDYP----------FPIDIDYMISDTLELLRPKMKLCVSLNESVRQVQDLEREFLTKLGLMNDKESKHSMTEGDLVYEDDDEEEEGGAE
ILSKG-------------------HLPLDIEFDLQDLFANLRPNMTRYSTIDEVNAAILQLEEREHASSGDKVSIERHSDTKPSNKSSSDVISSNGKSTA
YYIKKDAWDQEVAEQQPNSGGETGENQNPLDVQTSFPYEVELAYTELCRQFRQKKSNSLRWPKNLKEAQDIVTKIEKKFKGELKEFAGEHKDIEGDGLNE
YWFKKSHPVFSKTENTSD------LFPILMDHTYRDCLLNVRPKLKIYKSLEQAKAAIDHLQEKLYPQLKTTNNAQDPSLGTISEISEIDEGGTDEDSGS
VWWKKSLEVWTKDHP----------FPIDIDYMISDTLELLRPKIKLCNSLEESIRQVQDLEREFLIKLGLVNDKDSKDSMTEGENLEEDE-EEEEGGAE
TFIKE--------------------QPLPKETEFRVSSTFKKYENIFGNTKFERSENLVESASRLESLLKSLNAIKSKDDRVKGSSASIHNGKESAVPIE
FLIQP-------------------EMPLDMLYEFEDVIGYVRPSMKVYMHYEEARNALTERLQAISDDWEEDDTRPVFQGANDGDISSNEESVYLPEDIS
1110 1120 1130 1140 1150 1160 1170 1180 1190 1200
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
TEEQSGNESEMNE-QEEDASENEEDEREEEEEENTDYMT-------DSNKENETDEENNEVMIKGGGIKHVPCAEDEDFIQALDKMMLENLQQRSVESVK
KDIRENGEAHGEESDSDSGSGSVVRDGQNEELDDGNHERGSESGDGDDYDDGDGPGSDDDKFRVRQKVVTVDLEEQADFDQELKALLQESMEQRKLELRG
LNVIEEDDEEDEDENRDSELDEDDSEEDRQKIENFSNAVT--------KEEDDEFQRELDRMMGEGFRQSAMPVAAAQYDVTLPAAVKDRFNRSIKFAET
SNDQRERQVSGQEQDQSNDWTENEAEPPLPPLPPPEKSK-------EDLEFEQLYEKMTTDSYQERLKEPIKATAKDIPVPMMARLQKKSYDQITGAQTI
TEEQSGNESEVNEPEEEEGSDNDDDEGEEEEEENTDYLT-------DSNKENETDEENTEVMIKGGGLKHVPCVEDEDFIQALDKMMLENLQQRSGESVK
SITEDDEDEDDENDDGVDLLGEDEDAEISTPNTESAPGKHQAKQDESEDEDDEDDDEDDDDDDDDDDDDGEEGDEDDDEDDDDEDDDDEEEEDSDSDLEY
DESETDEESSGLEESDLLDSEDEDIDN--------------------------------------------EMQLSRELDEEFERLTNESLLTRMHEKN-
1210 1220 1230 1240 1250 1260 1270 1280 1290 1300
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
VHQLDVAIPLHLKSQLKKGPALS-----------------------IAEVDTESGDTMPFVMLTR--RGNKQQFKILNVPMSSQLAANHWNQQQAEQEER
RPALNMTIPMSVFEGSGKDHHHFGRVVGENG---------------EEVLDEENGEQREVQVKVLVKRGNKQQTRQMLIPSDCALVQSTKQKEAAELEEK
VKDEPAASSSKQDNDDDEDVYEK-----------------------SPTIAASGRQKQTRVTLMVRGKTNKPSLKTVNID-DDQLQERWKEEKAREEQER
GPGINNMSQISKSVPNQDGTPGSPGADSPDGNGKSGGGVGGSDVGAAGAAGASGATSVPFVLMVRGHKGGKQQFKSFVAPSDSHLATNLKRQEQMIREEK
VHQLDVAIPLHLKSQLRKGPPLG-----------------------GGEGEAESADTMPFVMLTR--KGNKQQFKILNVPMSSQLAANHWNQQQAEQEER
GGDLDADRDIEMKRMYEEYERKLK----------------------DEEERKAEEELERQFQKMMQESIDARKSEKVVASKIPVISKPVSVQKPLLLKKS
-PGFDVPLPLRASSLGSPYVTRN---------------------------EESASESSHVMFTLLTKRGNKQRSQYLEIPSHSSLVRSTKNQQTEEIMER
1310 1320 1330 1340 1350 1360 1370
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .
MRMKKLTLDINERQEQEDYQEMLQSLAQR-PAPANTNRERRPRYQHPKGAPNADLIFKTGGRRR--------
QDIKRLVLEYNERDEEE--ANGLGTQILNWTSGGSRGSTRTGEGSGKSGGSRHRFYYHQGGGGSYHARRK--
ADMKRLTLGQHRRIEMEEEKALLASLNSS-----RKGNAKRGQFRPQFPKPHLEGEW---------------
EKVKRLTLNITERIEEEDYQESLMPPQHRNFTQSYYQKPNKHKFKHQKGAPDADLIFH--------------
MRMKKLTLDINERQEQEDYQEMLQSLAQR-PAPANTNRERRPRYQHPKGAPNADLIFKTGGRRR--------
EEPSSSKETYEELSKPKKIAFTFLTKSGKKTQSRILQLPTDVKFVSDVLEEEEKLKTERNKIKKIVLKRSFD
KRVKEMVLNFE-------------------------------------------------------------
MIF4G 
Ac domain 
UPF1 binding 
UPF3 binding 
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Figure 3.1 UPF3 protein analysis.  
Sequence alignment of UPF3 in S.c., S.p., C.e., A.t., D.m., X.l. and human. Protein 
sequences are listed in Table 3.1. The alignment was performed with ClustalW, 
BioEdit (described in http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Identical 
residues are highlighted in red; similar residues in green. 
10 20 30 40 50 60 70 80 90 100
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
MKEDKEN----------TKPKER------------KGEQEAGE--------EGE-KSEKLKEKKEVLSKVVIRRLPPSLTKEQLEEHLQP-LPDHDY-FE
------------------------------------------------------------MKEPLQKKKVVVRHLPPSLSQSDLLSQIDPRFADRYNWVS
-----------------------------------------------------------MTDSKDGHVKVVLRRLPKYMTEHEVLEQISP-LPEEVIGTY
MAETFAE----------EKPKEK----------------------------SKASRRKDKKDKTNQIVKIVMRHLPPTMTEAQFLDQVGP-LPENDS-YY
MRSEKEGAGGLRAAVAARGPSGREKLSALEVQFHRDSQQQEAETPPTSSSGCGGGAGKPREEKRTALSKVVIRRLPPGLTKEQLEEQLRP-LPAHDY-FE
MKEEKE-----------HRPKEKRVTLLTPAGATGSGGGTSGDSS------KGEDKQDRNKEKKEALSKVVIRRLPPTLTKEQLQEHLQP-MPEHDY-FE
------------------------------------------------NYKRK---ARLGKSTENEGFKLVIRLLPPNLTADEFFAILRD----NNN---
--------------------------------------------------------MAPDISKKRLPCKVLVFNLPPTLPEQVFLQSINS-FLPHVEWHR
110 120 130 140 150 160 170 180 190 200
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
FFSNDSSLFP----HMFSRAYINFKSQ--DDIVLFRDRFDGYVFIDHRGQEYPAIVEFAPFQKVAKKKSK--KKDSKIGTIEDDPEYKKFLDSYTLDEEK
FRPGKSRLGYK--NQKYSRAYVSFKAP--EDVYEFAAFFNGHVFVNEKGAQFKAIVEYAPSQRVPKPSDK---KDPREGSISKDPDYLEFLKVIAQPVEN
FHPANFSFDR----CAYATLTVNFSEY-CDSMMEFERRFDGYIFVDSRGNDSAAVVEAASNQNFAKCDRNRMKEDTRVGAILTDKYYLDFCKKLEEERAI
YCKADWSLGQ----EATCRAYIDMSSKDIGEVVQFRDRFDGYVFVDHKGVEYMAIVEYAPFQCFLKNKAR--NDDSKVNTIESEPHYQEFIKRLAQEREE
FFAADLSLYP----HLYSRAYINFRNP--DDILLFRDRFDGYIFLDSKGLEYPAVVEFAPFQKIAKKKLR--KKDAKTGSIEDDPEYKKFLETYCVEEEK
FFSNDTSLYP----HMYARAYINFKNQ--EDIILFRDRFDGYVFLDNKGQEYPAIVEFAPFQKAAKKKTK--KRDTKVGTIDDDPEYRKFLESYATDNEK
DDGDKQDIQG----KLKYSDWCFFEGH-YSSKVFKNSTYSRCNFLFDNLSDLEKCANFIKTCKFIDNK-----DNITIPDMKLSPYVKKFTQTSKKDAAL
FSKGKATVGT--RSELLSFAYLKFQSA--TAVQEFFRVYQGHTFIDKKNNTYRAIVTIAPYQKIPPSKVK---ADSLEGSLEQDPKFQEFKVQR--ESYS
210 220 230 240 250 260 270 280 290 300
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
LTSTPETLLEEIEAKN--KEMIAKKTTPLLSFLKNR----QRLRDEKREERRRRELERKRLREEE--RRKWKEDERRKKKEAEKQKKYEKPSEKELEQSK
LPS-AEIQLERREAEQSGASKAAPIVTPLMEFIRQKR---ATVMGPQGLSDIRRGGRRTRVVSANKPSPRPSKRNSEKKKYVEKESSKNVPRKTTADVSS
PILTLEQQIRKLNQPDDARTQIDKMETPLVKYFFEK------------ETGKRRDYDARRQRRDE---KRAEKRDKVDKFEKHKN---------------
ASRMGDVKIDFNFER---RTEEKVKSTPLLQYLANK-------KEKRREEARRRNEEKRKQREEQKLLRLAAQSDASKLKEAEGGGGGGDTKKPAKKDVK
TSANPETLLGEMEAKT--RELIARRTTPLLEYIKNRKLEKQRIREEKREERRRRELEKKRLREEE--KRRRREEERCKKKETDKQK---KIAEK------
MTSTPETLLEEIEAKN--RELIAKKTTPLLSFLKNK----QRMREEKREERRRREIERKRQREEE--RRKWKEEEKRKRKDIEKLKKIDRIPER--DKLK
VGTIEEDE----------------IFKTFMNSMKQLN------------ENDEYSFQDFSVLKS-------LEKEFSKSIELEN----------------
QTASNDDVIEKLQTS-----------TPLLQYLAEK---------------KNAVVEKGKSKPSK-------KSVKAKKK--------------------
310 320 330 340 350 360 370 380 390 400
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
DEPKIKLLKKPEKEEERDTDK-KFKTRKFEKENIKEDR-----CATGKKSDGEVGEEKTKKDKEYRDKDYREKDYRDKEYDRERRQRDKEKSRYHEDDRR
SKPDYRQSNSSGKELPGNETAAIIDSSPPGIALTMDSGKKKILLLRSKDRDNPDNPPPQPEQHIDTNLSRNSTDSRQNQKSDVGGRLIKGILLRNDSRPS
-VLDILMKPSVPMASTSATTSKKDLKKEKP-------------------------MTEKEKERWEKQDAKRKERNMIRKQKFLDEKKKKHEEREQDGPRV
DPQSSGSQANDAKASRSKRRTERDQRRREEHEQRKLVKRDKKKDDGQGKQDKQDKQDKGKPSSGKQNKNSKSMDIVILKKANKPESNESLDVPSTSNAAE
-EVRIKLLKKPEKGEEPTTEKPKERGEEIDTGGGKQES-----CAPGAVVKARPMEGSLEEPQETSHSGS-DKEHRDVERSQEQ---ESEAQRYHVDDGR
DEPKIKLLKKPEKGDEKELDK-REKAKKLDKENLSDERASGQSCTLPKRSDSELKDEKPKRPEDESGRDYRERE-REYERDQERILRERERLKRQEEERR
-----KIAERTERVLTELVGTGDKVKNK-----------------------------NKKKKNKNAKKKFKEEEASAKIPKKKRNRGKKKRENREKSTIS
----LRLAEKPASNNSKAGKSSQESKK------------------------------SSKAPAESAAAVIKEDKVSDRKKSKKKPKKTPVSNSTASQASE
410 420 430 440 450 460 470 480 490 500
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
KPRDRYEKDRCFRRREEDYRKERDLVKEKTRKQDVTESPQSTDKSERIAREEKKEDS--AKRDRIRNKDRPAMQLYQPG-ARSRSRLTQCDESPAKTGEQ
QSSTFVQSEQRVEPSEAENYKRPSRPANTRAGKDYHTSGTISEKQERRTRNKDRPDRVMWAPRRDGSEDQPLSSAGNNGEVKDRMFSQRSGEVVNSSGGH
PRDKKKERLAKPPRPSPAKTVGEQQGEDWIKKLTDPKSAP--------MKKKHDLSVTTKLNKETDTRPRTAPSSTK-LPTRATTSNHPKRPSTAPNH--
ASKEKPATENTETPEAAVKVFTPAARGGRKEKRTGADKQPAGSAHETAEEAIKAAQFRASEERRIRNKDRPSIAIYQPK-ARIRASDELPQGAGGKDGSD
RHRAHHEPERLSRRSEDEQRWGKGPGQDRGKKG-SQDSGAPGEAMERLGRAQRCDDSPAPRKERLANKDRPALQLYDPG-ARFRARECGGNRRICKAEGS
RQKERYEKEKTFKRKEEEMKKEKDTLRDKGKKAESTESIGSSEKTE------KKEEV--VKRDRIRNKDRPAMQLYQPG-ARSRNRLCPPDDS-TKSGDS
KTKNSNVVIIEEAGKEVLKQRKKKMLLQEKLKISNSSQ-----------------------PQSSSAQTQPSFQPKENLFVPRVKILHRDDTKK------
NASDKKTKEKKSSGKQKIASKKKDQLTTDNV---------------------------------------------------------------------
510 520 530 540 550
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .|
NAEKK--VGDNNKVKEGE-------------------------------------
TLENGSARHSSRRVGGRNRKEEVVIGEGKTSRRGSGGGPSSHEKQMWIQKPSSGT
-----------------------------------------------------  
GEASVVEEKTSKRNKRPNRRNKPKPKEVKECELETRRFSKSSESSTSVK------
GTGPE-------KREEAE-------------------------------------
AAERKQESGISHRKEGGEE------------------------------------
-------------------------------------------------------
-------------------------------------------------------
Y14 binding 
UPF2 binding 
Xl-UPF3 
At-UPF3 
Ce-UPF3 
Dm-UPF3 
H-UPF3A 
Sc-UPF3 
Sp-UPF3 
H-UPF3B 
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to interact with Y14. This region is highly conserved in human, fly and Xenopus (Kim 
et al., 2001a). However it is not presented in S. pombe and S. cerevisiae UPF3 (Fig. 
3.3). 
3.2.2 SMG1, and SMG 5-7 homologs 
As mentioned in the introduction, SMG1 is the protein kinase that phosphorylates 
UPF1 in C. elegans, D. melanogaster and humans. SMG1 has not been reported in the 
rest of the model organisms, especially in yeast. In X. laevis, the putative protein 
(Table 3.1) is identified as the conserved SMG1 ortholog by Blastp in Xenobase 
(http://www.xenbase.org). The homolog of SMG1 seems also to be identified as TOR 
(target of rapamycin, Phosphatidylinositol-3 kinase family) in A. thaliana, S. pombe 
and S. cerevisiae, but they are questioned (Yamashita et al., 2001; Brumbaugh et al., 
2004).  
The multiple sequences alignment indicated that only the kinase catalytic domain is 
highly conserved, while the carboxyl terminal domain, and amino terminus are not 
well conserved (data not shown). The catalytic domain is similar to that of other 
protein kinases such yeast, TOR1 and TOR2, which are the subunits of TORC1 (TOR 
complex 1), a main regulator for cell growth in response to environmental signals 
(Heitman et al., 1991; Helliwell et al., 1994). However, there is no evidence that TOR1/2 
or TORC1 are involved in mRNA stability in yeast – most probably TOR1 and TOR2 
are not the homologs of SMG1 in yeast. Therefore, there is no indication of which 
could be the kinases that phosphorylate UPF1 and UPF2 in S. cerevisiae and S. 
pombe. 
I could not find apparent homologs of SMG5, SMG6, and SMG7 in S.cerevisiae and 
S. pombe. However some studies in S. cerevisiae, indicate that Ebs1p, as the homolog 
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of SMG6, SMG6 and SMG7. The shared region with Ebs1p is the14-3-3 domain. It is 
not clear whether Ebs1p is important for NMD in S. cerevisiae: while one study 
concluded Ebs1p is involved in NMD, the other suggested no effect (Ford et al., 2006; 
Luke et al., 2007). I also identified the Ebs1p homolog in S. pombe, but it is not well 
conserved relative to SMG7 (data not shown). 
3.2.3 EJC components  
By searching the S. pombe protein database for putative orthologs of EJC 
components, I identified orthologs of MAGO (Fig. 3.6), Y14 (Fig. 3.7) and RNPS1 
(Fig. 3.5). However the putative S. pombe Y14 only shares the similarity with the 
carboxyl terminus of other Y14 proteins, and appears to lost the amino terminal 
domain (Fig. 3.7). The lack of the amino terminal region in S. pombe Y14 has been 
previously reported (Lau et al., 2003; Shi and Xu, 2003). I could not identify any 
protein similar to MLN51 (barentsz in D. melanogaster). Compared to other EJC 
components MLN51 is also not very well conserved, even amongst multicellular 
organisms (Fig. 3.8). As in S. cerevisiae, there is also a clear ortholog of eIF4AIII 
(Fig. 3.4). All of them show the high conservations across organisms. The presence of 
clear orthologs of EJC components in S. pombe suggested that splicing might be 
required for NMD also in this organism, similar to mammalian cells. Alternatively, it 
is possible that these proteins might have a non-NMD function as reported in C. 
elegans and fly (see discussion below). 
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Figure 3.4 eIF4AIII protein analysis. 
Sequence alignment of eIF4AIII in S.p., C.e., A.t., D.m., X.l. and human. Protein 
sequences are listed in Table 3.1. The alignment was performed with ClustalW, 
BioEdit (described in http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Identical 
residues are highlighted in red; similar residues in green. No such homolog is 
identified in S. cerevisiae. 
Xl-eIF4AIII 
At- eIF4AIII 
 Ce- eIF4AIII 
 Dm- eIF4AIII 
 H- eIF4AIII 
 Sc- eIF4AIII 
 Sp- eIF4AIII 
10 20 30 40 50 60 70 80 90 100
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
MAAAAVAGVAGLTSGAGRKRLLREEDMTKVEFETSEEVDVTPTFDTMGLREDLLRGIYAYGFEKPSAIQQRAIKQIIKGRDVIAQSQSGTGKTATFCVSV
MATANPG-------RGGGRRGGGAMDDDKLVFETTDGIEPITSFNDMGIKEDVLRGVYEYGFEKPSAIQQRAVMPILQGRDVIAQAQSGTGKTSMIALSV
MAGKKAE----------------KDDMATVEFESSEEVNVIPTFDKMGLREDLLRGIYAYGFEKPSAIQQRAVPAILKARDVIAQAQSGTGKTATFSISV
MARKNAQ----------------AEDLSNVEFETSEDVEVIPTFNAMNLKEELLRGIYAYGFEKPSAIQQRSITPIVKGRDVIAQAQSGTGKTATFSISI
MATTATM----ATSGSARKRLLKEEDMTKVEFETSEEVDVTPTFDTMGLREDLLRGIYAYGFEKPSAIQQRAIKQIIKGRDVIAQSQSGTGKTATFSISV
MSFD-------------------REEDQKLKFKTSKKLKVSSTFESMNLKDDLLRGIYSYGFEAPSSIQSRAITQIISGKDVIAQAQSGTGKTATFTIGL
MA---------------------DEIMENVELTTSEDVNAVSSFEEMNLKEDLLRGIYAYGYETPSAVQSRAIIQICKGRDVIAQAQSGTGKTATFSIGI
110 120 130 140 150 160 170 180 190 200
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
LQCLDIQVRETQALILAPTRELAGQIQKVLLALGDYMNVQCHACIGGTNVGEDIRKLD-YGQHVVAGTPGRVFDMIRRRSLRTRAIKMLVLDEADEMLNK
CQVVDTSSREVQALILSPTRELATQTEKTIQAIGLHANIQAHACIGGNSVGEDIRKLE-HGVHVVSGTPGRVCDMIKRRSLRTRAIKLLILDESDEMLSR
LQSLDTQVRETQALILSPTRELAVQIQKVVLALGDYMNVQCHACIGGTNLGEDIRKLD-YGQHVVSGTPGRVFDMIRRRNLRTRAIKLLVLDEADEMLNK
LQSLDTTLRETQVLCLSPTRELAVQIQKVILALGDMMNVQCHVCIGGTNLGEDIRKLD-YGQHIVSGTPGRVFDMIKRRVLRTRAIKMLVLDEADEMLNK
LQCLDIQVRETQALILAPTRELAVQIQKGLLALGDYMNVQCHACIGGTNVGEDIRKLD-YGQHVVAGTPGRVFDMIRRRSLRTRAIKMLVLDEADEMLNK
LQAIDLRKKDLQALILSPTRELASQIGQVVKNLGDYMNVNAFAITGGKTLKDDLKKMQKHGCQAVSGTPGRVLDMIKKQMLQTRNVQMLVLDEADELLSE
LQSIDLSVRDTQALILSPTRELAVQIQNVVLALGDHMNVQCHACIGGTSVGNDIKKLD-YGQHVVSGTPGRVTDMIRRRNLRTRNVKMLILDEADELLNQ
210 220 230 240 250 260 270 280 290 300
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
--GFKEQIYDVYRYLPPATQVCLISATLPHEILEMTNKFMTDPIRILVKRDELTLEGIKQFFVAVEREEWKFDTLCDLYDTLTITQAVIFCNTKRKVDWL
--GFKDQIYDVYRYLPPDLQVCLVSATLPHEILEMTSKFMTEPVKILVKRDELTLEGIKQFFVAVEKEEWKFDTLCDLYDTLTITQAVIFCNTKRKVDYL
--GFKEQLYDIYRYLPPGAQVVLLSATLPHEILEMTSKFMTDPIRILVKRDELTLEGIKQFFVAVDREEWKFDTLIDLYDTLTITQAVLFCNTRRKVDWL
--GFKEQIYDVYRYLPPATQVVLISATLPHEILEMTSKFMTDPIRILVKRDELTLEGIKQFFVAVEREEWKFDTLCDLYDTLTITQAVIFCNTKRKVDWL
--GFKEQIYDVYRYLPPATQVVLISATLPHEILEMTNKFMTDPIRILVKRDELTLEGIKQFFVAVEREEWKFDTLCDLYDTLTITQAVIFCNTKRKVDWL
TLGFKQQIYDIFAKLPKNCQVVVVSATMNKDILEVTRKFMNDPVKILVKRDEISLEGIKQYVVNVDKEEWKFDTLCDIYDSLTITQCVIFCNTKKKVDWL
--GFKEQIYDIYRYLPPGTQVVVVSATLPQDVLEMTNKFTTNPVRILVKRDELTLEGLKQYFIAVEKEEWKFDTLCDLYDTLTITQAVIFCNSRRKVDWL
310 320 330 340 350 360 370 380 390 400
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
TEKMREANFTVSSMHGDMPQKERESIMKEFRSGASRVLISTDVWARGLDVPQVSLIINYDLPNNRELYIHRIGRSGRYGGKGVAINFVKNDDIRILRDIE
SEKMRSHNFTVSSMHGDMPQKERDAIMNEFRSGDSRVLITTDVWARGIDVQQVSLVINYDLPNNRELYIHRIGRSGRFGRKGVAINFVKSDDIKILRDIE
TDKMKEANFTVSSMHGDMEQKDRDEVMKEFRAGTTRVLISTDVWARGLDVPQVSLVINYDLPNNRELYIHRIGRSGRFGRKGVAINFVKQDDVRILRDIE
TEKMREANFTVSSMHGDMPQKERDEIMKEFRAGQSRVLITTDVWARGIDVQQVSLVINYDLPNNRELYIHRIGRSGRFGRKGVAINFVKSDDIRILRDIE
TEKMREANFTVSSMHGDMPQKERESIMKEFRSGASRVLISTDVWARGLDVPQVSLIINYDLPNNRELYIHRIGRSGRYGRKGVAINFVKNDDIRILRDIE
SQRLIQSNFAVVSMHGDMKQEERDKVMNDFRTGHSRVLISTDVWARGIDVQQVSLVINYDLPEIIENYIHRIGRSGRFGRKGVAINFITKADLAKLREIE
TEKMREANFTVTSMHGEMPQKERDAIMQDFRQGNSRVLICTDIWARGIDVQQVSLVINYDLPANRENYIHRIGRSGRFGRKGVAINFVTNEDVRILRDIE
410
. .. .| .. .. |. .. .| .. .
QYYSTQIDEMPMNVADLI
QYYSTQIDEMPMNVADLI
QYYSTQIDEMPMNIADII
QYYSTQIDEMPMNVADLI
QYYSTQIDEMPMNVADLI
KFYSIKINPMPANFAELS
QYYSTVIDEMPMNIGDMV
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Figure 3.5 RNPS1 protein analysis 
Sequence alignment of RNPS1 in S.p., C.e., A.t., D.m., X.l. and human. Protein 
sequences are listed in Table 3.1. The alignment was performed with ClustalW, 
BioEdit (described in http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Identical 
residues are highlighted in red; similar residues in green. No such homolog is 
identified in S. cerevisiae.
Xl- RNPS1 
 At- RNPS1 
Ce- RNPS1 
 Dm- RNPS1 
 H- RNPS1 
 Sp- RNPS1 
  
10 20 30 40 50 60 70 80 90 100
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
---------------------------MAPSPSKRKERSEDRAKERGKEKAPGKEVTEKDRGRDKAKKRRSGSSGSSSSSHSRSSSSSSSSSGSSSGSSS
---------------------------MAKPSRGRRSPSVSGSSSRSSSRSRSGSSPSRSISRSRS---RSRSLSSSSSPSRSVSSG--SRSPPRRGKSP
--------------------------MVEKEETKKRARSSSSSSSSSSGSSSSGSSSSGSRSSSSSSSGRSRSRSPRRRDTRPPARGGRSRSPIRRGSPP
MARAQSLAGEGEKEKDNKEKVAKEKDGKATSGSSRRDRERKRRGSASSSSDSRSSTSDSSSSRSSSGSSRSSSSSSSDSSSSSSSSSSDSDRSEKNRRRG
----MDLSGVKKKSLLGVKENNKKSSTRAPSPTKRKDRSDEKSKDRSKDKGATKESSEKDRGRDKTRKRRSASSGSSS-TRSRSSSTSSSGSSTSTGSSS
-------------------------MLISTFVFLLYEVTALSTAIHVTKSYTHTRTGTSFFMYQKEAFYRGRSSTRQFNNTRSPSGRSASRSSNFSHRSS
110 120 130 140 150 160 170 180 190 200
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
GSSSS-ASSRSGSSSSSRSSSSSSS----SGSPSP---------------------SRRRHDN-----------RRRSRSKSK----------------Q
AG--------------PARRGRSPP-------PPP---------------------------------------SKG-----------------------
RGARADRDRPMRPSPSPPRRRRPSP-------SPP---------------------------------------RRDRRDRSGSR--------------Q
GGAAGKDKDKDKPSARSRSRSRTRSPRRVSKSPRPGSKARKEPERDRDRRSRSRDRARRAGSNDRAAADSNNVKRERSRSASRSRSPRRRGRGSVERTPP
GSSSSSASSRSGSSSTSRSSSSSSS----SGSPSP---------------------SRRRHDN-----------RRRSRSKSK----------------P
SR-----------DSFSSNRSYSSS---------------------------------------------------------------------------
210 220 230 240 250 260 270 280 290 300
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
PKRDEKERKR-RSPSPRPTKVHIGRLTRNVTKDHILEIFSTYGKIKMIDMPVDRYHPHLSKGYAYVEFEAPEEAEKALKHMDGGQIDGQEITASAVLTPW
---AS---SPSKKAVQESLVLHVDSLSRNVNEAHLKEIFGNFGEVIHVEIAMDRAVN-LPRGHGYVEFKARADAEKAQLYMDGAQIDGKVVKATFTLPPR
RRRASPRRSPAARSASPAKRVVIKNLSRNVLKTHLEEIFSIYGAIKNVDLPPDRFHNHVHRGYGYVEYDNLEDAEKSIKHMDGGQIDGMAVHVEMTIG-R
PKRRERSRSRTRSPSPKQVRIHVGRLTRNVTKDHVFEIFSSFGDVKNVEFPVDRFHPNFGRGVAFVEYATPEDCESAMKHMDGGQIDGQEITVSPVVLVK
PKRDEKERKR-RSPSPKPTKVHIGRLTRNVTKDHIMEIFSTYGKIKMIDMPVERMHPHLSKGYAYVEFENPDEAEKALKHMDGGQIDGQEITATAVLAPW
---------LSRSPEEPLRTILVENLTRNVTKEHIAEIFGIYGLIDHIFMPIYKKSE-LNKGYCYIEYVYHDQAANAVDKMNNAELDGEELFVSIKRFPF
310 320 330 340 350 360 370 380 390 400
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
PMRPMP---------------------------------------------RRFSPPRRMLPP-------------------------------------
QKVSSPPKPVSAAPKRDAPKSDNAAADAEKDGGPRRPRETSPQRKTGLSPRRRSPLPRRGLSPRRRSPDSPHRRRPGSPIRRRGDTPPRRRPASPSRGRS
QSVPFQ-------------------------------RRSSPFR-------RRSPPPRDRMSPMRRG------------------------------GRS
Q-RPPM---------------------------------------------RRPSPP--MRRP-------------------------------------
P-RPPP---------------------------------------------RRFSPPRRMLPP-------------------------------------
ESLHKN-----------------------------------------------HKHYENSYRP-------------------------------------
410 420 430 440 450 460 470 480 490 500
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
----PPMWRRSPPRMRR------------------RSRSPRR-RSPVRR---------------RSRS----------PARRRHRSRSSSNSSR------
PSSPPPRRYRSPPRGSPRRIRGSPVRRRSPLPLRRRSPPPRRLRSPPRRSPIRRRSRSPIRRPGRSRSSSISPRKGRGPAGRRGRSSSYSSSPSPRRIPR
P---PPHRRRSPMGG-----RGSGANN---MPLGG----PNRFR-----------------RASRSRS----------PAGRRSRS--------------
----QNNRWRSPPQFNRFNNRGGGGGGG-----GGRRQSPMRNRRSPRR---------------RSRS----------PIRRRRRS-NSSDSSR------
----PPMWRRSPPRMRR------------------RSRSPRR-RSPVRR---------------RSRS----------PGRRRHRSRSSSNSSR------
------SRSQNNSHYND--------------------KSFHRSRYSRAR----------------SRS----------PGSNISEYSDQSPPYHSYRHRP
510 520 530
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .
------------------------------------
KISRSRSPKRPLRGKRSSSNSSSSSSPPPPPPPRKT
------------------------------------
------------------------------------
------------------------------------
------------------------------------
  85 
 
 
 
 
Figure 3.6 MAGO protein analysis 
Sequence alignment of MAGO in S.p., C.e., A.t., D.m., X.l. and human. Protein 
sequences are listed in Table 3.1. The alignment was performed with ClustalW, 
BioEdit (described in http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Identical 
residues are highlighted in red; similar residues in green. No such homolog is 
identified in S. cerevisiae. 
Sp- MAGO 
 Xl- MAGO 
 At- MAGO 
 Ce- MAGO 
 Dm- MAGO 
 H- MAGO 
 
10 20 30 40 50 60 70 80 90 100
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
-------MSDFYVRYYSGHHGRFGHEFLEFDYHSDGLARYANNSNYRNDSLIRKEMFVSELVLKEVQRIVDDSEIIKESDESWPPENKDGKQELEIRMNG
------MGSDFYLRYYVGHKGKFGHEFLEFEFRPDGKLRYANNSNYKNDVMIRKEAYVHKSVMEELKRIIDDSEVTKEDDALWPPPDRVGRQELEIVIGD
--MAAEEATEFYLRYYVGHKGKFGHEFLEFEFREDGKLRYANNSNYKNDTIIRKEVFLTPAVLKECKRIVSESEILKEDDNNWPEPDRVGKQELEIVLGN
MSGEEEKAADFYVRYYVGHKGKFGHEFLEFEFRPNGSLRYANNSNYKNDTMIRKEATVSESVLSELKRIIEDSEIMQEDDDNWPEPDKIGRQELEILYKN
-----MSTEDFYLRYYVGHKGKFGHEFLEFEFRPDGKLRYANNSNYKNDTMIRKEAFVHQSVMEELKRIIIDSEIMQEDDLPWPPPDRVGRQELEIVIGD
------MESDFYLRYYVGHKGKFGHEFLEFEFRPDGKLRYANNSNYKNDVMIRKEAYVHKSVMEELKRIIDDSEITKEDDALWPPPDRVGRQELEIVIGD
110 120 130 140 150
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .
KHIMFETCKLGSLADVQNSDDPEGLKVFYYLIQDLKALCFSLISLNFKLRPVKN
EHISFTTSKIGSLIDVNQSKDPEGLRVFYYLVQDLKCLVFSLIGLHFKIKPI--
EHISFATSKIGSLVDCQSSNDPEGLRIFYYLVQDLKCLVFSLISLHFKIKPI--
EHISFTTGKIGALADVNNSKDPDGLRSFYYLVQDLKCLVFSLIGLHFKIKPI--
EHISFTTSKTGSLVDVNRSKDPEGLRCFYYLVQDLKCLVFSLIGLHFKIKPI--
EHISFTTSKIGSLIDVNQSKDPEGLRVFYYLVQDLKCLVFSLIGLHFKIKPI--
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Figure 3.7 Y14 protein analysis 
Sequence alignment of Y14 in S.p., C.e., A.t., D.m., X.l. and human. Protein 
sequences are listed in Table 3.1. The alignment was performed with ClustalW, 
BioEdit (described in http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Identical 
residues are highlighted in red; similar residues in green. No such homolog is 
identified in S. cerevisiae. 
Xl- Y14 
 At- Y14 
Ce- Y14 
 Dm- Y14 
 H- Y14 
 Sp- Y14 
 
10 20 30 40 50 60 70 80 90 100
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
MADVL--DLHEAGGEDFAMDEDGDDSI------------------HKLKEKAKKRKGRGFGADEGTKTRIREVYDSVEQDGD---EPGPQRSVEGWILFV
MANIESEAVDFEPEEDDLMDEEGTAIDGADVSPRAGHPRLKSAIAGANGESAKKTKGRGFREEKDSDRQRRLSSRDFESLGS-DGRPGPQRSVEGWIILV
MSD-----------NEVEMED--------------------------VVANAERSRGRGLAQ---SRNRERITYDVVDEESS-ATSGAPQRSVEGWIVFV
MADVL--DIDNA--EEFEVDEDGDQGI------------------VRLKEKAKHRKGRGFGSDSNTREAIHS-YERVRNEDDDELEPGPQRSVEGWILFV
MADVL--DLHEAGGEDFAMDEDGDESI------------------HKLKEKAKKRKGRGFGSEEGSRARMREDYDSVEQDGD---EPGPQRSVEGWILFV
--------------------------------------------------------------------------------------MRPAKSVEGYIIIV
110 120 130 140 150 160 170 180 190 200
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
TGVHEEATEEDIHDKFGEFGEIKNIHLNLDRRTGFLKGYALVEYETYKEALAAMEGLNGQDLMGQPVSVDWGFVRGPPKGKRRSGR-----RRSRSPERR
SGVHEETQEEDITNAFGDFGEIKNLNLNLDRRSGYVKGYALIEYEKKEEAQSAISAMNGAELLTQNVSVDWAFSSGPSGGESYRRKNSRYGRSQRSRSPR
TNIHEEATEDDVHDKFSEYGKIKNIHLNLDRRTGFLKGYALVEYETQKEANEAIDQSNDTDLLGQNVKVDWCFVKGK-----------------KTSGKR
TSIHEEAQEDEIQEKFCDYGEIKNIHLNLDRRTGFSKGYALVEYETHKQALAAKEALNGAEIMGQTIQVDWCFVKGP--------------KRVKKSEKR
TGVHEEATEEDIHDKFAEYGEIKNIHLNLDRRTGYLKGYTLVEYETYKEAQAAMEGLNGQDLMGQPISVDWCFVRGPPKGKRRGGR-----RRSRSPDRR
TGVHPEATEEQVEDLFADFGPVKNLHLNLDRRTGYVKGYALIEYATLEQAQKAVDEKN-LSLLDEKLEVDFAFLEPPERAPRPSISTR---SRSQSPEVQ
210
. .. .| .. .. |.
RR---------
RRY--------
-----------
RR---------
RR---------
HRDRDVAMAEP
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Figure 3.8 MLN51 protein analysis 
Sequence alignment of MLN51 in C.e., A.t., D.m., X.l. and human. Protein sequences 
are listed in Table 3.1. The alignment was performed with ClustalW, BioEdit 
(described in http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Identical residues are 
highlighted in red; similar residues in green. No homologs of MLN51 are identified in 
S. pombe and S. cerevisiae.
10 20 30 40 50 60 70 80 90 100
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
MADRRRRRRRASQDSEGEEEEEESGSDSVGS-------------GGESGAPVRQERSEQGN------RKAEP--PREGKESECESEDGIEGDAVLSDYES
---------------------------------------------MATSEAEYESDPEELN-------------RSLATRRREASDDDSDD---------
---------------------------------------------MAAESATTETVEKSGN-------------------EESTVEVKVNG---------
MSFRRRSSSSSSEAENRRDPAMAEVEKPTAATPPTDIPQATAAPASEAPVAVTPTADTTVDVEPGTSPTQEPNSNSHPHDSEYDTASDLEGGEDYDDEES
MADRRRQR--ASQDTE-DEESGASGSDSGGSPLRGGGSCSGSAGGGGSGSLPSQRGGRTGALHL---RRVESGGAKSAEESECESEDGIEGDAVLSDYES
110 120 130 140 150 160 170 180 190 200
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
ADESEIVPTKEVEEAHYNEEEPLKATLKQENNVEEAPAARDQK----PKSKGTVTGERQSGDGQESNEPEEDKTIQKSQKQLDDDEDRKN--PAYIPRKG
-------------DDAVRDVKNQRAVVDSDLSDEEVGTVKYDN-----DEDGEDSYEDDEEESGGGIDNDKSGVVKEAGDMNGEEENEKEKLQAAVPTGG
-------------EAQNPPQESAKPAESVEDDDEPAPAK---------KRSGGDSEEKEDEAAEDGPEDGEEKS------NLDDDQNVEN--PAYIPKTG
ASGSAS--GSGSEEESETDDEDDEVGSETDDGEGEQAMDRSVADSEAQKKVDEDRSNPQYIPKRGTFYEHDDRTAETEGEILIEPENGAG--QAAAEPNG
AEDS------EGEEGEYSEEENSKVELKSEANDAVNSSTKEEKGEEKPDTKSTVTGERQSGDGQESTEPVENKVGKKGPKHLDDDEDRKN--PAYIPRKG
210 220 230 240 250 260 270 280 290 300
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
LFFEHDLRGHVND---EEVRPKGRHPRKLWKDEG--RWVHDRFHEDEQAPKSREELISIYGYDIRSCRNPEEIHPRRPGKPRFS-SPSRREE--NDEKPS
AFYMHDDRFQEMS---AGGNRRMRGGRRQWGSGEERKWGHDKFEEMNTGEKHSDRMSRGR---FRGHGRG------RGQGRGYARGSSSNTLTSSGQQIY
RFYMHDDNRRGDVNNSQVQDDDSDDRRNLKKSRADCDWKHDRFDEKFQRPKTKKQIVTKYGFDIRHKDGT----PIQDGEEIDAPAPESTEEE-------
ELNGLAAAGATPTGQTPQISQASKTMRKWQPASGGDRWSHDRFEATEQAPKSRAELLQTYGYDIRNEDAP----PRARRRRRYTRGPSKYSRNWEDEQAY
LFFEHDLRGQTQE---EEVRPKGRQ-RKLWKDEG--RWEHDKFREDEQAPKSRQELIALYGYDIRSAHNPDDIKPRRIRKPRYG-SPPQRDPNWNGERLN
310 320 330 340 350 360 370 380 390 400
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
RPSNRYQDSGVTQPLRPYTNRNAPPSSKVGPSR--TYSRQGGYKENRASYQSEEEAAPH------TYERRQDYGGHRSRSTDQGPPPPREYSP-EADPII
VPKAVSRGRGPRKSDTPLRNENQAHSEQSKQLRNSNGSQNSREKMPHLDSRRSPTAPAK------TENQGAHAKKNVAVSSLSSASPPFYPSAPSSNVVH
--SSDARQVSRQQKDRRVSSTTRGKVGKSGTSRRPMKQREREDTVDESKGEEEEDQGVR------PAQKRQVKQQEKPRKQKPAAPPSSEENEEDEDDGA
LKASNKERKPPRPQDFPALNERKPRGPRTSSSREEKENRRSVAAEGLVPEKQQPLASSSNPHRSQERERERERERERDREPKNRNFGRMNGGPGRQNGME
K-SHRHQGLGGTLPPRTFINRNAAGTGRMSAPR--NYSRSGGFKEGRAGFRPVEAGGQHGGRSGETVKHEISYRSRRLEQTSVRDPSPEADAP-VLGSPE
410 420 430 440 450 460 470 480 490 500
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
KEEAFTEKQTAEP--SPPPPDRPVEKKSYSRARRSRIKVGDTGKSMEDTTAAELPPPP--LMPPAVAAEFTPAPLNVKQGNWEPPAEGGMSGIDEELSQM
GIQVSMERLHTNESVTPSGKKYRNTKSGYSPVWTAKTLQS----------TSQGRGAPAAGNTFYPQSHSQGDRFSSPMQLNGDSKGTGQRPSGQGFDQH
IRRGQRRAVPLRRGTTSGPPSRLRGRMSHPMGPPRRSSGAPPSS-----ASNRRPVESSSRGPPPPPSSSSRRDYSHQGDRNDDRFENHRRGVIRGASRG
FKKNNRGQQLRERERGPDQLDNRNQKPSTPRSNQQQQPQQQPHHQQQ--PQQQRQPSQPQQSPQTPLSTSNLSQRLQQVQQRNDPSHVGSVQMHSLASQN
KEEAASEPPAAAPDAAPPPPDRPIEKKSYSRARRTRTKVGDAVK-----LAEEVPPPPEGLIPAPPVPETTPTPP-TKTGTWEAPVDSSTSGLEQDVAQL
510 520 530 540 550 560 570 580 590 600
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
NLTEQSWNQGQPAYISPR---GIPNPMHMGNGPP-QYSRMEGMAVQGGRVKRYSSQRQRPVPDPAA--MHISLMESHYYDPLQFQGPIYTHGDSSSSMPP
SAVVRSLSSSPQKTSLSR-------------------NRYPPDEIESSSETAALIAKGKGTLRPGGSSSFMYSGSQMMGRPESLTSADNSNFPTFLPVMQ
GGTVTRGTGGYGRTGAIR------------GGVRGSGAPRYGVRRTDTSEQSEGYQRGGSGTDYSSPRPNHQSDRSYQASSTNFRGGSHPHPSANVYPSS
QAPQQ--QQQQPLHQEQR---NAPKRYSSLRRSQQEASQHLAEQQQQQMQQQLHLQQQQQQQQSQIMIQDPHVLMQIAYQQQELQAQLQTMQLGP-PTAA
NIAEQNWSPGQPSFLQPRELRGMPNHIHMGAGPPPQFNRMEEMGVQGGRAKRYSSQRQRPVPEPPAPPVHISIMEGHYYDPLQFQGPIYTHGDSPAPLPP
610 620 630 640 650 660 670 680 690 700
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
QGMIVPPEMHLSHPGMHPHPSPATMSTPNLYPAPVSLPPGQQPPQQLLPPPYFPAPPNVMNFGNPTYPYPPGALPPPP-AHLYPNAQAQSQVY---GGVT
FGGQHGGVPTFG----MAYPGYVQSEDGVRNPEMTWMPVLAGPG--ALGASYSPPPYAAHQAHNPGLPSSAGFSSKDSSTNTLNDLVKPMESP----EVA
RGGYSSNNADYASRGGGGYHGPPQHHNNHHNHQQKRFVQGPPPPMVAVG----VVPGNVVPPPQMTRGSTHGGNQHNGGGGGGSGGQQRIRQP---TDVV
GAVPTPPKPHAPPAAAYPQAQAAPYYVTGTEPVPVPVP--QAPYVNPASAAYLPTTPAAVAYAQAGPPVVTQPTPPPAQAPPATQPAQPYQNYNTVGGTT
QGMLVQPGMNLPHPGLHPHQTPAPLPNPGLYPPPVSMSPGQPPPQQLLAPTYFSAPG-VMNFGNPSYPYAPGALPPPPPPHLYPNTQAPSQVY---GGVT
710 720 730 740 750 760 770 780 790 800
. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |. .. .| .. .. |
YYNPVQQQVQQPVLPKPSPPRRTSQPVTIKPPPPEENRHTKMKEKSKW----------------------------------------------------
ENGVSERQSNN-----PSKQPRRYSEMTFSK---------------------------------------------------------------------
YFDPQQQQGTR------QLPPRSKKVIPIVDPKDHQ----------------------------------------------------------------
YFVPPAQTTSR---PSALPQRRPTNAIPILPPSEKHKVKGGAKEEGISDNIDHIIDNMFVQRPSAFQATGEGATPGGGTKEEAAATPPAAEQNLQPVPAT
YYNPAQQQVQ----PKPSPPRRTPQPVTIKPPPPE----VVSRGSS------------------------------------------------------
. ..
---
---
---
GQE
---
Xl-MLN51 
At-MLN51 
Ce-Btz 
Dm-Btz 
H-MLN51 
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3.3 Discussion and implications for this research project 
The fact that UPF1, UPF2 and to a less extent of UPF3, are conserved in S. pombe 
implies that the mechanism of NMD is probably similar to S. cerevisiae. However, 
the fact that many EJC components are also present in fission yeast, and that 43% of 
genes typically have introns in this organism raises the question of whether splicing is 
required for NMD in S. pombe (Wood et al., 2002)? The presence of EJC components 
alone is not a sufficient indication of a link between splicing and NMD. In fact, 
several studies have reported that NMD does not require splicing in C. elegans and 
Drosophila S2 cells, despite EJC components being present in these two organisms 
(Gatfield et al., 2003; Longman et al., 2007). In addition in S. cerevisiae, a clear 
eIF4AIII homolog is present but still here is no evidence of a link between NMD and 
splicing. Instead S. cerevisiae eIF4AIII has an essential function in the biogenesis and 
maturation of ribosomal RNA (Kressler et al., 1997). Based on the fact that most of 
EJC components are present and given that about half of the mRNAs are spliced, I 
decided to investigate whether splicing and the EJC are involved in NMD in fission 
yeast. 
The fact that S. pombe UPF1 lacks the SQ motifs at the C-terminal and absence of 
SMG5, SMG6 and SMG7 homologs indicate that in S. pombe, UPF1, is not regulated 
by phosphorylation and dephosphorylation, unlike in mammalian cells, C. elegans 
and D. melanogaster. But the observation that UPF1 and UPF2 are the 
phospoproteins in S. cerevisiae suggest that that this issue should be still investigated 
(Wang et al., 2006). In addition, the absence of an obvious SMG6 homolog suggests 
that there might not have endonucleolytic cleavage in yeast NMD, unlike in D. 
melanogaster and human cells (Huntzinger et al., 2008; Eberle et al., 2009).  
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CHAPTER IV. THE FAUX 3’ UTR MODEL DOES NOT EXPLAIN 
NMD IN S. POMBE 
4.1 Introduction 
PTCs located within the 5’ half of the coding region usually trigger stronger NMD 
than PTCs within the 3’ half. This polar effect of PTCs is typical of NMD in S. 
cerevisiae (Losson and Lacroute, 1979; Peltz et al., 1993; Yun and Sherman, 1995). A 
similar polar effect has also been observed in D. melanogaster in the Adh gene, Cat 
gene and in GFP (Brogna, 1999; Gatfield et al., 2003; Behm-Ansmant et al., 2007). In 
addition, immunoglobulin µ gene reporters also show that 3’ proximal PTCs do not 
trigger strong NMD in human cells (Buhler et al., 2006; Eberle et al., 2008)  
The polar effect is currently explained by the faux 3’ UTR model (Amrani et al., 
2004; Eberle et al., 2008). This model proposes that translation termination at NMD-
inducing PTCs is biochemically abnormal and inefficient because it occurs away from 
the normal 3’ UTR; while the termination at normal stop codons is more efficient due 
to the interaction with certain trans acting factors located in the 3’ UTR. The original 
faux 3’ UTR model proposed that poly(A) tail binding protein (PABP) is the most 
important among these termination-enhancing factors. It has been suggested that 
cytoplasmic poly(A) binding protein (PABPC) plays a pivotal role in NMD as some 
studies have shown that artificial tethering of PABPC downstream of a PTC strongly 
inhibits mRNA reductions in budding yeast and S2 cells in D. melanogaster  (Amrani 
et al., 2004; Behm-Ansmant et al., 2007; Eberle et al., 2008). However, other studies 
have reported that transcripts without the poly(A) tail can still be subject to NMD, 
both in mammalian cells and in budding yeast (Maquat and Li, 2001; Meaux et al., 
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2008). It is then proposed other unknown factors recruited to the 3’ UTR might be 
involved in NMD (Singh et al., 2008). 
In this chapter, I have undertaken to investigate whether the faux 3’ UTR model could 
be applied in fission yeast and whether PABPC is required for NMD. In particular, I 
have investigated whether NMD is affected by positioning of PTCs along the gene, 
whether the length and nature of the 3’ UTR is a key NMD determinant and whether 
the distance between the 5’ end and a PTC is also important for NMD. 
4.2 Results 
4.2.1 NMD reporters used in the study 
To study NMD, I generated the plasmid reporters expressing green fluorescent protein 
(GFP). The reporters are based on the pREP41 plasmid, a widely used fission yeast 
shuttle vector regulated by a derivative of the nmt1 (no message thiamine) promoter, 
which allows episomal expression (Basi et al., 1993; Maundrell, 1993). Based on this 
GFP construct, three further constructs were made where the nonsense mutation 
(TAA) was introduced in the coding region at three different positions, replacing 
codons 6, 27 and 140 respectively (named as pPTC6, pPTC27 and pPTC140) (Fig. 
4.1A). 
4.2.2 NMD depends on the position of the PTC along the coding region 
For the assessment of NMD, the three PTC-containing reporters were transformed 
along with the PTC-less control into yeast, either a wild-type strain (SPJK039) or 
upf1Δ (SPJK033) and upf2Δ (SPJK029) mutants. Strong GFP fluorescence was 
observed both in the cytoplasm and in the nucleus in the control, but not in the PTC- 
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Figure 4.1 NMD polarity effect in S. pombe  
(A) Diagram of the GFP reporters. Nonsense mutations (TAA) were introduced at 
codon positions 6, 27 and 140. Detailed information is in Materials and Methods 
(Chapter II). 
(B-D) Northern blot analysis of total-RNA from wild-type (B), upf2Δ (C) and upf1Δ 
(D) cells, transformed with the plasmids indicated. Top panels show hybridization 
with a GFP specific probe; bottom panels show hybridization with a probe specific for 
the large ribosomal protein 32 (Rpl32) mRNA, as a loading control. The GFP probe 
was PCR amplified with primers gfp-ks and gfp-rev, and the rpl32 probe with rpl32-
sens and rpl32-rev (Appendix II Table 1). The values below each lane are percentages 
with standard deviation of the GFP mRNA present in the PTC-less control, lane 1. 
Bands intensities were quantified with a phosphor-imager and standardized to the 
RpL32 signal (described in Materials and Methods, Chapter II). Calculations are 
based on three independent experiments. 
  93 
containing constructs (Fig. 4.8D). Total RNA was extracted and analyzed by Northern 
blot, using 32P labeled probes. The PTC6 mutation triggered strong mRNA reduction 
in wild-type cells: the mRNA was less than 20% of that of the PTC-less control (Fig. 
4.B, lane 2). The PTC27 mutation triggered a moderate mRNA reduction (43%) and 
PTC140 triggered only a minor mRNA reduction (82%) (Fig. 4.1B, lanes 3-4).   
As expected, the mRNA levels were restored in both upf1Δ and upf2Δ cells: the 
mRNA levels were from 80% to 110% of that of the PTC-less control (Fig. 4.1C and 
1D). These results are consistent with the expectation that this mRNA reduction is the 
result of the canonical NMD, requiring UPF1 and UPF2 as in other organisms. The 
observation that early PTCs trigger stronger mRNA reduction also indicates that 
NMD in fission yeast is likely to be polar as reported in budding yeast and fly.  
4.2.3 Lengthening of the 3’ UTR only partially enhances NMD.  
The faux 3’ UTR model proposes that the distance between a PTC and the 3’ UTR is 
the key determinant of NMD. The model is supported by studies in S. cerevisiae, D. 
melanogaster and human cells (Amrani et al., 2004; Eberle et al., 2008; Singh et al., 
2008).  To investigate whether the distance of the PTC from the 3’ end is also 
important for NMD in S. pombe, I inserted either a 102 bp or 418 bp DNA fragment 
(derived from the firefly luciferase coding region) 6 nt downstream of GFP normal 
stop codon, immediately upstream of the nmt1 3’ UTR sequence (Fig 4.2A). The 
constructs were named pGFP-102, pPTC6-102, pPTC27-102, pPTC140-102, pGFP-
418, pPTC6-418, pPTC27-418, and pPTC140-418. According to the faux 3’ UTR 
model, it was expected that both insertions would enhance NMD as the distance 
between the PTC and the poly(A) tail is longer. For example, in PTC27-102 the 
distance between the PTC and the poly(A) tail is 890 nt, while in the original PTC6 
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reporter is 813 nt; the distances between the PTC and the poly(A) tail in PTC27-418 
and PTC140-418 are 1106 nt and 867 nt, respectively: these three constructs were 
expected to trigger strong NMD, similar to PTC6 in the original reporter. 
RNA analysis showed that the 102-nt insertion significantly enhanced NMD of the 
mRNA with PTC27 (27% vs. 43%, Fig. 4.2B lane 7 vs. lane 3). However, the 102-nt 
insertion did not enhance NMD in the reporter with PTC6 (Fig. 4.2B lane 2 and lane 
6). Furthermore, the level of the PTC140-102 mRNA was reproducibly higher than 
the one with the original 3’ UTR (Fig. 4.2B lane 4 vs. lane 8). In the reporters with 
the 418-nt insertion, the 418-nt insertion significantly decreased the level of the 
mRNAs with PTC27 and PTC140, 24% and 53% respectively of the mRNA produced 
by the GFP reporter with the original 3’ UTR (Fig. 4.2C lane 4 and lane 5); but the 
insertion did not affect the mRNA level of PTC6 (Fig. 4.2C lane 3). Notably, there 
was no relationship between the distance of the PTC from the 3’ end and mRNA 
reduction. For example, it was expected that the 418-nt insertion would make PTC140 
behave like PTC6 in the original reporter, triggering strong NMD; instead the 
PTC140 mRNA level was hardly reduced compare to the PTC-less control (Fig. 
4.2C). Consistent with the view that mRNAs with an artificially long 3’ UTR turn to 
be NMD substrates, the mRNA without PTCs was also reduced to about 50% of that 
with the normal 3’ UTR (Fig. 4.2C lane 2) and the mRNA level was restored in the 
upf2Δ strain (Fig. 4.2D lane 2).  
To further investigate whether NMD was affected by the distance between the PTC 
and poly(A) tail, a new set of constructs were made by inserting a 402 bp DNA 
fragment into the GFP coding region, 6 bp upstream of the normal stop codon 
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pGFP-102 
pPTC6-102 
pPTC27-102 
pPTC140-102 
 
pGFP-418 
pPTC6-418 
pPTC27-418 
pPTC140-418 
 
Fig. 4.2 
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Figure 4.2 NMD does not strongly correlate to the length of the 3’ UTR  
(A) Diagram of reporters with different length of 3’ UTRs. The pGFP-102 reporter 
carries a 102 bp insert at 9 bp downstream of the normal stop codon, and pGFP-418, a 
418 bp DNA fragment at the same position. The inserted DNA fragments were cloned 
from firefly luciferase coding region, described in Material and Methods (Chapter II). 
(B-D) Northern blot analysis of total-RNA from wild-type (B and C) and upf2Δ (D) 
cells, transformed with the indicated plasmids. Top panels show hybridization with a 
GFP specific probe as in Figure 4.1B; bottom panels with Rpl32 mRNA as a loading 
control as in Figure 4.1B. The values below each lane are percentages with standard 
deviation from three independent experiments. 
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(Fig. 4.3A). The constructs were named as pGFP-402, pPTC6-402, pPTC27-402, and 
pPTC140-402. 
The PTC140-402 and PTC27-402 were expected to show strong NMD: in the 
PTC140-402 reporter, the PTC is at the same distance from the poly(A) tail as PTC6 
in the original reporter (851 nt); in the PTC27-402 reporter the PTC is further away 
from the poly(A) tail, 1190 nt. RNA analysis showed that PTC6 still induced strong 
NMD (13%, Fig. 4.3B lane 2), like in the original reporter. However, NMD was only 
partially enhanced in the PTC27-402 (27% vs. 43%, Fig. 4.3B lane 3) and in PTC140-
402 reporters, compare to the original reporters (63% vs. 84%, Fig 4.3B lane 4). The 
mRNA levels were restored in the upf2Δ strain, consistent with the expectation that 
these mRNA reductions were the result of NMD (Fig 4.3C). 
In summary these data indicate that the distance between a PTC and the poly(A) tail is 
only a minor determinant of NMD in S. pombe. These data seems not to be consistent 
with the key prediction of the faux 3’ UTR model, which states that the strong NMD 
is mainly depended on an abnormally long distance between a PTC and the 3’ end. 
4.2.4 The nature of the 3’ UTR does not affect NMD 
To investigate whether the nature of the 3’ UTR is important for NMD, we exchanged 
the nmt1 3’ UTR of my NMD reporters with that of two other genes. One was the 3’ 
UTR of the ade6 gene. This 3’ UTR was chosen because it has been previously 
reported that nonsense mutations in this gene triggers strong NMD in S. pombe 
(Mendell et al., 2000). The other 3’ UTR from the adh gene was chosen because this 
gene is constitutively expressed at high level (data shown in Chapter V, Fig. 5.4A, 
lane 1-4). 
98 
 
Figure 4.3 Lengthening the distance between a PTC and the 3’ UTR does not 
greatly affect NMD. 
(A) Diagram of GFP reporters for long distance. A 402 bp DNA fragment from firefly 
luciferase gene was cloned 6 bp upstream of the normal stop codon. 
(B and C) Northern blot analysis of total-RNA from wild-type (B) and upf2Δ (C) 
cells, transformed with the plasmids indicated. Top panels show hybridization with a 
GFP specific probe as in Figure 4. 1B; bottom panels with a probe specific for Rpl32 
mRNA, a loading control as in Figure 4.1B. The values below each lane are 
percentages with standard deviation from three independent experiments. 
B C
A 
pGFP-402 
pPTC6-402 
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Figure 4.4 The nature of 3’ UTR does not affect NMD in S. pombe. 
(A) Diagram of GFP reporters with ade6 3’ UTR from S. pombe ade6 gene. Three 
nonsense mutations (TAA) are the same as described in Figure 4.2A. 
(B) Northern blot analysis of total-RNA from wild-type cells, transformed with the 
plasmids indicated. Top panels show hybridization with a GFP specific probe as in 
Figure 4.1B; bottom panels with Rpl32 as a loading control as in Figure 4.1B. 
pGFP-a6 
pPTC6-a6 
pPTC27-a6 
pPTC140-a6 
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RNA analysis of these reporters with the ade6 3’ UTR shows a similar NMD pattern: 
the mRNA levels of PTC6, 27 and 140, relative to the PTC-less control, are 
comparable to that of the reporters with the nmt1 3’ UTR (Fig. 4.4B). These results 
suggest that the nature of the 3’ UTR sequences might not have a major role in NMD. 
4.2.5 Shortening of the distance between a PTC and the poly(A) tail only 
modestly affects NMD 
The data reported above indicate that lengthening distance between a PTC and the 
poly(A) tail only slightly affects NMD in S. pombe. Here I tested the second 
prediction of the faux 3’ UTR model: shortening of the distance between a NMD-
inducing PTC and the 3’ end should prevent NMD. In particular, I reasoned that the 
drastic mRNA reduction associated with PTC6 should be suppressed by shortening of 
the 3’ UTR. To test this prediction, new constructs were made with a shorter GFP 
coding region (327 nt instead of the normal 729 nt) (Fig. 4.5A). In the shorter GFP 
reporter, named as pGFP-sh and pPTC6-sh, the distance between PTC6 and the 
poly(A) tail is the same between PTC140 and the poly(A) tail in the initial reporter 
with the full-length GFP (449 nt). RNA analysis showed a strong mRNA reduction of 
the PTC6-sh reporter (11% of the PTC-less control, Fig. 4.5B lane 2) Unexpectedly, 
the PTC6-sh mRNA level was only partially stabilized in upf2Δ, showing 42% 
mRNA level normalized by GFP-sh (Fig. 4.5B, lane 4).  
The northern blot showed an additional transcript with an approximate length of 1300 
nt. This transcript was probably generated due to the inefficient termination at the 
canonical poly(A) site; the polymerase probably read-through the first poly(A) site 
and allows processing at an alternative poly(A) site located further downstream of the 
stop codon. To evaluate this possibility, the 1020 nt nmt1 3’ UTR sequence was 
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analyzed bioinformatically with two poly(A) prediction programs: “S. cerevisiae 3’ 
end processing predictor” and human “PolyApred”  (Graber et al., 2002; Ahmed et 
al., 2009). The S. cerevisiae 3’ end processing predictor program (but not the 
PolyApred) predicted a poly(A) signal at about 140 nt downstream of normal stop 
codon; this is the experimentally verified main polyadenylation of the nmt1 gene 
(Aranda and Proudfoot, 1999). Whereas both the prediction programs identified a 
strong poly(A) signal about 850 nt further downstream; this polyadenylation site 
probably accounts for the long transcripts in the northern blot (Fig. 4.5B and 5C). The 
S. cerevisiae 3’ end processing predictor program identified a weak poly(A) signal in 
the middle of the nmt1 3’ UTR sequence, 460-500 nt from the start of 3’ UTR; but in 
the northern blot there is no evidence that this site is used (Fig. 4.5). Quantification of 
the short and long GFP-sh transcripts in upf2Δ indicates that the two poly(A) signals 
are used with equal frequency, which strongly suggested that shortening of the ORF 
activates downstream poly(A) processing. Furthermore, The long transcripts are 
strongly stabilized in the upf2Δ strain regardless of whether it carried the PTC6 
mutation (Fig. 4.5B, lane 3 and lane 4). This is consistent with the observations that 
mRNAs with the native long 3’ UTR were destabilized by NMD in S. cerevisiae, but 
this finding also contradicts the prediction according to the faux 3’ UTR model where 
PTC6 would be expected to cause a more intense NMD in the transcripts with the 
longer 3’ UTR; instead of what I found: that the level of the longer transcript was not 
affected by the PTC6.  
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Figure 4.5 Shortening of the distance between a PTC and the poly(A) tail does 
not prevent NMD. 
(A) Diagram of reporters with a deletion derivative of GFP. The 3’ half of GFP was 
deleted until the normal stop codon (402 bp deletion). 
(B) Northern blot analysis of total-RNA from wild type and upf2Δ cells. Top panels 
show hybridization with a GFP specific probe as in Figure 4.1B; bottom panels with a 
probe specific for Rpl32 mRNA, as a loading control as in Figure 4.1B. The values 
below each lane are percentages with standard deviation from two independent 
experiments. 
(C) Diagram of the transcripts with the short or the long 3’ UTR, generated from the 
two polyadenylation sites. 
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Figure 4.6 Prediction of polyadenylation signal sequence and cleavage site in nmt1 3’ UTR. 
The nmt1 3’ UTR was analyzed with the “S. cerevisiae 3’ end processing predictor” program. The most probable poly(A) sites are indicated 
by arrows; the red arrows indicate the sites that appear to be used in the NMD reporter (pA1 and pA3 shown in sequences); blue arrows 
indicate predicted sites that do not appear to be used in the reporters. Underlined in red are the poly(A) signal sequences, in orange putative 
cleavage sites. 
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4.2.6 Cytoplasmic PABP is not essential for NMD in S. pombe 
The third prediction of the original faux 3’ UTR model is that cytoplasmic PABP 
(PABPC) is important for NMD. To elucidate the function of PABPC in S. pombe 
NMD, the NMD reporters were transformed in a knock out strain, pab1Δ (Thakurta et 
al., 2002). PAB1 is the only gene encoding the PABPC homolog in S. pombe. Unlike 
in S. cerevisiae, S. pombe cells with the deletion of PAB1 are viable; although the 
deletion causes slow growth of the cells (Thakurta et al., 2002). RNA analysis showed 
strong NMD of the PTC6 reporter, moderate NMD with PTC27 and a weak NMD 
with PTC140; the results are very similar to the NMD pattern observed in the wild-
type strain (Fig. 4.7). The data indicate that in S. pombe, PABPC does not play an 
important role in NMD, suggesting that NMD might be independent of PABPC.  
4.2.7 The half-life of mRNA with a PTC is extended in NMD mutant strain  
The primary signature of NMD is the reduction of steady-state of mRNA caused by a 
reduced mRNA stability of the mature PTC-containing mRNA. To assess whether 
NMD is also due to a reduced mRNA stability in my system, I measured the half-life 
of the most affected NMD reporter, the PTC6 mRNA, and compared it with a PTC-
less control. The half-life of the mRNA was estimated following transcription 
inhibition with 1, 10 phenanthroline, which is a metal chelating compound that 
deplete Zn2+ from RNA polymerase II (Falchuk et al., 1976). GFP mRNA levels were 
assayed at six regular time intervals, 0, 2, 10, 20, 40, and 60 min, after 1,10-
phenanthroline was added to inhibit transcription. This drug has been previously used 
to inhibit transcription and to measure global mRNA stability in S. cerevisiae and S. 
pombe cells, and the effects on mRNA stability were similar to it in rpb1-1, a 
temperature-sensitive allele of RNA polymerase II (Rodriguez-Gabriel et al., 2003; 
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Grigull et al., 2004; Lackner et al., 2007). I found that the PTC6 mRNA decays faster, 
however the decay rate is not gradual like that of the PTC-less mRNA: it is initially 
fast but then becomes slow, compared to that of the control (Fig. 4.8A and 8C). This 
typical biphasic decay profile has been reported in mammalian cells and S. cerevisiae 
(Leeds et al., 1991; Lykke-Andersen et al., 2000; Maquat, 2004; Guan et al., 2006). In 
upf2Δ cells, the PTC6 mRNA was stabilized and the decay kinetics were similar to 
that of the PTC-less mRNA in the wild-type strain (Fig. 4.8B and 8C). Notably, in the 
upf2Δ, the PTC-less mRNA was also stabilized, indicating that the depletion of UPF2 
might also stabilize mRNAs without PTCs. It supported the observation that the 
fluorescence of GFP in upf2Δ was more intense than it seen in wild-type, which has 
been previously reported as the “photoshop” phenotype in D. melanogaster NMD 
mutants (Fig. 4.8D) 
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Fig 4. 7 Pab1p is not required for NMD. 
Northern blot analysis of total-RNA from pab1Δ cells. Top panels show hybridization 
with a GFP specific probe as in Figure 4. 1B; Bottom panel with a probe specific for 
Rpl32 mRNA-the loading control as in Figure 4. 1B. The values below each lane are 
percentages with standard deviation from three independent experiments.  
pab1Δ 
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Fig. 4.8 
  109 
Figure 4. 8 mRNA half-life analysis and GFP fluorescence. 
(A-C) Stability of the GFP mRNA in wild type (A) and upf2Δ (B) following 
transcription inhibition with 1, 10-phenanthroline. The PTC-less control (top panel) 
and PTC6 mRNA (bottom panel) were independently monitored and (C) quantified 
by Northern blot as mentioned above, except that values were standardized to the 18S 
rRNA signal (this RNA does not show visible decay over the time period of the 
experiment). Total-RNA was extracted at 6 different time points after adding the 
drug: 0, 2, 10, 20, 40 and 60 min. Error bars are standard deviations from three 
different experiments. 
(D) GFP fluorescence analysis by fluorescent microscope. The GFP and PTC in wild 
type, upf1Δ and upf2Δ, were observed under the 100X oil lens, and an image captured 
of GFP fluorescent by CCD camera with an exposure fixed at 0.1112 seconds, as 
describe in Materials and Methods (Chapter II).
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4.3 Discussion 
In agreement with what has been reported in S. cerevisiae and in D. melanogaster, the 
data presented in this chapter clearly indicate that in my reporter system, NMD is also 
polar in S. pombe: only early PTCs in GFP coding region lead to a drastic mRNA 
reduction. The more apparent NMD when a PTC is located at the beginning of the 
gene would suggest that a key NMD determinant is the length of the distance from the 
3’ end, as indicated by the faux 3’ UTR model. However, contrary to the faux 3’ UTR 
model, I found that NMD does not clearly correlate with the distance between a PTC 
and the 3’ end according to my NMD reporters. For example, neither lengthening of 
the 3’ UTR nor lengthening of the distance between a PTC and the 3’ end did strongly 
enhance NMD of the PTC140 reporter, even though in these new reporters the PTC 
was as far from the 3’ end as PTC6 in the original reporter showing strong NMD. 
Moreover, shortening of the distance between PTC6 and the poly(A) tail did not 
suppress NMD. In the reporter carrying the deletion of the 3’ half of GFP (pPTC6-sh), 
PTC6 still triggered strong NMD as much as it did in the original reporter, while it 
was expected that PTC6 should cause the minimal NMD when close of the 3’ UTR. 
These data challenge the notion that the distance between a PTC and the poly(A) tail 
is the key NMD determinant.  
The stabilization of the extra long transcripts of GFP-sh and PTC6-sh in upf2Δ 
mutants is in agreement with the observation that some transcripts with a long 3’ UTR 
are substrates for NMD. However, as mentioned above, it still contradicts to the faux 
3’ UTR model since the presence of PTC6 does not change the mRNA level, despite 
the longer distance between the termination codon and the 3’ end. This further 
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challenges the notion that the distance between a PTC and the poly(A) tail is a key 
determinant of NMD. 
In addition, I also found that lengthening of the distance between the start codon and 
the PTC only minimally affected mRNA levels (data not shown). I did not investigate 
whether the length of the 5’-UTR affects NMD because it was anticipated that such 
changes would also change the translation efficiency and therefore complicate the 
interpretation of the results as reported in a similar study in S. cerevisiae (Yun and 
Sherman, 1995). 
The NMD polarity is clearly seen in the NMD reporters carrying different 3’ UTRs. 
Thus NMD efficiency appears not to be related to the nature or length of the 3’ UTR. 
These observations are in agreement with a recent study in S. cerevisiae, which 
reported that the GFP and endogenous mRNA with a ribozyme-generated 3’ end is 
also subjected to NMD, even without the poly(A) tail (Meaux et al., 2008). Further 
challenging the key role of PABPC in NMD, this study also concluded that in S. 
cerevisiae, PTC-containing mRNAs without poly(A) tails are also subject to NMD 
even in a strain deleted of Pab1p (Meaux et al., 2008).  
However, it is feasible that other proteins associated with the 3’ end could affect 
NMD. Interestingly, a recent study has suggested that Pab2p, the homolog of the 
nuclear PABP in S. pombe, associates to ribosomes, and is not replaced by PABPC in 
the pioneer round translation (Lemieux and Bachand, 2009). Pab2p might play a role 
similar to Pab1p in the early stage of translation. Future studies should address 
whether Pab2p is involved in S. pombe NMD. 
In summary, these results indicate that the distance of the PTC from the both 5’ and 3’ 
end is not a key determinant for the efficient NMD in S. pombe. Instead, it is possible 
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that a downstream sequence element (DSE) plays an important role in the polarity 
effect of NMD, as suggested by early NMD models (Zhang et al., 1995; Ruiz-
Echevarria et al., 1998a). This will be further discussed in the Conclusion and 
Discussion (Chapter VII). 
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CHAPTER V. SPLICING ENHANCES NMD IN S. POMBE 
5.1 Introduction  
A number of studies have reported that in mammalian cells, NMD is a nucleus 
associated event and in some instances occurs only when a PTC is located upstream 
of at least one intron (Cheng et al., 1994; Carter et al., 1996; Thermann et al., 1998; 
Zhang et al., 1998a; Zhang et al., 1998b). In addition, it has been reported that NMD 
affects most of CBP80-associated mRNAs, and that UPF2, UPF3 and EJC associate 
with CBP80-associated mRNA but not with eIF4E-associated mRNA in human cells 
(Ishigaki et al., 2001; Lejeune et al., 2002). These studies strongly suggest that newly 
synthesized transcripts are subjected to NMD more than steady state mRNA 
associated with eIF4E. The linkage between introns and NMD is the exon-exon 
junction complex (EJC) – a multiprotein complex deposited on spliced mRNAs about 
20-24 nt before the splice junctions, which remains associated with the mRNAs 
during export to the cytoplasm (Le Hir et al., 2000a; Le Hir et al., 2000b). The EJC 
probably serves as a binding platform for the NMD factors (Le Hir et al., 2001b; 
Chamieh et al., 2008). It has been reported that UPF3B directly associates with 
Magoh/Y14 and RNPS1, three core protein components of the EJC (Kim et al., 
2001a; Le Hir et al., 2001b; Lykke-Andersen et al., 2001; Gehring et al., 2003; Singh 
et al., 2007). The other core components eIF4AIII and MLN51 are also required for 
efficient NMD in mammalian cells; RNAi depletion and mutation of these proteins 
strongly inhibit NMD (Shibuya et al., 2004; Gehring et al., 2005).  
However, the requirement for a downstream intron in mammalian NMD was recently 
challenged by many other studies in human cells. First, the PTCs that are closer than 
50-55 nt to the last exon-exon junction do still induce strong NMD in TCR-β and Ig-µ 
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transcripts (Carter et al., 1996; Wang et al., 2002a; Buhler et al., 2004). Second, at 
least one type of NMD appears to be independent of downstream introns; this 
alternative pathway is termed “failsafe NMD” and has been observed in human β-
globin transcripts (Neu-Yilik et al., 2001; Matsuda et al., 2007). More recent studies 
have reported that extending or shortening of the distance of a PTC from the 3’ end 
also strongly affects NMD in mammalian cells. And in agreement with the faux 3’ 
UTR model, tethering of PABPC downstream position close to the PTC inhibits 
NMD, (Buhler et al., 2006; Eberle et al., 2008). These investigators concluded that the 
faux 3’ UTR model explains NMD better than the EJC model in mammalian cells. 
Although all core EJC components are conserved in D. melanogaster and C. elegans, 
studies in both organisms have revealed that neither splicing nor EJC components are 
required for NMD (Gatfield et al., 2003; Longman et al., 2007). In S. cerevisiae there 
is no report of splicing enhancing NMD. In addition, most genes don’t have introns in 
budding yeast and the genome does not encode the homologs of EJC components 
with the exception of eIF4AIII. 
Study of the link between splicing and NMD is key to understand the mechanism by 
which pre-mRNA processing affects downstream events such as translation. To unveil 
this mechanism it is preferable to use a model organism that is amenable to genetic 
manipulations. My PhD project aimed to explore whether I could investigate these 
issues in the fission yeast, S. pombe. The genome of this organism encodes most of 
the EJC core components (described in Chapter III) and introns are commonly 
distributed in genes; therefore I wanted to investigate whether splicing affects NMD 
in S. pombe. In this chapter, I mainly focus on the relationship between introns and 
NMD, and whether the EJC is required for the intron-dependent NMD.
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5.2 Results 
5.2.1 Intron-containing NMD reporters 
To investigate the role of splicing in NMD, I inserted an intron in the coding region of 
the GFP reporter described in Chapter IV – the intron derives from the endogenous S. 
pombe gene ubc4. The insertion of the intron splits the GFP coding region at codon 
110. To assay NMD, the PTC6, PTC27, PTC140 mutations were introduced into the 
GFP coding region - the constructs were named pGFPivs, pPTC6ivs, pPTC27ivs and 
pPTC140ivs (Fig. 5.1A).  
Among these four constructs, PTC6 and PTC27 are located upstream of the intron, 
313 nt and 250 nt away from the intron, respectively; this is more than the 55 nt 
boundary beyond which introns do not appear to enhance NMD in mammalian cells 
(Zhang et al., 1998a). Instead PTC140 is 89 nt downstream of the intron. Strong GFP 
fluorescence was observed in the PTC-less control, suggesting that the intron is 
correctly and efficiently spliced (Fig. 5.1B). Also, the RT-PCR was performed to 
confirm the same length of the DNA bands between GFP without intron and GFP 
with intron, which suggests the intron is spliced correctly in the intron-containing 
constructs (Fig. 5.1C).  
5.2.2 An intron strongly enhances NMD and abolished the polar effect of NMD. 
To assess the intron’s function in NMD, these constructs were transformed into wild-
type and upf2Δ strains, the mRNA levels were analyzed by Northern blot. RNA 
analysis showed that the mRNA level was strongly reduced in all PTC-containing 
reporters: PTC6 induced a strong mRNA reduction (17% mRNA level of the control), 
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Figure 5.1 The presence of an intron enhances NMD in S. pombe. 
(A) Diagram of the intron-containing GFP reporters. Nonsense mutations (TAA) were 
introduced at codon positions 6, 27 and 140. The intron was PCR amplified with 
primers INubc4-sens and INubc4-rev, see Appendix II Table 1; and inserted between 
328th nt and 329th nt of codon 110.  
(B) GFP fluorescence of cells transformed with the indicated intron-containing 
reporters. No GFP fluorescence was observed in cells transformed with PTC6, PTC27 
and PTC140 reporters (data not shown for PTC 27 and PTC140).  
(C) RT-PCR confirmation of accurate splicing of the intron-containing reporters. 
Reverse transcription was performed as described in Chapter II. (D and E) Northern 
blot analysis of total-RNA from wild-type (C) and upf2Δ (D) cells transformed with 
the indicated reporters. The top panels show hybridization with the GFP probe (the 
slower migrating band corresponds to unspliced pre-mRNA), the bottom panels with 
the Rpl32 probe. Values are standardized percentages of the GFP mRNA in the PTC-
less control, lane 1. Quantifications are based on three independent experiments. 
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as in the corresponding intronless reporter (Fig. 5.1D, lane 2). However, PTC27 and 
PTC140 also triggered strong mRNA reductions, 25% and 20% mRNA levels of GFP 
with intron, respectively, while these mutations did not cause strong NMD in the 
intronless reporters (Fig. 5.1D, lane 3 and lane 4). The presence of the intron clearly 
enhanced NMD: the intron caused the additional 22% mRNA reductions in PTC27-
intron construct, corresponding to approximate 1 fold increase in NMD, and a 60% 
further reduction in the PTC140-intron reporter (3 fold increase in NMD), even 
though PTC140 is located 90 nt downstream of the intron. This suggested that the 
intron in the GFP coding region strongly enhances NMD (Table 5.1). The presence of 
the intron also abolished the NMD polarity effect that has been observed in the intron-
less reporters. More importantly, in contrast to the prediction of the EJC model, this 
splicing-dependent NMD enhancement is independent of whether the intron is located 
downstream or upstream of the PTC. In all cases the mRNA levels were restored in 
upf2Δ cells, indicating that the degradation is elicited by NMD, not from another 
RNA decay mechanism.  
5.2.3 Splicing also enhances NMD in an endogenous gene. 
To confirm whether introns enhance NMD in general, a new NMD reporter was 
generated based on the endogenous gene SPAC18G6.03, which encodes a GTPase, 
named as Ypt3p in S. pombe. The gene has two introns in the coding region. I cloned 
the wild-type gene with the introns and a cDNA derivative without any intron into 
pREP41. Two nonsense mutations were introduced into the coding region at residue 6 
and residue 131 (Fig. 5.2A).  
RNA analysis showed that PTC6 and PTC135 cause a strong mRNA reduction in the 
endogenous gene constructs, 19% and 24% of ypt3 mRNA levels respectively, and 
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Figure 5.2 Introns are necessary for strong NMD in the ypt3 gene. 
(A) Diagram of the reporters expressing either the wild-type endogenous ypt3 gene or 
a cDNA derivative lacking both introns; PTCs are at codon positions 6 and 131, 
detailed information described in Materials and Methods, Chapter II. 
(B and C) Northern blot analysis of total-RNA from wild-type (B) and upf2Δ (C) cells 
transformed with the indicated reporters. Top panels show hybridization with a ypt3 
specific probe which was amplified with primers, ypt3-sens and ypt3-rev (listed in 
Table 2.1, Materials and Methods); bottom panels with the RpL32 probe as in Fig. 4. 
1B. Values are standardized percentages of the ypt3 mRNA signal in the PTC-less 
control, lane 1; standard deviations are from three independent experiments.  
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the mRNA levels were increased in the upf2Δ strain (Fig. 5.2B and 2C). Instead, 
minimal mRNA reduction occurred in the cDNA constructs, 57 % of mRNA levels 
for PTC6 normalized by the wild-type control and 84% for PTC131 (Fig. 5.2B, lane 5 
and lane 6). These data indicate that the intron-dependent enhancement might be 
general feature of NMD in S. pombe. 
5.2.4 Intron-dependent NMD depends on splicing 
To further assess whether the intron effect on NMD is splicing dependent, I generated 
four additional constructs carrying a mutation at the 5’ splice site, GTAG to ATAA 
(Fig. 5.3A). Additional information is mentioned in Materials and Methods (Chapter 
II). The constructs were named as pGFPivs-mut, pPTC6ivs-mut, pPTC27ivs-mut and 
pPTC140ivs-mut, respectively. 
As expected, the 5’ splice site mutation almost abolished most of splicing, resulting in 
the accumulation of a longer size transcript because the intron failed to be removed. A 
PTC leads to an obvious reduction in mRNA level but, like in the original intronless 
report, only when the PTC is located at the beginning of the gene: PTC6-5’ splice site 
mutant (PTC6-ss) still triggered strong mRNA reduction; PTC27-ss triggered 
moderated NMD; and PTC140-ss caused minimal mRNA reduction, (Fig. 5.3B). The 
absence of strong mRNA reduction in PTC27-intron and PTC140-intron further 
indicate that splicing is able to enhance NMD in S. pombe. As mentioned above, the 
retention of the intron generates additional intron-encoded PTCs; therefore in the 
GFP-wt and PTC140 reporter the earliest PTC is actually at the triplets position 110.  
It is possible that the unspliced transcripts escape NMD because they are retained 
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Figure 5.3 Inhibition of splicing prevents NMD. 
(A) Diagram of the GFP reporters carrying a mutation in the intron 5’ splice site. The 
mutagenesis of 5’ splice site and generation of constructs are described in Materials 
and Methods, Chapter II.  
(B) Northern blot analysis of total RNA from wild-type cells transformed with the 
indicated reporters. Top panel shows hybridization with the GFP probe as describe in 
Fig. 4.1B; bottom panel hybridization with the Rpl32 probe as Fig. 4.1B. Values are 
percentages of the standardized intensity of the GFP mRNA in lane1 (lanes 1-4) and 
lane 5 (lanes 5-8). Calculations are based on three independent experiments. 
(C) FISH analysis of cells transformed with reporters carrying either the original 
intronless reporter (GFP), or the intron-containing construct (GFPivs), 5’ splice site 
mutant constructs with or without a PTC as indicated (GFPss and GFPssPTC27). The 
mRNA appears to be distributed throughout the cell in all strains, including the one 
carrying a PTC and the mutated intron (GFPssPTC27). The rightmost column shows 
FISH of cells not expressing GFP. 
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in the nucleus, as suggested by previous study (Legrain and Rosbash, 1989). To 
investigate the issue further, I assayed the sub-cellular distribution of GFP mRNAs by 
fluorescent in situ hybridization (FISH). However, the FISH data confirmed that the 
unspliced RNA with the mutated 5’ ss accumulates throughout the cell, similar to the 
fully spliced mRNA (Fig. 5.3C). These results suggest that transcripts that fail to be 
spliced are not necessarily retained in the nucleus in S. pombe. Meanwhile, these data 
indicated that the unspliced mRNAs become NMD substrates  
Furthermore, in the unspliced transcript, PTC111 (the earliest intron-encoded PTC) 
did not cause apparent NMD in GFP-ss and PTC140-ss, despite the fact that the 
distance between PTC110 and the 3’ UTR (~760 nt) is longer than that between PTC6 
and the 3’ UTR (711 nt) in the intronless reporter. Therefore, this piece of data further 
supports the results in Chapter IV and indicates that a long distance between a PTC 
and the 3’ UTR is not sufficient to trigger NMD (Fig. 5.3B).  
5.2.5 Splicing enhances NMD also in chromosomal reporters.  
To assess whether NMD is affected by the reporters expressed from a plasmid or from 
a chromosomal location, the GFP and PTC constructs, with or without introns, were 
cloned into the integration vector, pDUAL. pDUAL can be integrated by homologous 
recombination into the leu1 locus and rescue the phenotype of leucine auxotroph by 
the leu1D32 null allele.  
The integration strains were generated as described in Materials and Methods, 
Chapter II. The mRNA levels were analyzed in the integration strains and showed a 
similar mRNA reduction as in the episomal reporters. PTC6 still triggered strong 
mRNA reduction; but PTC27 and PTC140 did not. Instead in the intron-containing 
reporters the PTC triggered strong mRNA reduction at all three positions (19% to  
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Figure 5.4 Intron enhanced NMD in the integration strains. 
(A and B) Northern blot analysis of total RNA from the integration strains (derived 
from the wild-type or the upf2Δ strain) carrying the reporters indicated. Top panels 
show hybridization with the GFP probe as Fig. 4.1B; bottom panels with the Rpl32 
probe as Fig. 4.1B. (A) Values are percentages of the standardized intensity of the 
GFP mRNA in lane1 (lanes 1-4) or lane 5 (lanes 5-8); (B) standardization relative to 
lane 1 and lane 4.  
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Figure 5.5 An Intron enhanced NMD independently of the nature of the 3’ UTR. 
Northern blot analysis of total RNA from cells transformed with the indicated 
reporters. Top panel shows hybridization with the GFP probe as Fig. 4.1B; bottom 
panel with the Rpl32 probe as Fig. 4.1B. Values are percentages of the standardized 
intensity of the GFP mRNA in lane 1. 
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27% of GFP control), as in the episomal intron-containing reporters (Fig. 5.4A). In all 
cases the mRNA levels were increased in the upf2Δ strain, indicating that the mRNA 
reduction is caused by the canonical NMD (Fig. 5.4B). Four similar constructs with 
different 3’ UTRs also showed a similar NMD pattern. The constructs which have the 
ade6 instead on the nmt1 3’ UTR (described in Materials and Methods, Chapter II), 
were transformed into S. pombe cells (Fig. 5.5). PTC6, PTC27 and PTC140 still 
triggered strong mRNA reductions similar to the constructs with the nmt1 3’ UTR. 
These results indicate that splicing enhances NMD regardless of the nature of the 3’ 
UTR. 
5.2.6 Splicing-dependent NMD does not require EJC components. 
As reviewed in the Introduction, studies from mammalian cells indicated that 
eIF4AIII, MAGO/Y14, MLN51 and RNPS1 are essential for NMD, and depletion of 
any of these components by RNAi in human cells strongly inhibited NMD (Gehring 
et al., 2005; Gehring et al., 2003; Lykke-Andersen et al., 2001; Shibuya et al., 2004). 
To address the EJC function in S. pombe NMD, I assayed for NMD in S. pombe 
strains deleted for known orthologs of EJC components. The fission yeast genome 
carries proteins highly similar to these EJC components with the exception that there 
is no homolog of MLN51 (Chapter III). The eIF4AIII ortholog could not be deleted, 
probably because it is essential like the homologous protein in S. cerevisiae, which 
functions in ribosome biogenesis and 40s ribosome subunit maturation (Kressler et 
al., 1997). In S. pombe Y14 does not have the conserved N-terminal domain, which 
has been reported as the additional interaction site for MAGO binding (Kataoka et al., 
2001; Lau et al., 2003; Shi and Xu, 2003). Therefore, two knock out strains, magoΔ 
and rnps1Δ, were selected to study whether NMD depends on the presence of these 
proteins - rnps1Δ was generated by homologous recombination as described in 
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Figure 5.6 MAGO and RNPS1 are not required for NMD 
(A and B) Northern blot analysis of total-RNA extracted from mago or rnps1 deletion 
strains transformed with the indicated reporters. The top panels show hybridizations 
with the GFP probe as described in Fig. 4.1B, the bottom panel with the Rpl32 probe 
in Fig. 4.1B. Values are percentages of the intensity of the GFP mRNA in the PTC-
less control in lane 1; standard deviations are from three independent experiments.
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Materials and Methods (Chapter II); the magoΔ is viable and has been previously 
described (Decottignies et al., 2003).  
The four intron-containing NMD constructs were transformed into magoΔ and rnps1Δ 
cells and the mRNA levels were analyzed by Northern blot. The results showed the 
similar phenomenon of NMD as in the wild-type strain- the three intron-containing 
constructs have the strongest NMD. In particular, PTC27 and PTC140 caused a strong 
mRNA reduction  (27% and 21% in magoΔ and 24% and 20% in rnps1Δ). These data 
indicate that splicing-dependent NMD does not require the EJC components, MAGO 
and RNPS1 (Fig. 5.6A and 6B). 
5.2.7 Introns in 3’ UTR trigger strong mRNA reduction 
Some studies revealed that an intron in the 3’ UTR caused strong mRNA reductions 
in mammalian cells (Mendell et al., 2004; Wittmann et al., 2006; Giorgi et al., 2007; 
Singh et al., 2008). To assess whether a 3’ UTR intron has a similar effect in fission 
yeast, an intron was inserted 9 nt downstream of the normal stop codon. RNA 
analysis of strains transformed with these reporters, revealed a strong mRNA 
reduction only in the PTC-less reporter and in PTC6 reporter (~20% mRNA levels of 
GFP control), but not in PTC27 or PTC140 reporter. The fact that strong mRNA 
reduction occurred in the PTC-less reporter is consistent with the view that an intron 
downstream of a termination codon can make a normal stop codon behave like a PTC 
and trigger strong NMD. The finding is in agreement with the prediction of the EJC 
model and a key distinction between normal termination and NMD-inducing 
termination is the presence of a downstream intron. However, against the prediction 
of the EJC model, PTC27 and PTC140 transcripts were not affected, perhaps  
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Figure 5.7 intron in 3’ UTR caused GFP as the NMD substrate. 
(A) Diagram of the reporters with a 3’ UTR intron. The generation of these constructs 
is described in Materials and Methods, Chapter II. In the construct the intron is 
located 9 nt after GFP ORF. 
(B and C) Northern blot analysis of total-RNA extracted from wild-type (B) or upf2Δ 
(C) strains transformed with the reporters with the 3’ UTR intron. Top panels show 
hybridization with the GFP probe as described in Fig. 4.1B, bottom panels with the 
Rpl32 probe as Fig. 4.1B. The values in B are percentages of the GFP mRNA signal 
of the PTC-less control; standard deviations are from three independent experiments. 
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suggesting that splicing can affect NMD only when termination occurs close to the 
splice site (Fig. 5.7B). In agreement with this prediction, in the reporters with the 
intron in the coding region, NMD was enhanced in PTC140-intron reporter much 
more than that in PTC27- intron (60% vs. 20%), while NMD in PTC6-intron was not 
affected by the intron at all. In these reporters the intron is located at codon position 
110, which is far away from PTC6 (313 nt) and PTC27 (250 nt), but close to PTC140 
(89 nt). However, in the reporter containing the 3’ UTR intron, the intron is close to 
normal strop codon (12 nt), but far way from PTC140 and PTC27 (324 and 657 nt, 
respectively). It seems that the intron enhances NMD, only if the PTC is closer than 
~240 nt to the splice site (Table 5.1 and Fig. 5.9).  
5.2.8 An Intron enhances NMD only when is close to the PTC 
To further investigate whether the effect of an intron on NMD depends on the 
distance from the PTC, I have made new constructs in which the distance between 
PTC140 and the intron is lengthened by either 147 bp or 291 bp - the two fragments 
derive from the EGFP coding region and lead to longer ORFs, which give rise to 
larger proteins in the PTC-less reporters. In the reporter with the 147 bp insertion 
(PTC140ivs-147), the distance between the PTC and the intron was extended to 249 
nt (83 triplets) which is exactly the same as the distance between PTC27 and the 
intron in pGFPivs-PTC27; Meanwhile, in the PTC140ivs-291 construct, the distance 
between the PTC and the intron was extended to 390 nt (130 triplets) which is longer 
than the distance between PTC6 and the intron (313 nt) or the distance between 
PTC140 and the 3’ UTR intron (323 nt) which do not have the enhancement of NMD 
even in the presence of a downstream intron. RNA analysis of cells transformed with  
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Figure 5.8 NMD depends on the distance between PTC and intron 
(A) Diagram of the reporters in which the distance between the intron and the PTC 
was expanded. In the constructs, two insertions, 147 bp and 291 bp, are located 
between codons 120 and 121 (described in Materials and Methods, Chapter II). 
(B) Northern blot analysis of total- RNA extracted from wild-type cells transformed 
with the reporters with the indicated reporters. Top panels show hybridization with 
the GFP probe as described in Fig. 4.1B, bottom panels with the Rpl32 probe as Fig. 
4.1B. Values are percentages with standard deviations (from three experiments) of the 
intensity of the PTC-less GFP mRNA control. 
(C) Western blot analysis of whole-cell protein extracts of cells transformed with the 
indicated reporters. The top panel shows a blot probed with a goat polyclonal anti-
GFP (AbD Serotec), bottom blot re-probed with the monoclonal 8WG16 (Covance) 
anti-Pol II antibody, as loading control. The secondary antibody was a rabbit HRP-
conjugated anti-goat IgG (probe the anti-GFP) and anti-mouse IgG (probe the anti-Pol 
II) which was detected with chemiluminescent HRP substrate. 
  136 
these reporters showed that both insertions suppressed the mRNA reduction: the 
reporter with the 147 bp insertion produced 43% of the mRNA level of the related 
control, a clear increase of the PTC140-mRNA level compared to 20% of the initial 
reporter (pGFPivs-PTC140); and the reporter with the 291 bp insertion yielded 91% 
of the level of the related control mRNA, a clear increase of relative levels (20% to 
91%)- the enhancement of mRNA reduction by the intron was fully suppressed, as the 
extent of mRNA reduction is similar to the PTC140 intronless construct. The 
experimental data suggest that both insertions suppress NMD and confirm that the 
enhancement of NMD in the intron-containing reporters depends on the distance 
between the PTC and the intron.  
The insertion of two spacers in the PTC-less reporter did not noticeably change the 
mRNA level, arguing against the inserts per-se having major effects on transcription 
or processing. Moreover, the protein yield was either comparable or increased, 
suggesting that the insertions also do not inhibit translation. Thus the reduced NMD is 
not caused by less efficient translation of the mRNA (Fig. 5.8C). In summary, it 
appears that the extent of intron-enhancement NMD depends on the distance from the 
intron to the PTC: the shorter the distance between the splice site and the PTC, the 
stronger NMD enhancement occurred (Fig. 5.9).    
5.2.9 PABPC is not involved in NMD in S. pombe 
As referred in the Introduction (Chapter IV), several studies suggest that PABPC play 
an important role in NMD. To address the function of PABPC in splicing-dependent 
NMD in S. pombe, the intron-containing reporter was transformed into the pab1Δ 
strain. RNA analysis showed that strong mRNA reductions still occurred in all three  
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Table 5.1 The extent of NMD and the distance of PTC to splice junction 
 
The grey-scaled data are used to make the Figure 5.9 for the relationship between 
NMD enhancement and the PTC-intron distance. 
Constructs 
 
Splice 
junction 
(nt position) 
PTC  
(nt position) 
NMD 
enhancement 
(fold increase) 
Distance from 
splice junction to 
PTC (nt) 
pGFP-3’ivs 745 730-732 3.54 12 
pGFPivs-PTC140 329 418-420 3.08 89 
pPTC140ivs-147 329 577-579 0.98 248 
pGFPivs-PTC27 329 79-81 0.74 250 
pPTC140-3’ivs 745 418-420 0.1 321 
pGFPivs-PTC6 329 16-18 0 316 
pPTC140ivs-291 329 721-723 0 394 
pPTC27-3’ivs 745 79-81 0 664 
pPTC6-3’ivs 745 16-18 0 727 
138
Figure 5.9 Splicing enhancement of NMD is depended on the PTC-intron 
distance. 
An intron enhances NMD only when it is close to the PTC. Plot shows the 
relationship between the distance (in nucleotides) of the intron from the PTC and 
NMD enhancement. The figures are based on the data reported in this paper; from left 
to right (close to distant): pGFP-3’ivs, pGFPivs-PTC140, pPTC140ivs-147, 
pGFPivs-PTC27, pPTC140-3’ivs, and pPTC140ivs-291 (Table 5.1). NMD level 
correspond to the folds of mRNA reduction standardized by the reduction of the 
corresponding intronless reporter.
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PTC-intron containing constructs, very similar to the intron enhancement in wild-type 
strain (Fig. 5.10). This suggests that PABPC is not involved in splicing-dependent 
NMD, similar to what was previously shown for intronless reporters (Chapter IV, Fig. 
4.8). 
5.2.10 Splicing-dependent NMD does not correlate with a reduced stability of the 
mature mRNA  
The data I have presented in this chapter clearly show that splicing enhances NMD 
when the intron is close to the PTC. To address whether the reduction is caused by a 
lower mRNA stability, the mRNA half-lives were estimated after transcription 
inhibition with 1, 10-phenathroline (described in Chapter II and Chapter IV Section 
2.10). RNA samples were harvested at six time points and assayed by Northern blot. 
Surprisingly, RNA analysis showed that in the intron-containing reporter, the decay of 
spliced PTC140 mRNA is very similar to that of the PTC-less control, despite that the 
fact that mRNA levels of PTC140 are very low compared to the control mRNA (Fig. 
5.11A). The decay rate of spliced PTC140 mRNA was also not greatly affected in 
upf2Δ cell (Fig. 5.11C). These data strongly suggest that only newly made and spliced 
PTC140 mRNAs undergo accelerated decay in the pioneer round of translation as 
mentioned in the Introduction.  
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Figure 5.10 Intron enhancement in NMD does not require PABPC in S. pombe.  
Northern blot analysis of total RNA extracted from wild-type cells transformed with 
the indicated reporters. Top panel shows hybridization with the GFP probe, bottom 
panel with the Rpl32 probe as described in Fig. 4.1B. Values are percentages with 
standard deviations (from three experiments) of the intensity of the PTC-less GFP 
mRNA control. 
pab1Δ 
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Figure 5.11 mRNA half-life analysis of the intron-containing constructs. 
(A-C) Stability of the GFP mRNA in wild type (A) and upf2Δ (B) following 
transcription inhibition with 1, 10-phenanthroline. The PTC-less control (top panel) 
and PTC6 mRNA (bottom panel) were independently monitored and (C) quantified 
by Northern blot as described in Fig. 4.10, except that values were standardized to the 
18S rRNA signal (this RNA does not show visible decay over the time period of the 
experiment). Total-RNA was extracted at 6 different time points after adding the 
drug: 0, 2, 10, 20, 40 and 60 min. Error bars are standard deviations from three 
different experiments. 
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5.3 Discussion  
An open issue in the field was whether the link between splicing and NMD is a new 
acquisition of multicellular organisms or instead whether it has been lost in budding 
yeast (in which all the available experimental evidence indicates that introns are not 
involved in NMD). Fission yeast is an ideal model organism to address this issue, 
because 43 % of its genes (~2200 genes) carry introns (Wood et al., 2002). It was 
estimated that fission yeast diverged from budding yeasts 330-420 Myr ago (Wood et 
al., 2002). In particular, as reported above (Chapter III), the genome of this organism 
contains orthologs of EJC components.  
Here, I found that introns play a very important role in fission yeast NMD by using 
NMD reporters. The presence of an intron close to the PTCs enhanced NMD in both 
GFP and the reporter derived from the endogenous gene ypt3. This intron-
enhancement is directly coupled to splicing because mutations of the 5’ splice site that 
blocks splicing, strongly inhibits NMD. In addition, an intron located in the 3’ UTR 
induced strong NMD of the wild-type mRNA. It appears, that an intron in the 3’ UTR 
can make a normal stop codon behave like a PTC; this observation is in agreement 
with a number of reports in mammalian cells (Carter et al., 1996; Thermann et al., 
1998). However, in contrast to what has been reported in mammalian system, an 
intron enhances NMD even when it is very close to the stop codon, and there is no 
evidence of a 50-55 nt boundary in this system, unlike what was reported by several 
studies in mammalian cells (Cheng et al., 1994; Zhang and Maquat, 1996; Zhang et 
al., 1998a; Zhang et al., 1998b).  
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A second intriguing finding is that an intron can enhance NMD regardless of whether 
it is positioned upstream or downstream of the PTC in my system. The results 
contradict the main prediction of the EJC model: that an intron can induce NMD only 
if located downstream of the termination codon. The fact that an intron can also 
enhance NMD when positioned before the PTC seems to exclude that an EJC is 
mediating the influence in NMD. To recognize the PTC the ribosome has to scan 
through the splice site region and strip off any associated proteins. In addition, I found 
that NMD is not affected by deletion of RNPS1 and MAGO, which are two core 
components of EJC that appear to be essential for NMD in human cells. Therefore, 
the EJC seems not appear to be involved in S. pombe NMD (Discussed in Chapter 
VII). 
Another interesting discovery is that the extent to which an intron can enhance NMD 
depends on the distance between the PTC and the intron. My data suggest that in 
splicing dependent NMD, the intron must be within ~240 nt from the PTC, regardless 
of whether it's downstream or upstream.
  145 
CHAPTER VI. ADDITIONAL DATA IN S. POMBE NMD. 
As described in the previous chapters, the main focus of my research was to study the 
link between pre-mRNA splicing and NMD in S. pombe. However, I have also 
investigated other issues in this project. In one of these spin-off projects, I tested 
whether NMD is initiated by endonucleolytic cleavage in S. pombe, as reported in 
Drosophila and mammalian cells (Gatfield and Izaurralde, 2004; Huntzinger et al., 
2008; Eberle et al., 2009). In addition, in this chapter I present some initial data that 
indicate UPF1 may associate with both large and small ribosome subunits.  
6.1 No evidence of endonucleolytic cleavage in S. pombe NMD 
6.1.1 Introduction  
Initial studies in Drosophila S2 cells have shown that low molecular weight RNA 
degradation intermediates, deriving from PTC-containing transcripts, were 
accumulated in cells depleted of XRN1(Gatfield and Izaurralde, 2004). This strongly 
suggested that endonucleolytic cleavage initiates NMD in Drosophila S2 cells. After 
the endonucleolytic cleavage, the 5’ and 3’ fragments are vulnerable to exosome 
mediated 3’ to 5’ degradation and to XRN1 mediated 5’ to  3’ decay, thus they are not 
normally detected in wild-type cells. Recent studies suggested that the 
endonucleolytic cleavage also initiates NMD in mammalian cells and that SMG6 is 
the main endonuclease in both mammalian cells and Drosophila S2 cells (Huntzinger 
et al., 2008; Eberle et al., 2009). 
It is not known whether endonucleolytic cleavage occurs in S. pombe NMD. A 
previous study in S. cerevisiae showed no evidence for endonucleolytic cleavage 
(Doma and Parker, 2006). It was reported that the endonuleolytic cleavage can occur 
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in the proximity of stem loops that cause ribosome stalling, but this endonucleolytic 
cleavage occurred only in mRNAs with a stem loop, but not in rare codon or PTC-
containing mRNAs (Doma and Parker, 2006). As I described in Chapter III, there is 
no SMG6 homolog in S. pombe and in S. cerevisiae; thus endonucleolytic cleavage is 
not expected in S. pombe or S. cerevisiae NMD. In agreement with this prediction, the 
data I report below confirm that the endonucleolytic cleavage is not involved in S. 
pombe NMD. 
6.1.2 Results 
6.1.2.1 No evidence of endonucleolytic cleavage in exo2Δ  cells 
To address whether PTCs trigger endonucleolytic cleavage of the mRNA in S. pombe, 
I assayed the available NMD reporters in a strain deleted for exo2 (SPAC17A5.14) – 
this codes for the S. pombe otholog of XRN1 (Szankasi and Smith, 1996). Similar to 
previous studies, it was expected that if an endonucleolytic cleavage occurred in S. 
pombe, then 3’ degradation fragments should be readily detectable in exo2Δ cells. In 
addition, the length of these 3’ half fragments should correlate with the PTC position 
– earlier PTCs should produce longer 3’ fragments than later ones. Contrary to this 
expectation, I could detect only the full-length mRNA with all of the NMD reporters 
(Fig. 6.1). Furthermore, the overall NMD was not affected in the exo2Δ strain, with 
none of the reporters (Fig. 6.1). These results indicated that the endonucleolytic 
cleavage is unlikely to occur during NMD in S. pombe.  
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Figure 6.1 NMD in exo2Δ-XRN1 mutant. 
Northern blot analysis of total RNA from exo2Δ cells transformed with the NMD 
reporters indicated, (A) intronless reporters and (B) intron-containing reporters. As in 
Fig. 4.1B, top panels shows hybridization with the GFP probe and bottom panels with 
the Rpl32 probe.  
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6.2 UPF1 is associated with both polyribosome and separated 
ribosomal subunits 
6.2.1 Introduction 
As reported in the Introduction, UPF1 plays a pivotal role in NMD and understanding 
its molecular function (or functions) is key to a full understanding of the NMD 
phenomenon. It is believed that UPF1 is recruited to the terminating ribosome by an 
interaction with eRF1 and eRF3; this is mainly based on observations that eRF1 and 
eRF3 interact with UPF1 directly (Czaplinski et al., 1998; Wang et al., 2001; 
Kobayashi et al., 2004; Kashima et al., 2006; Ivanov et al., 2008). Polysome profiling 
in S. cerevisiae has shown that UPF1 mainly associates with monosome and 
polyribosomes and is unlikely to interact with split subunits (Atkin et al., 1995; Atkin 
et al., 1997). I was interested in investigating the association of UPF1 with ribosomes 
in S. pombe further. Below, I report some initial data indicating that UPF1 probably 
associates with the dissociated ribosome subunits as well as polyribosomes. The data 
suggest that UPF1 might be also involved in translation initiation.  
6.2.2.1 UPF1 associates with polyribosomes 
To investigate the association of UPF1 with ribosomes, I used a strain expressing a 
human influenza hemagglutinin (HA) tagged UPF1 (UPF1-HA3) (Rodriguez-Gabriel 
et al., 2006). The HA tagged UPF1 can be easily detected with commercially 
available anti-HA antibodies. To test whether UPF1 associates with functional 
ribosomes, I assayed whether they are associated with polysomes: cell extracts were 
separated by sucrose gradient (10% -50%) centrifugation and the fractions - 
corresponding to free proteins, 40S, 60S, 80S and polysomes - analyzed by 
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Figure 6.2 UPF1 and PTC-mRNA distribution analysis by polysome profile 
(A) Sucrose gradient analysis of ribosomes. The gradient was monitored for AU258 
254 by pumping the content through a UV detector connected to a charter recorder. 16 
fractions were collected but the first two and the last one fraction were discarded. The 
fractions were analyzed by native agarose gel electrophoresis to visualize 25S and 
18S rRNAs (panel below polysome profile). 
(B) Western blot of the polysome fractions, to visualize the distribution of UPF1. 
UPF1 was detected with a monoclonal anti-HA antibody (12CA5, Cancer Research 
UK). Lanes 1-12 correspond to fractions 1 to 12; C is an aliquot of the unfractionated 
protein extract. 
 (C) Northern blot analysis of the RNA isolated from the fractions to visualize the 
distribution of the GFP mRNA using a specific probe as in Fig 4.1B. Top one shows 
the GFP mRNA distribution in cells expressing the PTC6 transcript, bottom panel the 
distribution in cells expressing the PTC-less control. The polysome profile in A was 
obtained with cells expressing the PTC6 reporter.  
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immunoblotting with tag-specific antibodies  (Fig. 6.2) (procedures described in 
Chapter II, 2.4.10). I found that UPF1 is associated not only with polyribosomes but 
also with 80S monosome, 40S and 60S ribosome subunits (Fig. 6.2B). I also 
investigated the distribution of the GFP reporter mRNA in these fractions. As 
expected, the PTC-less mRNA is mostly associated with polyribosome fractions (Fig. 
6.2C). Instead the mRNA with PTC6 was mostly associated with lighter fractions 
corresponding to monosome or separate subunits (Fig. 6.2C). The association of the 
PTC6 mRNA with light polyribosome and monosome fractions is in agreement with 
the prediction that no more than one translating ribosome should associate with this 
mRNA (Fig. 6.2C), because the open reading region (18 nt) is shorter than the region 
protected by a single ribosome (30 nt) (Ingolia et al., 2009) 
6.2.2.2 UPF1 interacted with separated ribosome subunits 
The association between ribosome subunits depends on the presence of Mg2+ ions. 
Therefore, incubation with EDTA dissociates the ribosomes into 40S and 60S 
subunits; this step makes it possible to distinguish polyribosome association from the 
association with RNP or other large complexes.  
The western blot revealed that UPF1 mainly associates with 60S subunits, and weakly 
with 40S subunits (Fig. 6.3). Therefore, in translating ribosomes UPF1 might 
associate only with the 60S, while it might associate with both subunits prior to 
subunits joining and initiating translation (Fig. 6.2B) (see discussion below). For 
unknown reasons in my assays the mRNAs were strongly degraded in the presence of 
EDTA so that I could not study the mRNAs distribution in EDTA-treated polysome 
fractions as done above. 
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Figure 6.3. UPF1 distributions upon EDTA-induced polysome breakdown. 
(A) Sucrose gradient analysis of ribosomes. The gradient was monitored for AU258 
254 by pumping the content through a UV detector connected to a charter recorder. 16 
fractions were collected but the first two and the last one fraction were discarded.  
(B) Western blot of the polysome fractions, to visualize the distribution of UPF1.
UPF1 was detected with a monoclonal anti-HA antibody. Lanes 1-12 correspond to 
fractions 1 to 12.  
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6.3 Discussion 
6.3.1 Is an endonucleolytic cleavage required for NMD in S. pombe?  
In contrast to the studies in Drosophila and mammalian cells, here I did not find the 
supported evidence of the PTC-induced endonucleolytic cleavage. The results also 
indicate that NMD might not require XRN1 and is not affected by XRN1 deletion. 
The fact that there is no SMG6 homolog in this organism further supports this 
conclusion. SMG6 and the endonucleolytic cleavage might be specific to NMD in 
multicellular organisms.  
However, the possibility of an endonucleolytic cleavage for some kind of mRNA 
decay in mammalian cells and Drosophila S2 cells has not been discounted yet. As 
referred above, there is evidence that a stem loop structure can elicit the 
endonucleolytic cleavage in S. cerevisiae (Doma and Parker, 2006); therefore, it is 
possible that other forms of ribosome stalling during translation elongation can induce 
the endonucleolytic cleavage in yeast. This indicates that either the endonucleolytic 
cleavage is not specific in PTC-borne mRNAs or that it might have different 
mechanisms between yeasts and metazoa. The endonucleolytic cleavage still requires 
to be further confirmed in S. pombe. 
6.3.2 UPF1 function in NMD 
On the basis of published data, indicating that UPF1 interacts with eRF1 and eRF3, it 
is widely expected that UPF1 should be found associated only with terminating 80S 
ribosomes. Here, however, I found that UPF1 seems to associate with separate 40S 
and 60S subunits. This observation suggests that UPF1 might function in stages of 
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translation other than termination, for example translation initiation or re-initiation. In 
agreement with my findings, it has been recently reported that in mammalian cells 
phosphorylated UPF1 suppresses translation initiation by interacting with eIF3 to 
inhibit the forming of 80S/Met-tRNAiMet/mRNA initiation complexes (Isken et al., 
2008). Additionally, another study indicates that UPF1 is required for suppressing 
translation of specific mRNAs but not required for their mRNA decay (You et al., 
2007).  
The fact that most of the UPF1 in the cells is found associated with polyribosomes, 
suggest that this protein has a general role in translation and it is not just recruited to 
NMD substrates. If UPF1 was only recruited to NMD substrates, it should only be 
found in light polyribosomes and 80S fractions, because NMD degrades most of 
mRNAs with early PTCs. Further studies will need to be performed to clarify the 
function of UPF1 in translation.
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CHAPTER VII. CONCLUSION AND DISCUSSION 
7.1 Development of a new experimental system to study NMD in S. 
pombe 
As mentioned in the introduction, the NMD mechanism in S. pombe has not been well 
characterized in previous studies; we only knew that mRNA derived from some 
nonsense alleles of the ade6 gene is subjected to NMD and that UPF1 and UPF2 are 
required for this to occur (Mendell et al., 2000; Rodriguez-Gabriel et al., 2006). The 
aim of my project was to develop a system in which I could investigate the NMD 
mechanism more in detail. To achieve this I used a gfp reporter gene which was 
known to be subject to NMD in S. cerevisiae (Kuperwasser et al., 2004). In the initial 
constructs I introduced PTCs at three different triplets positions: 6, 27 and 140. The 
GFP constructs were cloned in the pREP41 vector, which allows GFP expression 
from the nmt41 promoter (Basi et al., 1993; Maundrell, 1993). The nmt41 promoter is 
less active than the original nmt1 promoter and chosen mainly to prevent saturation of 
the NMD machinery. There is no evidence that the NMD machinery can be saturated 
by a high level of mRNA substrates, however I reasoned that the level of the UPF 
proteins is low in S. cerevisiae (especially UPF2 and UPF3), and it would therefore be 
safer to keep the expression of the reporters at a low level (Maderazo et al., 2000; 
Ghaemmaghami et al., 2003).   
To assay NMD, I introduced these reporters into the cells either by transformation 
(for episomal expression) or by homologous recombination-mediated chromosomal 
integration. As described in the Results and in Material and Methods, I have produced 
several NMD reporters. All the constructs and the corresponding NMD phenotypes 
are listed in Table 7.1. 
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Constructs 
(pREP-) 
PTC position 
(nt) 
mRNA 
reduction (%) Extent of NMD 
GFP-418 730-732 37 Moderate 
GFP-102 730-732 -12 No 
GFP-ss 331-333 19 Weak 
GFP-3’ivs 730-732 76 Strong 
ivsPTC140-291 721-723 9 Weak 
ivsPTC140-147 577-579 57 Moderate 
PTC140 418-420 18 Weak 
PTC140-ss 331-333 18 Weak 
PTC140-102 418-420 -7 No 
PTC140-418 418-420 47 Moderate 
PTC140-402 418-420 33 Moderate 
ivsPTC140 418-420 80 Strong 
PTC140-3’ivs 418-420 15 Weak 
PTC27 79-81 57 Moderate 
PTC27-ss 79-81 69 Strong 
PTC27-102 79-81 73 Strong 
PTC27-418 79-81 76 Strong 
PTC27-402 79-81 73 Strong 
ivsPTC27 79-81 75 Strong 
PTC27-3’ivs 79-81 56 Moderate 
PTC6 16-18 84 Strong 
PTC6-ss 16-18 83 Strong 
PTC6-102 16-18 82 Strong 
PTC6-418 16-18 84 Strong 
PTC6-402 16-18 87 Strong 
PTC6-sh 16-18 89 Strong 
ivsPTC6 16-18 83 Strong 
PTC6-3’ivs 16-18 78 Strong 
PTC6-291 319-321 71 Strong 
PTC6-147 175-177 77 Strong 
Table 7.1 the extent of mRNA reductions in NMD constructs. 
Gray columns mean intron-containing NMD reporters; the PTC-less control 
constructs are not listed. 
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7.2 NMD is polar in S. pombe 
As mentioned above, in many systems it has been reported that NMD is polar: the 
PTC at the beginning of the gene induced stronger NMD than the PTC located further 
downstream. Previous studies have reported that nonsense mutations located at the 
beginning of the S. pombe ADE6 gene also induce stronger NMD than mutations 
further downstream (Mendell et al., 2000). In this study, I have also found that PTCs 
induce strong NMD only when they are located at the beginning of the coding region, 
while PTCs in the second half of the coding region do not induce strong NMD. 
Surprisingly, I found that this strong NMD does not require Pab1p, the unique 
cytoplasmic PABP in S. pombe, and the extent of NMD does always correlate with 
the distance between the PTC and either the poly(A) tail or 5’ end. These observations 
argue that the faux 3’ UTR model cannot explain the polarity of NMD in S. pombe.  
7.3 Splicing dependent NMD 
A key discovery of this study is that in the presence of a nearby intron, PTCs located 
in the second half of the coding region also cause strong NMD. It appears that 
splicing abolishes the PTC polar effect that was seen with intronless reporters. 
Additionally, inserting an intron in the 3’ UTR makes the normal stop codon behave 
like a PTC and causes a strong mRNA reduction, as previously reported for 
mammalian systems (Carter et al., 1996; Thermann et al., 1998). Similarly, I found 
that the removal of the introns from an endogenous gene also drastically reduces 
NMD, arguing that introns have a general role in S. pombe NMD. Collectively, these 
results suggest the existence of splicing dependent NMD in S. pombe. The 
observation that the half-life of the PTC-containing mRNA (PTC140-ivs) does not 
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differ significantly from the corresponding PTC-less control, suggests that splicing -
dependent NMD might only occur in the pioneer round of translation. These 
observations are in agreement with studies in mammalian cells, where it was found 
that only newly made transcripts are subject to NMD, while mRNAs that survive the 
initial stages are stable at the steady state (Urlaub et al., 1989; Baserga and Benz, 
1992; Cheng and Maquat, 1993). 
As referred in the introduction, many recent studies have questioned the role of 
splicing in NMD (Gatfield et al., 2003; Amrani et al., 2004; Buhler et al., 2006; 
Behm-Ansmant et al., 2007; Eberle et al., 2008; Singh et al., 2008). However my data 
clearly indicate that splicing is an important NMD determinant in fission yeast and 
strongly support the view that pre-mRNA splicing can affect the stability of the PTC-
containing mRNA (Cheng and Maquat, 1993; Carter et al., 1996; Zhang et al., 1998a; 
Le Hir et al., 2000a; Nott et al., 2004; Gudikote et al., 2005). On the basis of these 
findings, one would have expected intron-containing genes to be over-represented 
with in the set of endogenous NMD substrates identified in a microarray study of 
NMD mutant strains in S. pombe (Rodriguez-Gabriel et al., 2006). However, only 
22% these putative NMD substrates contain introns (6 out of 27 genes) (Rodriguez-
Gabriel et al., 2006). Given that 43% of the genes have introns in S. pombe, the 
findings suggest that intron-containing genes are not preferred NMD substrates.  
In addition, splicing of several genes is alternatively regulated during the cell cycle in 
S. pombe (Nakamura et al., 1997; Malapeira et al., 2005; Moldon et al., 2008). 
However, none of these genes is affected by NMD, in contrast to the view that 
unspliced transcripts are the most abundant NMD substrates in S. cerevisiae (He et 
al., 1993; He et al., 2003).   
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7.3.1 Splicing-dependent NMD does not require EJC components  
Initially, the discovery that splicing enhances NMD, suggested the involvement of the 
EJC as in mammalian cells. However, I found that contrary to the prediction of the 
EJC model, the intron enhanced NMD, regardless of whether it was positioned before 
or after a PTC in NMD reporters in S. pombe. It is difficult to explain how the 
ribosome could recognize the PTC without scanning through preceding exon 
junctions -the ribosome tunnel through which the mRNA moves is just large enough 
to accommodate naked single stranded RNA, suggesting that the mRNP is stripped 
off during ribosome scanning (Yusupova et al., 2001).  
Furthermore, in contrast with the EJC model, I found that NMD was not affected by 
the deletion of orthologs of EJC components MAGO and RNPS1, of which MAGO 
appears to be a core component (Chamieh et al., 2008). These results are also in 
disagreement with the report that in mammalian cells, MAGO/Y14 is required for 
standard NMD and RNPS1 for UPF2-dependent NMD (Gehring et al., 2005). Among 
the other core EJC components which are essential in mammalian NMD, MLN51 is 
not present in S. pombe; and Y14 lacks the amino terminus that is important but 
dispensable for the interaction with MAGO (Kataoka et al., 2001; Lau et al., 2003; 
Shi and Xu, 2003); and eIF4AIII, the putative core of the EJC, the gene could not be 
deleted in S. pombe, probably because like in S. cerevisiae the protein might have an 
essential function in rRNA biogenesis and maturation (Kressler et al., 1997). My 
results clearly indicate that MAGO and RNPS1 are not involved in either splicing-
dependent or splicing-independent NMD in S. pombe. I can’t exclude that eIF4AIII 
can assemble an EJC complex alone in S. pombe, but this is unlikely. For example, 
there is a protein very similar to eIF4AIII in S. cerevisiae yet no evidence of the 
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existence of an EJC (Chapter III, Fig. 3.4). Conclusively, if an EJC is present in S. 
pombe, most probably is not involved in NMD.  
Observations that an intron can also enhance NMD when positioned before the PTC, 
have been reported for the β-globin gene in mammalian cells: it was found that an 
upstream intron is required for NMD when downstream introns are absent (Matsuda 
et al., 2007). However, this mode of NMD appears to require some of the EJC 
proteins, although RNPS1 was also dispensable (Matsuda et al., 2007).    
The homologs of eIF4AIII, MAGO, RNPS1 and Y14 are present and well conserved 
in S. pombe. It would be interesting to further investigate whether they can assemble 
an EJC-like complex and whether they have a function in linking pre-mRNA splicing 
with downstream events such as mRNA export, transport and translation. Perhaps in 
S. pombe the EJC is involved in mRNA localization, as it has been observed of oskar 
mRNA in D. melanogaster (Le Hir et al., 2001a; Hachet and Ephrussi, 2004; Palacios 
et al., 2004). Some studies suggest that some proteins specially associate to spliced 
mRNAs in the nucleus and are involved in mRNA export in S. pombe (Carnahan et 
al., 2005; Thakurta et al., 2007).  
7.3.2 Local mRNP anisotropy can affect NMD: a new model 
An alternative explanation of why introns enhance NMD might be that spliced 
mRNAs are translated more efficiently and as a result PTCs are recognized more 
frequently, enhancing NMD. Several studies reporting that splicing can enhance 
translation support this view (Nott et al., 2003; Wiegand et al., 2003; Nott et al., 2004; 
Sanford et al., 2004; Ma et al., 2008; Michlewski et al., 2008). In particular, it has 
been reported that strengthening of splice signals enhances both translation and NMD, 
while mutations that weakened splicing have the opposite effects (Gudikote et al., 
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2005). It has been suggested that the EJC enhances the initiation of the pioneer round 
of translation directly, but the efficiency of the first round might positively affect 
subsequent rounds and steady-state translation (Ishigaki et al., 2001; Ma et al., 2008). 
Splicing might also enhance translation in S. cerevisiae and in other yeast species 
including S. pombe (Juneau et al., 2006; Man and Pilpel, 2007). However, I found that 
splicing strongly enhances NMD only if the intron is positioned close to the PTC; 
indeed this enhancement disappears if the PTC is more than 240 nt away from the 
intron (Chapter V, Fig. 5.9 and Table 5.1). These observations argue that it is the 
proximity of an intron to PTCs, which influences NMD, not just whether the mRNA 
has undergone splicing.  
In agreement with the above view, I found no correlation between changes in 
translation yields attributable to the position of the intron along the coding region and 
NMD. Thus, my data indicate that pre-mRNA splicing impinges on NMD directly, 
yet exclude that an EJC-like protein complex mediates the effect. While I propose that 
proteins remaining associated with the mRNA after splicing mediate the interaction, 
the effect is not caused by a specific factor deposited at a particular distance before 
the splice junction (Le Hir et al., 2000b; Le Hir et al., 2001b); instead, I postulate that 
there are splicing-associated proteins (SAP) that bind at either sides of the splice 
junction, and the recruitments of SAPs change the local mRNP configuration. Such 
splicing-specific changes in mRNP composition have been reported in recent studies: 
it has been found that in both in human cells and S. cerevisiae there are difference in 
mRNP composition around the exon junction between spliced and unspliced mRNA 
(Merz te al., 2007; Fabrizio et al., 2009). The region near the splicing joint, termed as 
the splicing affected region, where splicing could affect NMD. I postulate that 
translation termination in this region is not efficient during the pioneer round of 
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translation. If the termination codon were close to SAPs, the transient interaction 
would trigger strong NMD by accelerating the recruitment of UPF proteins. When 
termination occurs away before the splicing affected region, the mRNP will not 
influence termination.  
I propose that these proteins deposited at either side of the junction change the local 
mRNP arrangement compared to the same sequence in the intronless reporter. This 
model postulates that during translation of newly synthesized transcripts, the mRNP 
local arrangement affects either translation termination or the fate of the post 
termination ribosome, leading to NMD (Fig. 7.1). It is also feasible that there is a 
connection between the splice region and the mRNP components outside the 
translated sequence, which could affect termination or post-termination events. Some 
of the physical interactions of splicing with 5’ capping and 3’ end formation, which 
occur during pre-mRNA processing, may be maintained in the mature mRNP 
(Proudfoot et al., 2002). In particular, interactions between cap binding complex 
(CBC) and splicing have been reported in S. cerevisiae (Colot et al., 1996; Fortes et 
al., 1999); notably the yeast CBC can interact with the translation initiation factor 
eIF4G plus the CBP80 subunit of CBC has a structural similarity to eIF4G (Fortes et 
al., 2000; Marintchev and Wagner, 2005); furthermore, NMD substrates are 
preferentially associated with CBC rather than the translation initiation factor eIF4E 
in mammalian cells (Ishigaki et al., 2001). A key assumption of the model is that the 
anisotropy in mRNP composition and structure is only transient; the prediction is that 
splicing only enhances the NMD of newly synthesized transcripts before the 
disassociation of the “processing” factors, in agreement with some earlier data 
indicating that steady-state mRNA is immune to splicing-dependent NMD in 
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Figure 7.1 Anisotropy mRNP model of splicing dependent NMD 
mRNP anisotropy around the splice junction enhances NMD. Pre-mRNA splicing 
deposits proteins around the splice junction. These proteins remain associated with 
the mRNA and change the local structure of the mRNP in nucleus and mRNA export 
to cytoplasm. The proteins remain associated with the mRNA transiently, possibly 
until the first round of translation. The cap binding complex (CBC) might be 
associated with the splicing region and together with other proteins affects either 
translation termination of the fate of the post-termination ribosome (e.g. ribosome 
release). White ovals are non-specific RNA binding proteins; black circles are 
proteins deposited by splicing. R1, translation release factor 1; R3, translation release 
factor 3. 
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mammalian cells (reviewed in Maquat, 2004). Instead, provided that the PTC is in a 
region not subjected to splicing-independent NMD-the transcripts are stable 
afterward. 
Finally, there might be other mechanism that could explain the link between splicing 
and NMD. For example, the spliced mRNA that carries covalent modifications near 
the splicing junction which are absent in the mRNA generated by intronless reporters. 
In agreement with this speculation, it has been reported that adenosine methylation 
might be involved in pre-mRNA processing and mRNA translation (Carroll et al., 
1990; Tuck et al., 1999).  
7.4 How to explain the polarity effect in intronless genes? 
7.4.1 The faux 3’ UTR model does not explain NMD in S. pombe 
In agreement with observations in other organisms, I observed PTCs induced NMD 
also in intronless reporters. However, NMD was apparent only with PTCs located at 
the beginning of the GFP coding region. Instead, PTCs in the second half of the 
coding region did not induce apparent NMD. Initially, these observations seem in 
agreement with the faux 3’ UTR model (Chapter I, Section 1.2.4.2 and Fig. 1.1A). 
However, while this model predicts that the distance between PTC and poly(A) tail 
determine the extent of mRNA reduction, I found that extending the distance only 
slightly enhanced NMD (from the 18% mRNA reduction to 33%, PTC140). As seen 
in Table 7.2 (a lists the NMD phenotype in relation to 3’ UTR length), the cumulative 
result of my study is that there is no apparent correlation between NMD and the 
distance of the PTC from the 3’ end (Fig. 7.2). I also found no correlation with the 
distance from the 5’ end. Furthermore, I found that PABPC is not required for NMD 
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The gray columns indicate the variance of mRNA reductions in the PTC constructs 
with the similar distance between the PTC and the poly(A) tail. 
Constructs 
(pREP-) 
PTC position 
(nt) 
mRNA 
reduction (%) 
Distance from 3’ 
end to PTC (nt) 
GFPwt N 0 84 
GFP-402 N 0 84 
GFP-sh N 0 84 
GFP-102 730-732 -12 186 
PTC140 418-420 18 411 
PTC6-sh 16-18 89 411 
GFP-418 730-732 37 502 
PTC140-102 418-420 -7 513 
PTC27 79-81 57 750 
PTC140-ss 331-333 18 769 
GFP-ss 331-333 19 769 
PTC6 16-18 84 813 
PTC140-402 418-420 33 813 
PTC140-418 418-420 47 829 
PTC27-102 79-81 73 852 
PTC6-102 16-18 82 915 
PTC27-ss 79-81 69 1120 
PTC27-402 79-81 73 1152 
PTC27-418 79-81 76 1168 
PTC6-ss 16-18 83 1183 
PTC6-402 16-18 87 1215 
PTC6-418 16-18 84 1231 
Table 7.2 Relationship between NMD and the distance of PTC from the 3’ end. 
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Figure 7.2 No clear correlation exists between NMD and distance of the PTC 
from the 3’ end. 
Circles show the extent of NMD in reporters with different 3’UTR lengths (constructs 
listed in Table 7.2). The X axis indicates the distance between PTCs and 3’ end, the Y 
axis show mRNA reduction. The mRNA levels are normalized by the level of the 
mRNA in the PTC-less control (0% reduction). 
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of either spliced or unspliced mRNAs; this observation is in agreement with the recent 
report that neither the poly(A) tail nor PABPC are required for NMD in S. cerevisiae 
(Meaux et al., 2008). In conclusion, these results argue against the notion that it is 
primarily a long distance from either the 3’ end or the 5’ end which triggers splicing-
independent NMD; instead the data suggest that some sequence elements flanking the 
PTC might affect NMD; this view is in agreement with earlier studies in S. cerevisiae 
which concluded that downstream sequence elements (DSE) located after the PTC 
modulate NMD (Peltz et al., 1993; Zhang et al., 1995).  
7.4.2 Is NMD affected by a DSE sequences in S. pombe? 
One of the observations of this study is that PTC6 always triggers strong NMD 
regardless of the distance between PTC6 and the 5’ or 3’ end (Table 7.1). Instead 
PTC140 is always weakly affected in all intronless reporters, again regardless of the 
distance from the ends (Table 7.1). Given that neither the distance of the PTC from 
the 3’ end nor the distance from the 5’ end is the essential NMD determinant , how 
can the polarity effect be explained? 
Based on these experiments, I propose that there might be a sequence downstream of 
PTC6, which enhances NMD. The DSE should reside in the coding region between nt 
19 and 327 (Fig. 7.3), corresponding to PTC6-downstream sequence of the short-
PTC6 reporter (PTC6-sh) that showed very strong NMD. It is likely that the core DSE 
sequence is located between nt 19 and 81, because PTC6 triggered strong NMD but 
PTC27 only caused moderate NMD. Therefore, in the GFP coding region, there might 
be at least one DSE-like sequence enhancing NMD. This DSE is probably different  
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Figure 7.3 Multiple DSEs might be involved in NMD. 
The schematic maps of the NMD constructs and northern blot are shown in Figure 4.1 
Figure 4.5 and Figure 5.3. The presence of a DSE in Region 1 is suggested by the 
strong NMD in all reporters with PTC6 and by the weak NMD in PTC110 and 
PTC140. The presence of a DSE in Region 2 is suggested by the strong NMD of the 
long transcript with a further downstream poly(A) site (produced by the GFP-sh 
reporter). Probably there a sequence downstream of the normal poly(A) site that 
function as a DSE when included in the transcript. 
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from DSE consensus proposed in S. cerevisiae (Zhang et al., 1995; Ruiz-Echevarria et 
al., 1998a). In S. cerevisiae the DSE consensus is TGYYGATGYYYYY (Y stands 
for either T or C), but I could not find it in the GFP coding region. Perhaps the DSE 
might not be well-conserved sequence in different organisms and alternative sequence 
motifs can act as DSE in S. pombe. Perhaps in all cases the DSE enhances recruitment 
of UPF proteins. 
7.5 NMD cannot be explained by a single mechanism 
None of the available NMD models explains all published data. We have proposed 
that this is probably due to the fact that several mechanisms might act together to 
destabilize PTC-containing mRNAs (Brogna and Wen, 2009).  
My data suggests that there are at least two different NMD mechanisms in S. pombe; 
splicing-dependent NMD and splicing-independent NMD. Given that deletion of 
UPF1 and UPF2 suppresses NMD in both cases, the mechanisms are probably not 
entirely distinct. However, the genetic analysis alone may be misleading because 
NMD mutants might have a non-specific mRNA stabilization phenotype: In upf1Δ 
and upf2Δ strains PTC-less mRNAs are also stabilized. This is not an idiosyncrasy of 
my experimental system, similar observations have been previously reported in 
Drosophila both in cell culture and in flies (Gatfield et al., 2003; Metzstein and 
Krasnow, 2006); examples of over-stabilization of control PTC-less mRNAs upon 
knock-down of NMD factors were also reported in mammalian cells yet not explained 
(Fig. 1 and 4, Eberle et al., 2008). Furthermore, early studies in budding yeast also 
reported the cases of over-stabilization of wild-type mRNAs in UPF1 mutants (table 
1 in Peltz et al., 1994). Additionally, microarray expression studies have clearly 
indicated that mRNAs with no obvious NMD features are also stabilized in NMD 
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mutants (Rehwinkel et al., 2005). Furthermore, I cannot conclude that the two mRNA 
reduction mechanisms are similar just because lack of UPF1 or UPF2 suppresses 
them both. Generally, NMD is viewed as a single well-defined biochemical process, 
which, similar to other cellular mechanisms, should be conserved across all groups of 
eukaryotic organisms. Against this view, there are cases in which UPF2 and UPF3 are 
not required for NMD (Gehring et al., 2005; Chan et al., 2007). On the basis of these 
conflicting observations it is plausible that the nonsense-mediated mRNA reduction 
(NMMR), typically attributed to NMD, is actually the compound effect of diverse 
mechanisms that destabilize translated mRNPs and destroys the released and 
unprotected mRNAs which are not efficiently translated (Wen and Brogna, 2008; 
Brogna and Wen, 2009)  
Although various mechanisms may contribute to NMD, it is clear that there are 
features like the PTCs polar effect that are common to many experimental systems. 
We have recently proposed a model to explain the polar effect in general (Fig. 7.4) 
(Brogna and Wen, 2009). This model proposes that ribosome subunits are released 
efficiently after translation termination and the release is not affected by the position 
of PTCs. However, if releasing occurs at the beginning of the coding region, the long 
mRNA region downstream of the PTC will not be traversed by ribosome subunits, 
destabilizing the mRNP. Once the mRNP is destabilized, it will become accessible to 
nucleases, either exonucleases or endonucleases. As mentioned above, recent studies 
indicate that NMD might be initiated by endonucleases (Gatfield and Izaurralde, 
2004; Huntzinger et al., 2008; Eberle et al., 2009). This model does not imply that 
NMD is a passive mechanism that degrades mRNAs that are protected by ribosomes. 
Instead, it proposes an active role for UPF1: UPF1 triggers NMD by stimulating the  
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Figure 7.4 Ribosome release NMD model (Brogna and Wen, 2009). 
(A) Following termination at early PTCs, the 80S splits into 60S and 40S subunits. 
UPF1 promotes the detachment of post-terminated ribosome from mRNA. Release of 
the ribosome subunits leaves the long region downstream of the PTC unprotected, 
destabilizing the mRNP and translation circuit, causing rapid mRNA decay.  
(B) Termination at PTCs located near the normal 3′ UTR leaves only a short region 
that is not trafficked by translating ribosomes, which is not sufficient to destabilize 
the mRNP and translation circuit. Proximity to the normal 3′ UTR also promotes the 
recycling of 40S subunits, which remains associated with the mRNA and migrate to 
the 5′ end of the same mRNA. Both factors synergize to maintain normal mRNP 
stability. 
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release of ribosome subunits as the consequence of its interaction with eIF3. In UPF1 
deleted strains, the sequence downstream of the PTC is still traversed by the ribosome 
subunits that fail to detach from the mRNAs. Ribosome release might be affected by 
depletion of the translation initiation factor eIF3. Recent studies proposed that eIF3 is 
required to release the ribosome subunits after translation termination (Pisarev et al., 
2007). In agreement with our model, it has been reported that depletion of eIF3 
affects NMD in both S. cerevisiae and human cells (Welch and Jacobson, 1999; Isken 
et al., 2008); recent studies also reported that UPF1 interacts with eIF3, and that 
phosphorylation of UPF1 suppresses translation initiation (Isken et al., 2008). 
Probably, the interaction between phosphorylated UPF1 and eIF3 prevents the joining 
of 40S and 60S into translation competent 80S.  
7.6 Perspectives 
This work clearly demonstrated that pre-mRNA splicing is linked to NMD in S. 
pombe. However, I don’t yet know which are the trans-acting factors that mediate this 
linkage. The identification of these proteins would be extremely important to 
understand the mechanism that links splicing to NMD. It will also be important to 
further investigate the idea that NMD depend on cis-acting sequences like the DSE 
sequence proposed in the early studies in S. cerevisiae.  
I believe that to further broaden our knowledge of NMD, it is essential to elucidate 
the molecular functions of UPF1. I found out that deletion of UPF1 impairs cell 
growth in S. pombe (4.5 hours/generation of upf1Δ strains compared to ~3 
hours/generation of the wild-type strain in YES media, data not shown). Together 
with recent studies, this observation suggests that UPF1 might have an important 
function that is not related to NMD. In higher organism, UPF1 depletion delays the 
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cell cycle, (Dinman and Wickner, 1994; Azzalin and Lingner, 2006).  The 
identification of additional NMD factors and finding out the molecular functions of 
UPF1 are clearly key priority for the future. 
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APPENDIXES 
Appendix I. The recipe for E. coli and S. pombe growth media 
LB broth  
Dissolve 10 g Bacto-tryptone, 5 g yeast extract, and 10 g NaCl in 800 mL dH2O.  
Adjust pH to 7.5 with NaOH, bring the volume to 1L with dH2O, transfer to a bottle 
and sterilize it by autoclaving at 121 °C for 15 minutes. Add antibiotics to cold media 
at the required concentration just before using it. 
Agar-LB plates  
Dissolve 10 g Bacto-tryptone, 5 g yeast extract, 10 g NaCl and 10 g agar are dissolved 
in 800 mL of dH2O. Adjust pH to 7.5 with NaOH, bring the volume to 1 L with 
dH2O, transfer to a bottle and sterilize it by autoclaving at 121 °C for 15 minutes. 
Cool the media to about 60 °C, add the required antibiotic (for example, 1 mL of 100 
mg/mL ampincillin) and pour 25-30 ml/plate (9 cm Petri dishes). Plates can be stored 
at 4 °C. 
SOC 
Dissolve 20 g Bacto-tryptone, 5 g yeast extract, 0.6 g NaCl and 0.18 g KCl in 970 mL 
of dH2O and sterilize by autoclaving at 121 °C for 15 minutes (before autoclaving, the 
media can be aliquoted into 20 mL glass bottles for convenience). Before using it, add 
the following (for 20 mL aliquot): 200 µL of 1 M MgCl2, 200 µL of 1 M MgSO4 and 
240 µL of 30% glucose.  
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YES  
Dissolve 5 g yeast extract, 225 mg each of the amino acid and nucleotides 
supplements (adenine, histidine, leucine, uracil and lysine hydrochloride), in 900 mL 
of dH2O, transfer to a bottle and sterilize by autoclaving at 121 °C for 15 minutes. 
After autoclaving add 30 mL of sterile 30% glucose stock). The desired antibiotic is 
added to media just before use (for example the 100 µg/mL G418 for the screening of 
knockout strain by KanMX6 cassette). Agar YES media was made by adding extra 
2% agar, adding 3% glucose and desired antibiotics after autoclaving. 
EMM without leucine  
Dissolve 3 g potassium hydrogen phthalate, 2.2 g Na2HPO4, 5 g NH4Cl and 225 mg 
of each of the amino acid and nucleotide supplements  (adenine, histidine, uracil and 
lysine hydrochloride), in 875 mL of dH2O and then sterilized by autoclaving at 121 
°C for 15 minutes.  After autoclaving, to cold media add 2% glucose, 1× salt stock, 
vitamin stock and mineral stock (see recipes below) (EMM agar media is made by 
adding 2% agar. After autoclaving, add 2% glucose.) 
Stocks in media 
1. 10× Glucose stock 
300 g glucose dissolved in 1L dH2O, autoclaved and stored at RT. 
2. 50× Salt stock 
52.5 g MgCl2⋅6H2O, 0.735 g CaCl2⋅2H2O, 50 g KCl and 2 g Na2SO4 in 1 L dH2O. 
Autoclaved and stored at RT. 
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3. 1000× Vitamin stock 
0.1 g pantothenic acid, 1 g nicotinic acid, 1 g inositol and 1 mg biotin in 100 mL 
dH2O. Autoclaved and stored in dark environment. 
4. 10000× Mineral stock 
0.5 g boric acid, 0.4 g MnSO4, 0.4 g ZnSO4⋅7H2O, 0.2 g FeCl2⋅6H2O, 40 mg molybdic 
acid, 0.1 g KI, 40 mg CuSO4⋅5H2O and 1 g citric acid in 100 mL dH2O. Autoclaved 
and stored in dark environment. 
5. 1000× antibiotics stocks 
100 mg/mL ampicillin and 50 mg/mL kanamycin for LB and 200 mg/L G418 and 100 
mg/L hygromycin for YES. Filtration steriled and stored in -20 °C. 
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Appendix II. Primers, plasmids and yeast strains used in this study. 
Table 1. Primers  
 
Primer names Primer sequences Comments 
gfp-ks GGAGTCGACGGATCCAATGGCTAGCAAAGGAGAAGAAC 3'  
BamH I, cloning GFP ORF 
into pREP41 
gfp-rev AAGGAAGGATCCTTAGCAGCCAGATCCTTTGTATAG  
BamH I, cloning GFP ORF 
into pREP41 
SSP41? GGAATCCTGGCATATCATCA? Sequencing primer in nmt41 promoter?
RSP41? CGTAATATGCAGCTTGAATGG? Sequencing primer in nmt1 terminator ?
N6-sens  GGAGTCGACGGATCCAATGGCTAGCAAAGGATAAGAAC BamH I, PTC6 introduced 
Sens-N27 GATGTTAATGGGCACTAATTTTCTGTCAGTG PTC27 introduced 
Rev-N27 CACTGACAGAAAATTAGTGCCCATTAACATC PTC27 introduced 
Sens-N140 AACATTCTTGGGCACTAATTGGAATACAACT PTC140 introduced 
Rev-N140 AGTTGTATTCCAATTAGTGCCCAAGAATGTT PTC140 introduced 
N6-ch-sens CCAATGGCTAGCAAAGGAT Confirmation of PTC6 mutagenesis 
N27-ch-sens  TGGTGATGTTAATGGGCACT Confirmation of PTC27 mutagenesis 
N140-ch-sens  GGAAACATTCTTGGGCACT Confirmation of PTC140 mutagenesis 
Gavr-2-sens ? TCGACGGATCCAATGCCTAGGGCTAGCAAAGGAGAAGAAC? Avr II introduced at residue 2?
PTC6avr-2-
sens ?
TCGACGGATCCAATGCCTAGG
GCTAGCAAAGGATAAGAAC?
Avr II introduced at residue 2; 
PTC6 introduced?
InHAeG-sens  
 
CTTGAGCCTAGGTACCCATAC
GATGTTCCTGA 
Avr II, 147 bp, 291 bp and 
402 bp DNA cloned 
InHAeGL-rev   TTGGTTCCTAGGGGTCAGGGTGGTCACGAG Avr II, 291 bp DNA cloned 
InHAeGS-rev   TTTGTACCTAGGCTCGACCAGGATGGGCAC Avr II, 147 bp DNA cloned 
HAeG402-
rev ?
 
AACAATCCTAGGGAAGAAGAT
GGTGCGCTCC?
Avr II, 402 bp DNA cloned?
luc102 rev? ATATTCCCGGGCGCAACTGCAACTCC?
XmaI, 102 bp and 418 bp 
DNA insertion?
luc102 sens? AACGACCCGGGCTGAATACAAATCACA? XmaI, 102bp DNA insertion?
  201 
luc418 rev? ACTATCCCGGGCCACACCCTTAGGTAACC? XmaI, 418 bp DNA insertion?
Gavr2-243-
rev ?
GGAAGGATCCTTACCTAGGGC
AGCCAGATCCTTTGTATAG?
Avr II introduced 
immediately before stop 
codon?
Gluc402-sens? ACTGCCCTAGGAATCACAGAATCGTCGTATG?
Avr II, 402 bp DNA 
introduced in GFP ?
Gluc402-rev? CCACTCCTAGGCACACCCTTAGGTAACCCA?
Avr II, 402 bp DNA 
introduced in GFP ?
ade6-3Us  AAACCCGGGCGACCATAGACATAACTG  
Xma I, replacement of the 
nmt1 3’ UTR 
ade6-3Ur AAAGAGCTCGATGAACGCACTAATTTG 
Sac I, replacement of the 
nmt1 3’ UTR 
Sgfp-sens AGCGTTCAACTAGCAGACC Sequencing primer in GFP coding region 
Sgfp-rev TGTAGTTCCCGTCATCTTTG Sequencing primer in GFP coding region 
GFP-Sh rev?
 
TTCTGGATCCTTATGTCTTGTA
GTTCCCGTCATC?
Primer for short GFP with 
gfp ks?
INubc4 sens GTATGTAACTATTTAGTCTTGTGT 
Intron introduced into GFP 
coding region 
INubc4 rev CTACGAATATGCTGTTAGTTATC 
Intron introduced into GFP 
coding region 
5SP_SENS? GAACTACAAGACACATATCTAACTATTTAGTCTTGT?
Mutagenesis of the 5’ splice 
site of the intron?
5SP_REV? AGACTAAATAGTTAGATATGTGTCTTGTAGTTCCC?
Mutagenesis of the 5’ splice 
site of the intron?
5sp-ch-sens? CGGGAACTACAAGACACATATC?
Confirmation of the 
mutagenesis of 5’ splice site?
IN3UTR-sens AAAACCCGGGGTATGTAACTATTTAGTCTTGTGT 
Xma I, Intron introducing into 
3’ UTR 
IN3UTR-rev AAAACCCGGGCTACGAATATGCTGTTAGTTATC 
Xma I, Intron introducing into 
3’ UTR 
Gavr-120-
sens ?
GTCAAGTTTGAAGGTGATCCT
AGGACCCTTGTTAATAGA?
Avr II introduced at residue 
120?
Gavr-120-rev ? GATTCTATTAACAAGGGTCCTAGGATCACCTTCAAACTT?
Avr II introduced at residue 
120?
ypt3-sens ? CCACCGGATCCATGTGTCAAGAGGACGAATAC?
BamH I, ypt3 cloned into 
pREP41?
ypt3N6-sens ? CCACCGGATCCATGTGTCAAGAGGACTAATACGATTATTTG? BamH I, PTC6 introduced?
ypt3-rev ? GTCCGGGATCCTAACAACATTGGGAAGAAGAC?
BamH I, ypt3 reverse 
transcribed and cloned into 
pREP41?
ypt3N130-rev ?AGATACAGCTCTTTAATGTAGTAAATCCG? PTC130 introduced?
ypt3N130-
sens ?
GATTTACTACATTAAAGAGCTG
TATCTACT? PTC130 introduced?
KOS2s GCCCAGAATACCCTCCTTGA Confirmation of the KanMX6 
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cassette in S. pombe genome 
KOS2r GCTTGATGGTCGGAAGAGGC Confirmation of the KanMX6 cassette in S. pombe genome 
upf1ch-sens1 TAATCTATAGTACGACCAGCTGT Confirmation of upf1 deletion 
upf1ch-rev1 GATGCATTTACTAGACAAAGAGG Confirmation of upf1 deletion 
upf1ch-sens CCGCTAAGCACCACATAA Combination with kan inp1s to confirm the upf1Δ 
upf2ch-sens TCATACTGGAAAGGCTGCTA Combination with kan inp1s to confirm the upf2Δ 
kan-inp1s  CGTATGTGAATGCTGGTCG Specific for KanMX6 and HphMX6 cassette 
kan-inP1r TATTCTGGGCCTCCATGTC Specific for KanMX6 and HphMX6 cassette 
rpl32-sens GGCTGCTGTCAATATCAT Amplifying rpL32-2 gene  
rpl32-rev GTGACCTTTACACCGAGA Amplifying rpL32-2 gene 
28rRNA-
SENS? AGGCGTGGAGGTTTGTGAC? Amplifying the 28S rDNA?
28rRNA-
REV? TTAGATGACGAGGCATTTGG? Amplifying the 28S rDNA?
exo2-sens? CCTTCCTTCGCCTCAATG? Confirmation of XRN1 deletion ?
exo2-rev? ATGGTCCTGCTGCTCCTT? Confirmation of XRN1 deletion?
ura4ch-rev? CTGGGACAGCAATATCGTAC? Specific primer for URA4 cassette?
pabORF-sen ? ACTCGCCGTTCTTTGGGTT? Confirmation of pab1 deletion?
pabORF-rev ? GCAAGCATACGCTGGTTCA? Confirmation of pab1 deletion?
urach-rev1 ? ATGCTCCTACAACATTACCAC? Specific primer for URA4 cassette?
urach-sens1 ? TGGTAGGACAATACGGTAAGA? Specific primer for URA4 cassette?
RV_AD_dT TAGAATTCAGCATTCGCTTCTTTTTTTTTTTTTTTTTV 
Primer for reverse 
transcription; V, the mixture 
of C, G and A equally?
RV_ADAPT
OR TAGAATTCAGCTTCGCTTC 
Universal reverse primer to 
amplify the reverse 
transcription products 
5SP_SENS? GAACTACAAGACACATATCTAACTATTTAGTCTTGT?
Mutagenesis of the 5’ splice 
site of the intron?
5SP_REV? AGACTAAATAGTTAGATATGTGTCTTGTAGTTCCC?
Mutagenesis of the 5’ splice 
site of the intron?
5sp-ch-sens? CGGGAACTACAAGACACATATC?
Confirmation of the 
mutagenesis of 5’ splice site?
ADHterm F? CTCTTATTGACCACACCTCTACC?
Primer for screening the 
integration colonies?
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Leu1 Rev? GGTCATAAAGTTGAACGGATGTCG?
Primer for screening the 
integration colonies?
ADH_termF2? CGCTAGGGATAACAGGGTAA? Primer for screening the integration colonies?
Leu1_Rev2? TGGAAGTTTCAGCTAACCAAG? Primer for screening the integration colonies?
RNPS1-Sens?
TCCTCTCAAAAGTTTAGTAATA
AAATATAAAACATTCTCAATTA
TGCTTTTTGTAATACTcggatccccg
ggttaattaa?
Primer for RNPS1 deletion?
RNPS1-Rev?
TTCAAACTGGAAATTTGTTTTC
ACTTTTCTTTTTTATTCAGTAGG
CCACAATTTGCGGGAgaattcgagct
cgtttaaac?
Primer for RNPS1 deletion?
RNPS1ch-S? GTAATATGCGGCAAGGAGC? Primer for screening of RNPS1 deletion?
RNPS1-ch-
S2? CGGTATCCAGTTCGTCAAG?
Primer for screening of 
RNPS1 deletion?
eIF4A3-Sens?
TTTCTCTCCTTCATTTTCCTCAA
GTTGGGCTGACATAACATAACT
ACTACAACTTCCATTcggatccccgg
gttaattaa?
Primer for eIF4AIII deletion?
eIF4A3-Rev?
TTTCCCCCAAATCTGTACAATA
ATCCAAAAAAAACCAGCTTTTT
TTTTCCAATGGAAAATgaattcgag
ctcgtttaaac?
Primer for eIF4AIII deletion?
eIFch-sens? GTCTAATTCTAAGAAACCGCTAG?
Primer for screening of 
eIF4AIII deletion?
eIF4A-ch-S2? TCTATGCGTATGGCTATGAGAC? Primer for screening of eIF4AIII deletion?
KD209 
GT*GCCCATTAACAT*CACCAT
CTAATT*CAACAAGAAT*TGGG
ACAACT*CCAGT 
KD210 
GTACAT*AACCTTCGGGCAT*G
GCACTCTT*GAAAAAGTCAT*G
CCGTTTCAT*AT 
KD211 
 
GATTCCAT*TCTTTTGTT*TGTC
TGCCAT*GATGTATACAT*TGT
GTGAGTT*ATA 
KD212 
CCCAGCAGCT*GTTACAAACT*
CAAGAAGGACCAT*GTGGTCT*
CTCTTTTCGT*T 
FISH probes for GFP mRNA 
(Dower and Rosbash, 2002) 
In bold restriction enzyme recognition sites (introduced for cloning purpose). In bold 
italic are PTCs. In lower case are gene specific homologous sequences for gene 
knock-out. T* means amino-modified dT for Cy3 fluorochrome conjugation.
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Table 2. Plasmids  
Plasmids name? Resistance in E.coli 
Marker in 
yeast Comments 
pFA6a-KanMX6 amp KanMX6 KanMX6 cassette for knocking out a gene (Bahler et al., 1998) 
pREP41 amp LEU2 
Episomal expression vector in S. 
pombe by nmt41 promoter (Basi et al., 
1993; Maundrell, 1993) 
pREP-GFP amp LEU2 Derived from pREP41; GFP ORF cloned in Bam HI 
pPTC6 amp LEU2 Derived from pREP41; GFP ORF cloned in Bam HI, PTC6 introduced 
pPTC27 amp LEU2 Derived from pREP41; GFP ORF cloned in Bam HI, PTC27 introduced 
pPTC140 amp LEU2 Derived from pREP41; GFP ORF cloned in Bam HI, PTC140 introduced 
pGFPivs amp LEU2 Derived from pREP-GFP, intron DNA inserted in Pml I site  
pPTC6ivs amp LEU2 Derived from pGFP-PTC6, intron DNA inserted in Pml I site 
pPTC27ivs amp LEU2 Derived from pGFP-PTC27, intron DNA inserted in Pml I site 
pPTC140ivs amp LEU2 Derived from pGFP-PTC140, intron DNA inserted in Pml I site 
pGFP-ade6 amp LEU2 Derived from pREP-GFP, nmt1 3’ UTR replaced by ade6 3’ UTR 
pPTC6-ade6 amp LEU2 Derived from pGFP-PTC6, nmt1 3’ UTR replaced by ade6 3’ UTR 
pPTC27-ade6 amp LEU2 Derived from pGFP-PTC27, nmt1 3’ UTR replaced by ade6 3’ UTR 
pPTC140-ade6 amp LEU2 Derived from pGFP-PTC140, nmt1 3’ UTR replaced by ade6 3’ UTR 
pGFPivs-ade6 amp LEU2 Derived from pGFPivs, nmt1 3’ UTR replaced by ade6 3’ UTR 
pPTC6ivs-ade6 amp LEU2 Derived from pGFPivs-PTC6, nmt1 3’ UTR replaced by ade6 3’ UTR 
pPTC27ivs-ade6 amp LEU2 Derived from pGFPivs-PTC27, nmt1 3’ UTR replaced by ade6 3’ UTR 
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pPTC140ivs-ade6 amp LEU2 Derived from pGFPivs-PTC140, nmt1 3’ UTR replaced by ade6 3’ UTR 
pGFP 3'ivs amp LEU2 Derived from pREP-GFP, intron DNA inserted in Xma I site 
pPTC6 3'ivs amp LEU2 Derived from pGFP-PTC6, intron DNA inserted in Xma I site 
pPTC27 3'ivs amp LEU2 Derived from pGFP-PTC27, intron DNA inserted in Xma I site 
pPTC140 3'ivs amp LEU2 Derived from pGFP-PTC140, intron DNA inserted in Xma I site 
pGFP-102 amp LEU2 Derived from pREP-GFP, 102 bp DNA inserted in Xma I site 
pPTC6-102 amp LEU2 Derived from pGFP-PTC6, 102 bp DNA inserted in Xma I site 
pPTC27-102 amp LEU2 Derived from pGFP-PTC27, 102 bp DNA inserted in Xma I site 
pPTC140-102 amp LEU2 Derived from pGFP-PTC140, 102 bp DNA inserted in Xma I site 
pGFP-418 amp LEU2 Derived from pREP-GFP, 418 bp DNA inserted in Xma I site 
pPTC6-418 amp LEU2 Derived from pGFP-PTC6, 418 bp DNA inserted in Xma I site 
pPTC27-418 amp LEU2 Derived from pGFP-PTC27, 418 bp DNA inserted in Xma I site 
pPTC140-418 amp LEU2 Derived from pGFP-PTC140, 418 bp DNA inserted in Xma I site 
pGFP-avrII3 amp LEU2 Derived from pREP-GFP, Avr II site introduced at codon 3 
pPTC6-avrII3 amp LEU2 Derived from pGFP-PTC6, Avr II site introduced at codon 3 
pGFP-S amp LEU2 Derived from pGFP-avrII3, 147 bp DNA inserted in Avr II site 
pPTC6-S amp LEU2 Derived from pPTC6-avrII3, 147 bp DNA inserted in Avr II site 
pGFP-L amp LEU2 Derived from pGFP-avrII3, 291 bp DNA inserted in Avr II site 
pPTC6-L amp LEU2 Derived from pPTC6-avrII3, 291 bp DNA inserted in Avr II site 
pGFPivs-avrII120 amp LEU2 Derived from pGFPivs, Avr II site introduced at codon 120 
pPTC140ivs- amp LEU2 Derived from pPTC140ivs, Avr II site 
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avrII120  introduced at codon 120 
pGFPivs-147 amp LEU2 Derived from pGFPivs-avrII120, 147 bp DNA inserted in Avr II site 
pPTC140ivs-147 amp LEU2 Derived from pPTC140ivs-avrII120, 147 bp DNA inserted in Avr II site 
pGFPivs-291 amp LEU2 Derived from pGFPivs-avrII120, 291 bp DNA inserted in Avr II site 
pPTC140ivs-291 amp LEU2 Derived from pPTC140ivs-avrII120, 291 bp DNA inserted in Avr II site 
pGFP-avrII243 amp LEU2 Derived from pREP-GFP, Avr II site introduced at codon 243 
pPTC6-avrII243 amp LEU2 Derived from pGFP-PTC6, Avr II site introduced at codon 243 
pPTC27-avrII243 amp LEU2 Derived from pGFP-PTC27, Avr II site introduced at codon 243 
pPTC140-avrII243 amp LEU2 Derived from pGFP-PTC140, Avr II site introduced at codon 243 
pGFP-402 amp LEU2 Derived from pGFP-avrII243, 402 bp DNA inserted in Avr II site 
pPTC6-402 amp LEU2 Derived from pPTC6-avrII243, 402 bp DNA inserted in Avr II site 
pPTC27-402 amp LEU2 Derived from pPTC27-avrII243, 402 bp DNA inserted in Avr II site 
pPTC140-402 amp LEU2 Derived from pPTC140-avrII243, 402 bp DNA inserted in Avr II site 
pYPT3 amp LEU2 Derived from pREP41; endogenous YPT3 cloned in Bam HI 
pYPT3N6 amp LEU2 
Derived from pREP41; endogenous 
YPT3 cloned in Bam HI; Nonsense 
mutation introduced at codon 6 
pYPT3N143 amp LEU2 
Derived from pREP41; endogenous 
YPT3 cloned in Bam HI; Nonsense 
mutation introduced at codon 143 
pcYPT3 amp LEU2 Derived from pREP41; YPT3 cDNA cloned in Bam HI 
pcYPT3N6 amp LEU2 
Derived from pREP41; YPT3 cDNA 
cloned in Bam HI; Nonsense mutation 
introduced at codon 6 
pcYPT3N143 amp LEU2 
Derived from pREP41; YPT3 cDNA 
cloned in Bam HI; Nonsense mutation 
introduced at codon 143 
pDUAL-GFF41 amp LEU1, Integration plasmid, (Matsuyama et 
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URA3 al., 2004) 
pDUAL-nmt41 amp LEU1, URA3 
Derived from pDUAL-GFF41, Bam 
HI digestion to remove the DNA and 
self ligated 
pDUAL-GFP amp LEU1, URA3 
Derived from pDUAL-nmt41, GFP 
ORF cloned in Bam HI 
pDUAL-PTC6 amp LEU1, URA3 
Derived from pDUAL-nmt41, GFP 
with nonsense mutation (codon 6) 
cloned in Bam HI 
pDUAL-PTC27 amp LEU1, URA3 
Derived from pDUAL-nmt41, GFP 
with nonsense mutation (codon 27) 
cloned in Bam HI 
pDUAL-N140 amp LEU1, URA3 
Derived from pDUAL-nmt41, GFP 
with nonsense mutation (codon 140) 
cloned in Bam HI 
pDUAL-GFPivs amp LEU1, URA3 
Derived from pDUAL-nmt41, GFP 
ORF with an intron cloned in Bam HI 
pDUAL-PTC6ivs amp LEU1, URA3 
Derived from pDUAL-nmt41, GFP 
with a nonsense mutation (codon 6) 
and an intron cloned in Bam HI 
pDUAL-PTC27ivs amp LEU1, URA3 
Derived from pDUAL-nmt41, GFP 
with a nonsense mutation (codon 27) 
and an intron cloned in Bam HI 
pDUAL-
PTC140ivs amp 
LEU1, 
URA3 
Derived from pDUAL-nmt41, GFP 
with a nonsense mutation (codon 140) 
and an intron cloned in Bam HI 
pGFPivs-mut amp LEU2 Derived from pGFPivs, 5’ splice site mutated in GFP ORF 
pPTC6ivs-mut amp LEU2 Derived from pGFPivs-PTC6, 5’ splice site mutated in GFP ORF 
pPTC27ivs-mut amp LEU2 Derived from pGFPivs-PTC27, 5’ splice site mutated in GFP ORF 
pPTC140ivs-mut amp LEU2 Derived from pGFPivs-PTC140, 5’ splice site mutated in GFP ORF 
pGFP-sh amp LEU2 Derived from pREP41, short GFP ORF cloned in Bam HI 
pPTC6-sh amp LEU2 
Derived from pREP41, short GFP 
ORF with a nonsense mutation (codon 
6) cloned in Bam HI 
Underlined plasmids were shown their maps in Appendix III. 
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Table 3. S. pombe strains 
Stock Strain name Genotype Source 
SPJK029 upf2∆ h
- leu1-32 ura4-D18 
upf2::ura4+ 
(Mendell et al., 
2000) 
SPJK033 MR3571 h
- leu1-32 ura4-D18 ade6-M26 
upf1::kanMX6 
(Rodriguez-Gabriel 
et al., 2006) 
SPJK039 GP937 h
- his3D leu1-23 ura4-D18 
ade6-M216 
(Szankasi and Smith, 
1996) 
SPJK043 GP1255 h
+ leu1-32 ura4-D18 ade6-
M216 exo2::ura4 
(Szankasi and Smith, 
1996) 
SPJK045 sppab1∆ h
- leu1-32 ura4-D18 ade6-M216 
sppab1::ura4 
(Thakurta et al., 
2002) 
SPJK049 rnps1∆ h
- leu1-32 ura4-D18 ade6-M216 
rnps1::kanMX6 This study 
SPJK051 spbc3b9.08c∆ h
- leu1-32 ura4-D18 ade6-M210 
mago::kanMX6 
(Decottignies et al., 
2003) 
SPJK039-1 Int-GFP 
h- leu1-32:: [GFP leu1+] ura4-
D18 ade6-M216 (pGFP-wt 
integrated) 
This study 
SPJK039-2 Int-PTC6 
h- leu1-32:: [GFP-PTC6 leu1+] 
ura4-D18 ade6-M216 (pGFP-
PTC6  integrated ) 
This study 
SPJK039-3 Int-PTC27 
h- leu1-32:: [GFP-PTC27 
leu1+] ura4-D18 ade6-M216 
(pGFP-PTC27 integrated ) 
This study 
SPJK039-4 Int-PTC140 
h- leu1-32:: [GFP-PTC140 
leu1+] ura4-D18 ade6-M216 
(pGFP-PTC27 integrated ) 
This study 
SPJK039-5 Int-GFPivs 
h- leu1-32:: [GFPivs leu1+] 
ura4-D18 ade6-M216 (pGFPivs-
wt integrated ) 
This study 
SPJK039-6 Int-PTC6ivs 
h- leu1-32:: [GFPivs-PTC6 
leu1+] ura4-D18 ade6-M216 
(pGFPivs-PTC6 integrated ) 
This study 
SPJK039-7 Int-PTC27ivs 
h- leu1-32:: [GFPivs-PTC27 
leu1+] ura4-D18 ade6-M216 
(pGFPivs-PTC27 integrated ) 
This study 
SPJK039-8 Int-PTC140ivs 
h- leu1-32:: [GFPivs-PTC140 
leu1+] ura4-D18 ade6-M216 This study 
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(pGFPivs-PTC140 integrated ) 
SPJK029-1 upf2-GFP 
h- leu1-32::[GFP leu1+]  ura4-
D18 upf2::ura4+ (pGFP-wt 
integrated ) 
This study 
SPJK029-2 upf2-PTC6 
h- leu1-32::[GFP-PTC6 leu1+]  
ura4-D18 upf2::ura4+ (pGFP-
PTC6 integrated ) 
This study 
SPJK029-3 upf2-PTC27 
h- leu1-32::[GFP-PTC27 leu1+]  
ura4-D18 upf2::ura4+ (pGFP-
PTC27 integrated ) 
This study 
SPJK029-4 upf2-GFPivs 
h- leu1-32::[GFPivs leu1+]  
ura4-D18 upf2::ura4+ 
(pGFPivs-wt integrated ) 
This study 
SPJK029-5 upf2-PTC6ivs 
h- leu1-32::[GFPivs-PTC6  
leu1+]  ura4-D18 upf2::ura4+ 
(pGFPivs-PTC6 integrated ) 
This study 
SPJK029-6 upf2-PTC27ivs 
h- leu1-32::[GFPivs-PTC27  
leu1+]  ura4-D18 upf2::ura4+ 
(pGFPivs-PTC27  integrated ) 
This study 
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Appendix III. Plasmid maps. 
Below are maps of 11 plasmids (Map 1 to Map 11). Map 1 and Map 2 show the 
diagrams of the two starting vectors used to generate all the NMD reporters, pREP41 
and pDUAL-nmt41 respectively. pREP-GFP (Map 3) represents the initial intronless 
reporters and GFP reporters with short PTC-3’ end distance; pGFP-L (Map 4), GFP 
reporters with long AUG-PTC distance; pGFP-418 (Map 5), GFP reporters with long 
3’ UTR; pGFP-402 (Map 6), GFP reporters with long PTC-3’ end distance; pGFPivs 
(Map 7), intron-containing reporters and GFPivs reporters with 5’ splice-site mutation; 
pGFP3’ivs (Map 8), GFP reporters with 3’ UTR intron; pGFPivs-291 (Map 9), GFPivs 
reporters with long PTC-intron distance; pDUAL-GFP (Map 10), integrated GFP 
reporters (intronless and intron-containing); pcYPT3 (Map 11), the endogenous NMD 
reporters.  
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Map 1: pREP41. 
The expression is driven by the nmt41 promoter flanking the cloning sites. The nmt41 
artificial-promoter was attenuated from the endogenous nmt1 promoter by 
mutagenesis in TATA region; nmt41 is middle-strength promoter suppressed by 
thiamine (Basi et al., 1993; Maundrell, 1993).  
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Map 2: pDUAL-nmt41 
The expression is driven by nmt41 promoter flanking the cloning site. URA4 can be  
the complementary of uracil auxotroph in episomal expression. LEU1 5’ half and 3’ 
half were used to integrated DNA fragment in chromosome by homologues 
recombination. The enzyme sites in dashed rectangle are used to linearize the plasmid 
to facilitate integration (Matsuyama et al., 2004).  
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Map 3: pREP-GFP (parental plasmid for the intronless NMD reporters). 
The GFP coding region was PCR amplified with primers gfp-ks and gfp-rev and 
cloned into the Bam HI site of pREP41. PTC6 was introduced directly by the primers 
sens-N6; PTC27 and PTC140 were introduced by overlap PCR with the primers sens-
N27/rev-N27 and sens-N140/rev-N140, combined with gfp-ks and gfp-rev. The 
sequence of the primers is shown in Table 1, Appendix II.  
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Map 4: pGFP-L (AUG-PTC lengthening constructs) 
The 147 bp and 291 bp DNA fragments were PCR amplified from the EGFP coding 
region with primers InHAeG-sens, InHAeGS-rev and InHAeGL-rev, and cloned into 
a Avr II site. The Avr II site was introduced with primers Gavr-2-sens and PTC6avr-2-
sens, and located immediately downstream of AUG. The primer sequences were listed 
in Table 1, Appendix II. 
  215 
 
Map 5: pGFP-418 (3’ UTR lengthening constructs) 
A 418 bp of DNA fragments was PCR amplified from firefly luciferase coding region 
with primers luc102-sens, luc102-rev and luc418-rev, and cloned into the Xma I site 
of the intronless NMD reporters (pREP-GFP or derivatives, map 3). The Xma l is 
located 9 nt downstream of the GFP normal stop codon. The primer sequences are 
shown in Table 1, Appendix II. 
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Map 6: pGFP-402 (PTC-3’ end lengthening constructs) 
A 402 bp DNA fragment was amplified from EGFP coding region with primers 
InHAeG-sens and HAeG402-rev and cloned into an Avr II site introduced in 
intronless constructs. The Avr II site was introduced by PCR the GFP coding region 
with primers GAvr243-rev and gfp-ks immediately upstream of the normal stop 
codon. The primer sequences are listed in Table 1, Appendix II. 
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Map 7: pGFPivs (intron-containing NMD reporters) 
UBC4 intron was amplified with the primers INubc4 sens and INubc4 rev, and cloned 
into Pml I site then split GFP coding region at triplets position 110. GFP with intron 
were cloned into pREP41 and three nonsense mutations were introduced by overlap 
PCR as described in Materials and Methods, and Map 3. The primer sequences are 
listed in Table 1, Appendix II. 
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Map 8: pGFP 3’ivs (3’ UTR intron reporters) 
UBC4 intron was amplified with the primers IN3UTR-sens and IN3UTR-rev, and 
cloned into Xma I site of intronless NMD reporters. Then the intron is located 12 nt 
downstream of the GFP normal stop codon. The primer sequences are listed in Table 
1, Appendix II. 
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Map 9: pGFPivs-291 (PTC-intron lengthening constructs) 
The distance between the PTC and splicing was extended by inserting two different 
lengths of DNA fragments, 147 bp and 291 bp, which were amplified by PCR with 
the primers InHAeG-sens, InHAeGS-rev and InHAeGL-rev and cloned into Avr II 
site at triplets position 120 in the GFP coding region. The primer sequences are listed 
in Table 1, Appendix II. 
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Map 10: pDUAL-GFP  (integrated NMD reporters) 
GFP reporters with/without intron were cloned to BamH I site of pDUAL-nmt41 to 
make the integration of GFP reporters into S. pombe genome. 
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Map 11: pcYPT3 (endogenous NMD reporters) 
The endogenous YPT3 and its cDNA were amplified with primers ypt3-sens and 
ypt3-rev and cloned into the BamH I site of pREP41. Then the nonsense mutations 
were introduced by PCR with the primers ypt3N6-sens (PTC6), ypt3N130-sens and 
ypt3N130-rev (PTC130). The primer sequences are listed in Table 1, Appendix II. 
  222 
 
References 
Bahler, J., Wu, J.Q., Longtine, M.S., Shah, N.G., McKenzie, A., 3rd, Steever, A.B., 
Wach, A., Philippsen, P., and Pringle, J.R. (1998). Heterologous modules for efficient 
and versatile PCR-based gene targeting in Schizosaccharomyces pombe. Yeast 14, 
943-51. 
Basi, G., Schmid, E., and Maundrell, K. (1993). TATA box mutations in the 
Schizosaccharomyces pombe nmt1 promoter affect transcription efficiency but not the 
transcription start point or thiamine repressibility. Gene 123, 131-6. 
Decottignies, A., Sanchez-Perez, I., and Nurse, P. (2003). Schizosaccharomyces 
pombe essential genes: a pilot study. Genome Res 13, 399-406. 
Dower, K., and Rosbash, M. (2002). T7 RNA polymerase-directed transcripts are 
processed in yeast and link 3' end formation to mRNA nuclear export. RNA 8, 686-
97. 
Matsuyama, A., Shirai, A., Yashiroda, Y., Kamata, A., Horinouchi, S., and Yoshida, 
M. (2004). pDUAL, a multipurpose, multicopy vector capable of chromosomal 
integration in fission yeast. Yeast 21, 1289-305. 
Maundrell, K. (1993). Thiamine-repressible expression vectors pREP and pRIP for 
fission yeast. Gene 123, 127-30. 
Mendell, J.T., Medghalchi, S.M., Lake, R.G., Noensie, E.N., and Dietz, H.C. (2000). 
Novel Upf2p orthologues suggest a functional link between translation initiation and 
nonsense surveillance complexes. Mol Cell Biol 20, 8944-57. 
Szankasi, P., and Smith, G.R. (1996). Requirement of S. pombe exonuclease II, a 
homologue of S. cerevisiae Sep1, for normal mitotic growth and viability. Curr Genet 
30, 284-93. 
Thakurta, A.G., Ho Yoon, J., and Dhar, R. (2002). Schizosaccharomyces pombe 
spPABP, a homologue of Saccharomyces cerevisiae Pab1p, is a non-essential, 
shuttling protein that facilitates mRNA export. Yeast 19, 803-10. 
 
 
 
 
 
